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 Diet-induced obesity (DIO) is linked to several adverse neurobiological and 
behavioral changes, including altered trace element homeostasis, dysregulated 
dopamine biology, increased anxiety, and reduced physical activity.  These DIO-
associated harmful effects on the brain can be influenced by sex and strain.  The studies 
presented in this dissertation address both main effects and interactions between diet, 
sex, and strain on the obesity-induced dysregulation of iron, manganese, copper, and 
zinc status in the brain, dopamine release and clearance, behavior related to physical 
activity, anxiety, motivation, and memory, and mRNA expression of genes related to 
trace element homeostasis, behavior, and neurodegenerative disease.  Male and female 
C57BL/6J (B6J) and DBA/2J (D2J) mice were fed either a low fat diet (LFD) with 10% kcal 
from fat or a high fat diet (HFD) with 60% kcal from fat for 16 weeks.  Our studies 
revealed a heterogeneous effect of DIO on many of the neurobiological variables that 
we evaluated.  For example, in the striatum, iron was significantly elevated in B6J female 
mice but not male mice due to DIO.  Similarly, in the hippocampus, zinc was increased in 
D2J males but deceased in D2J females.  There was also a dramatic induction of divalent 
metal transporter 1, alpha synuclein, and amyloid precursor protein in this brain region 
due to DIO, but only in the B6J males.  Behavior assessments demonstrated that B6J 
male mice fed a HFD were impacted the most through their display of significantly 
reduced locomotion, reduced rate of habituation, lack of motivation, and elevated 
anxiety levels.  Interestingly, these mice also showed a significant upregulation of 
dopamine receptor D2.  Dopamine clearance in the dorsal striatum was significantly 
reduced in both male and female D2J mice due to DIO, while in the nucleus accumbens 
core, reductions in dopamine clearance occurred for male mice of both strains fed HFD.  
Collectively, these data provide evidence for important sex and strain differences on the 
impact of DIO-associated behavior alterations and neurobiology dysregulation.  As the 
incidence of obesity continues to rise worldwide, these findings have key health 
implications related to debilitating behavior disorders and the development of 
neurodegenerative disease that can be triggered by an energy dense diet and a state of 
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 Obesity and overweight prevalence is escalating worldwide, with an estimated 
39% of adults classified as obese or overweight (Chooi et al., 2019).  The adverse effects 
of diet-induced obesity (DIO) have been linked to neurobiological disruptions, including 
altered trace element homeostasis (Han et al., 2019; Liu et al., 2016), dysregulated 
dopamine biology (Leite and Ribeiro, 2019), and gene expression alterations (Gan et al., 
2015; Huang et al., 2005; Wu et al., 2017).  Furthermore, DIO is associated with negative 
behavioral changes such as reduced physical activity (Sanyaolu et al., 2019), increased 
anxiety (Baker et al., 2017), and compromised memory (Davidson et al., 2014).  
Biochemical consequences of obesity include inflammation, oxidative stress, and 
mitochondrial dysfunction, all of which are common pathologies of neurodegenerative 
disease (Mazon et al., 2017).  Increasing evidence implicates obesity as a risk factor for 
two of the most common forms of neurodegenerative disease: Alzheimer’s disease and 
Parkinson’s disease (Martin-Jiménez et al., 2017; Mazon et al., 2017).  As conditions of 
overweight and obesity are increasing in both males and females worldwide, these 
alterations in neurobiology and behavior due to obesity can have serious consequences 
related to declining health, reduced productivity, and increased health care costs 
(Trogdon et al., 2008).   
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Sex and genetics are important biological factors to consider in the study of DIO.  
The inclusion of both males and females in research studies is a key initiative proposed 
by the National Institutes of Health (Clayton, 2018).  Supporting evidence for sex 
differences in response to a high fat diet and a state of DIO can be found in several 
recent human and rodent obesity reports (Bridgewater et al., 2017; Charradi et al., 
2017; Malpetti et al., 2018).  Furthermore, genetic background is an important biological 
variable, as several recent studies indicate that strain or genetic variation can influence 
the effect of DIO on disease risk (Palacios et al., 2011), gene expression (Norris et al., 
2016), and behavior (DeJesus et al., 2016).  These human and animal studies highlight 
the significant influence of sex and genetics on biological alterations and eventual health 
outcomes that can be triggered by DIO. 
Preclinical studies of DIO in rodents have provided a valuable model to elucidate 
the biological impact and health consequences of obesity (Barrett et al., 2016).  
Currently, there are very few rodent studies that address the influence of both sex and 
strain on DIO-associated alterations of neurobiology and behavior.  To address this gap 
in the literature, our study design used male and female C57BL/6J (B6J) and DBA/2J 
(D2J) mice fed either a low fat diet with 10% kcal from fat or a high fat diet with 60% 
kcal from fat for 16 weeks to study the impact of DIO on the brain.  These strains were 
selected based on their frequent use in behavioral neuroscience and prior studies 
exhibiting differential traits (Mozhui et al., 2010).  B6J and D2J mice represent key 
strains in the Mouse Phenome Project Database (Bogue et al., 2018; Grubb et al., 2014) 
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and are used as parental strains in the BXD recombinant inbred strain set for the 
GeneNetwork open source project (Philip et al., 2010).  Furthermore, these strains have 
been validated as appropriate models for DIO (Alexander et al., 2006; Montgomery et 
al., 2013; West et al., 1992). 
Our lab seeks to understand the influence of sex and strain on neurobiological 
and behavioral changes induced by DIO.  Our major study objectives included the 
following: 
1. Identify interaction effects between diet, sex, and strain on trace element 
dysregulation and gene expression due to DIO in specific brain regions.  We 
hypothesized that the influence of sex on DIO would impact the B6J strain more 
than the D2J strain based on a pilot study from our lab, and trace element 
dysregulation would be region-specific based on our previous published studies 
(Han et al., 2019; Liu et al., 2016).  We also hypothesized that DIO would cause 
increases in iron, zinc, and alpha synuclein gene expression in the olfactory bulb, 
as these physiological changes have been implicated in the pathogenesis of 
Parkinson’s disease (Adler and Beach, 2016; Gardner et al., 2017).  To test these 
hypotheses, we evaluated four trace elements (iron, manganese, copper, and 
zinc) and six genes for mRNA expression (divalent metal transporter 1, iron 
regulatory protein 1, ceruloplasmin, copper transporter 1, alpha synuclein, and 
amyloid precursor protein) in the following brain regions: hippocampus, 
midbrain, striatum, and olfactory bulb.  These brain regions were selected based 
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on their importance to trace element neurobiology.  The specific genes 
evaluated in our study were selected based on their role in trace element 
regulation in the brain and their potential connection to neurodegeneration. 
2. Investigate the impact of DIO on behavior change, gene expression, and 
dopamine release and reuptake using male and female B6J and D2J mice as a 
model to examine sex and strain influences.  We hypothesized that DIO would 
have a greater impact on males compared to females, and that D2J mice would 
be more resistant to behavior and neurobiological changes compared to the B6J 
strain based on previous studies (Bridgewater et al., 2017; Gelineau et al., 2017; 
Kulesskaya et al., 2014; Yin et al., 2011).  In this study, mRNA gene expression for 
brain-derived neurotrophic factor, dopamine receptor D2, and tyrosine 
hydroxylase was evaluated in the striatum, hippocampus, and olfactory bulb. 
Dopamine release and reuptake were assessed in the dorsal and ventral 
striatum.  Behavior assessments included the open field test (for locomotion, 
velocity, habituation, and anxiety), nestlet shredding (for motivation, 










The World Health Organization defines obesity as abnormal or excessive fat 
accumulation that may impair health.  Approximately 13% of the global adult population 
was obese in 2016, and worldwide prevalence of obesity has nearly tripled since 1975 
(“WHO | Obesity”).  In the United States, obesity prevalence since 2016 was 39.8%, 
affecting 93 million adults (Hales et al., 2017).  Biochemical consequences of obesity 
include inflammation, oxidative stress, and mitochondrial dysfunction, all of which are 
common pathologies of neurodegenerative disease (ND) (Mazon et al., 2017).  
Increasing evidence implicates obesity as a risk factor for two of the most common 
forms of ND: Alzheimer’s disease (AD) and Parkinson’s disease (PD) (Martin-Jiménez et 
al., 2017; Mazon et al., 2017).  The risk of developing a ND depends on a combination of 
genetic background and the environment (Brown et al., 2005).  The mechanisms by 
which environmental factors, such as diet-induced obesity (DIO), can lead to ND are not 
fully understood.  Trace element dysregulation and gene expression alterations have 
been associated with various NDs (Hwang et al., 2017; Mezzaroba et al., 2019) and with 
DIO (Han et al., 2019; Huang et al., 2005a; Lee et al., 2010), making it possible that these 
disease states share common mechanisms.  Furthermore, obesity has been linked to 
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various behavioral disorders (Baker et al., 2017; Davidson et al., 2014) and dysregulated 
dopamine metabolism (Leite and Ribeiro, 2019).  As conditions of overweight and 
obesity are increasing in both males and females worldwide, these alterations in 
behavior and biochemistry due to obesity can have serious consequences related to 
declining health, reduced productivity, and increased health care costs (Trogdon et al., 
2008). 
Trace Element Dysregulation in the Brain 
Trace elements iron (Fe), manganese (Mn), copper (Cu), and zinc (Zn) are 
essential for numerous physiological processes in humans and animals, such as energy 
production, synaptic transmission, and regulation of oxidative stress (Genoud et al., 
2017; Peres et al., 2016).  These metals participate in a variety of functions, serving as 
redox agents, enzyme cofactors, and stabilizers in protein structure (Genoud et al., 
2017; Mezzaroba et al., 2019).  The dysregulation of one or more of these trace 
elements can disrupt brain homeostasis and normal cellular processes, leading to 
neurodegeneration and disease (Mezzaroba et al., 2019).  For example, Fe, Cu, and Zn 
disruptions in the hippocampus have been associated with AD (Cristóvão et al., 2016; 
Mezzaroba et al., 2019; Sensi et al., 2018).  Fe accumulation and Cu depletion in the 
midbrain have been linked to PD (Belaidi and Bush, 2016; Liddell and White, 2018).  Mn 
deficiency and Fe overload in the brain have been implicated in the development of 
Huntington’s disease (HD) (Bryan and Bowman, 2017; P. Chen et al., 2019; Farina et al., 
2013).  In a study using post-mortem male and female human brain tissue, Fe 
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concentration was 25% higher in PD olfactory bulbs compared to controls (Gardner et 
al., 2017).  Furthermore, in a study using brain tissue from AD patients, Fe and Zn were 
significantly elevated in the olfactory bulb (Samudralwar et al., 1995).  Trace elements 
Fe, Cu, and Mn share some common transporters and enzymes, such as divalent metal 
transporter 1 and ceruloplasmin, allowing their uptake mechanisms to interact 
(Skjørringe et al., 2012; Ye et al., 2017).  Therefore, a disruption in homeostasis of one 
element can impact the other elements, leading to potentially detrimental effects on 
the brain (Herrera et al., 2014; Skjørringe et al., 2012; Ye et al., 2017).   
DIO Impact on Iron and Gene Expression in the Brain 
Recently it has been discovered that DIO can lead to Fe dysregulation and gene 
expression disruption in Fe-rich brain regions (Han et al., 2019; Liu et al., 2016).  In one 
study using male C57BL/6J (B6J) mice fed a high fat diet (HFD) for 20 weeks, DIO 
resulted in significant Fe reductions in the thalamus, increased Fe in the midbrain, and 
no effect on the hippocampus or striatum (Han et al., 2019).  The expression of alpha 
synuclein increased by threefold in the midbrain, and heavy chain ferritin was reduced 
in the hippocampus to almost half the amount of the control.  In another study using 
male B6J mice fed a HFD for 20 weeks, mice with DIO had significantly reduced Fe in the 
striatum, but no change in Fe in the hippocampus, midbrain, or thalamus (Liu et al., 
2016).  Total distance travelled, a measure of locomotion in rodents, was significantly 
reduced for DIO mice.  Additionally, there was a positive correlation between midbrain 
Fe and sleeping time for mice fed a HFD.  A survey of the current scientific literature 
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indicates that there is limited research regarding the effects of DIO on trace element 
status in the brain.  The studies described here provide preliminary evidence for region-
specific Fe dysregulation and gene expression alterations in the brains of male rodents 
fed a HFD, implicating DIO as a potential risk for neurodegeneration and behavior 
impediments. 
Sex as a Biological Factor 
The inclusion of sex as a biological factor in research studies is a key initiative 
proposed by the National Institutes of Health (Clayton, 2018).  Supporting evidence for 
sex differences in response to a HFD can be found in several recent obesity studies.  For 
example, in a study using male and female rats, males fed a HFD were found to be more 
prone to brain oxidative stress and trace element disruptions than females (Charradi et 
al., 2017).  Specifically, there was a reduction in whole brain Mn and an increase in 
plasma Mn for male rats only.  In a DIO study using male and female C57BL/6 (B6) mice, 
males fed a HFD displayed more anxiogenic behavior and had reduced locomotion 
compared to females (Bridgewater et al., 2017).  Another study that examined 
neurodegeneration and brain connectivity in a group of patients with probable AD 
found that the effect of obesity on brain metabolism was more significant in females 
versus males (Malpetti et al., 2018).  Based on research indicating sex differences in 
response to DIO, and in compliance with the NIH initiative, both males and females 




Genetics as a Biological Factor 
Genetic background is another important factor to consider in the study of DIO.  
Despite several studies that support a link between obesity and PD risk, some human 
qualitative studies reveal conflicting results.  For example, obesity was associated with 
PD in both men and women in a Finnish cohort (Hu et al., 2006) and a South Korean 
cohort (Nam et al., 2018), yet no association was found in several large U.S. cohorts 
(Chen et al., 2004; Palacios et al., 2011).  These discrepancies could be attributed to 
genetics when studying diverse populations.  A DIO study using female B6J and DBA/2J 
(D2J) mice revealed distinct trends in gene expression in mice fed a HFD, with B6J mice 
upregulating glutathione peroxidase I and D2J mice downregulating glutathione 
reductase (Norris et al., 2016).  Another study using different strains of male mice, 
including B6J and DBA/2 (D2) strains, found that while all mice became obese when fed 
a HFD, biomarkers for glucose homeostasis differed by strain (Montgomery et al., 2013).  
These human and animal studies highlight the unique responses to DIO based on 
genetics and imply a gene-environment interaction effect that should be further 
explored.   
Combined Sex and Genetic Factors 
The combined influence of sex and genetics on trace element dysregulation and 
gene expression has been described in aging and DIO research.  For example, an aging 
study using male and female B6 and D2J mice found that aged D2J mice had greater 
whole-brain Fe levels compared to B6 mice, and sex differences were significant for D2J 
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mice only (Hahn et al., 2009).  In a systems genetics report, recombinant inbred BXD 
strains derived from B6J and D2J progenitors were fed low Fe diets and evaluated for Fe 
and gene expression changes in the midbrain and striatum (Jellen et al., 2012).  Fe was 
reduced in both brain regions but varied from 0-40% reduction depending on the strain.  
There was a diet by strain interaction in the midbrain, and a three-way interaction 
between diet, strain, and sex in the striatum.  Differences in gene expression between 
males and females can impact susceptibility to disease in a sex-dependent manner 
(Torres-Rojas and Jones, 2018).  For example, the Sry transcript, which regulates the 
enzyme tyrosine hydroxylase, is present in males but not females (Torres-Rojas and 
Jones, 2018).  Environmental exposure to toxins that can downregulate the Sry gene will 
affect males only and could explain the increased risk for PD in males versus females.  
Collectively, these studies provide evidence that DIO or HFD could be considered a 
potential environmental stimulus for neurophysiological dysregulation, and may exert 
its effects in a sex and genetic-dependent manner.  For this reason, the use of male and 
female subjects from different genetic backgrounds or strains should be considered for 
DIO investigations in the brain. 
Behavior and DIO 
Obesity has been linked to various behavioral and biochemical changes, such as 
reduced physical activity (Sanyaolu et al., 2019), increased anxiety (Baker et al., 2017), 
and compromised memory (Davidson et al., 2014).  Furthermore, DIO can lead to gene 
expression alterations in the brain (Gan et al., 2015; Huang et al., 2005a; Wu et al., 
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2017) and dysregulated dopamine metabolism (Leite and Ribeiro, 2019).  A brief review 
of the current literature describing the relationship between obesity and each of these 
categories is provided below. 
DIO and Physical Activity 
Physical activity or mobility can be impacted by a state of obesity in humans and 
rodents.  In humans, obesity has been associated with decreased fine motor control and 
speed (C. Wang et al., 2016), reduced functional mobility in adults (Forhan and Gill, 
2013; Trivedi et al., 2015), and decreased physical activity in children and adolescents 
(Sanyaolu et al., 2019).  In rodents, there are mixed results.  In some studies, B6J and B6 
mice fed a HFD show reduced locomotion due to HFD (Almeida-Suhett et al., 2017; 
Krishna et al., 2016; Tsai et al., 2018; Wu et al., 2018), while other studies show no 
impact of diet on physical activity (Bridgewater et al., 2017; Zilkha et al., 2017).  
Furthermore, there are known sex effects that impact mobility in humans and rodents 
(Rosenfeld, 2017).  In children and adolescents, boys generally show higher physical 
activity levels compared to girls (Rosenfeld, 2017).  On the contrary, female rodents 
tend to have higher activity levels compared to males.  Sex differences in physical 
activity or locomotion in the context of obesity have also been reported.  In a cross-
sectional study in 964 community dwelling older adults, obese women were found to be 
less active than obese men (Gretebeck et al., 2017).  In B6J and B6 mice, male mice fed a 
HFD are frequently reported as having reduced locomotion in an open field (Almeida-
Suhett et al., 2017; Gelineau et al., 2017; Tsai et al., 2018; Wu et al., 2018), while female 
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mice show mixed results, with some having decreased locomotion (Krishna et al., 2016), 
some increased locomotion (Krishna et al., 2015), and others with no effect 
(Bridgewater et al., 2017; Gelineau et al., 2017).  These discrepancies may be due to the 
duration of diet treatment, age of behavioral testing, and diet composition.   
The striatum is a primary regulator of spontaneous physical activity (Rosenfeld, 
2017).  Although the precise mechanisms of how DIO can impact mobility are not clear, 
it is possible that DIO may disrupt the expression of genes such as dopamine receptor 
D2 and tyrosine hydroxylase, which are associated with dopamine and physical activity 
(Gallo, 2019; Jang et al., 2017).  Furthermore, it is possible that DIO may disrupt 
dopamine signaling in the striatum.  A discussion of dopamine and dopamine-related 
genes is discussed in more detail later in this chapter. 
DIO and Anxiety 
Obesity has been associated with a higher prevalence of anxiety, as 
demonstrated in several human studies (Baker et al., 2017; Gariepy et al., 2010; Strine 
et al., 2008) and rodent studies (Almeida-Suhett et al., 2017; Krishna et al., 2016).  For 
example, a cross-sectional study of 217,379 adults in the United States found a positive 
association between obesity and anxiety (Strine et al., 2008).  Similarly, a study in the 
United States with 9125 adults found that obesity lead to an approximate 25% increase 
in odds of having an anxiety disorder (Simon et al., 2006).  In other populations, a meta-
analysis in China that included 17,894 children and adolescents found a significantly 
higher incidence of anxiety in obese and overweight subjects (40%) compared to normal 
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weight subjects (14%) (Wang et al., 2019).  Furthermore, anxiety was also found to be 
associated with obesity during pregnancy and the postpartum stage, increasing health 
risks for mothers who have gained excessive weight beyond normal pregnancy weight 
(Nagl et al., 2015).  In rodent DIO studies, B6J male mice (Almeida-Suhett et al., 2017) 
and B6 female mice (Krishna et al., 2016) fed a HFD displayed higher anxiety-like 
behavior in an open field as assessed by decreased center time.  Additionally, male 
Fischer 344 rats (Buchenauer et al., 2009) and female Long Evans rats (Sivanathan et al., 
2015) fed a HFD also exhibited more anxiety-like behavior compared to normal weight 
rats fed a control diet.  In contrast, there are other reports in humans and rodents that 
found no link between obesity and anxiety (Araujo et al., 2017; Gelineau et al., 2017; 
Tsai et al., 2018).  The relationship between obesity and anxiety is complex, often due to 
comorbidities and a potential bidirectional association (Baker et al., 2017).  More 
research is needed to understand the physiological mechanisms that may connect 
obesity to anxiety.  
While there is extensive research on sex differences regarding associations 
between obesity and depression, less is known about sex factors involved in 
relationships between obesity and anxiety (Tronieri et al., 2017).  Some studies show a 
more significant relationship between overweight or obesity and anxiety in females 
compared to males (Anderson et al., 2006; Barry et al., 2008; DeJesus et al., 2016; 
Hofmann et al., 2015; Svenningsson et al., 2012).  However, there are other reports that 
suggest a higher incidence of anxiety in obese males compared to obese females 
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(Bjerkeset et al., 2007; Bridgewater et al., 2017; Tronieri et al., 2017).   More work is 
needed to understand the physiological mechanisms involved and the influence of sex 
on this relationship between obesity and anxiety. 
The relationship between obesity and anxiety may also depend on genetics.  A 
cross-sectional study in the Midwest found a positive association between BMI and 
anxiety in Caucasians and African Americans, but not in Asians or Hispanics (DeJesus et 
al., 2016).  An epidemiological study in the United States found that the correlation 
between obesity and a specific form of anxiety depended on ethnicity (Rosen-Reynoso 
et al., 2011).  For example, obesity was associated with African Americans with general 
anxiety disorder, non-Latino whites with panic disorder, Latinos with agoraphobia 
without panic disorder, and Asians with post-traumatic stress disorder.  In contrast, one 
study found no significant difference across ethnic groups when comparing the 
association of obesity and anxiety in Caucasians, African Americans, and Latinos 
(Bodenlos et al., 2011).  Compared to literature that describes the influence of sex on 
the relationship between obesity and anxiety, there is less information available 
regarding the impact of ethnicity or genetics on this relationship.  More human studies 
on this topic should stratify by ethnicity, and more rodent studies should include strain 
comparisons to address this gap in the literature. 
DIO and Memory 
Obesity may also have a negative impact on memory.  In a study of 513 
Malaysian adolescents, high body mass index (BMI) was associated with poor working 
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memory (Tee et al., 2018).  A study in 60 adults <41 years old found that BMI was 
negatively associated with working memory, but not with learning and memory (Coppin 
et al., 2014).  In a secondary analysis of older adults (average age of 74) comprising 701 
normal weight, 1,082 overweight, and 902 obese individuals, the obese group had a 
statistically significant lower memory training score compared to the normal weight 
group (Clark et al., 2016).  An extensive review of the impact of HFD on learning and 
memory in rodent studies using various test measures found that most studies, but not 
all, found an association between HFD or DIO and memory decline (Cordner and 
Tamashiro, 2015).  Taken together, most of these studies show a pattern of obesity with 
reduced memory, but few distinguish between males and females or differences in 
genetics that may cause discrepancies in the results. 
DIO and Dopamine 
Dopamine plays an important role in regulating motor control, cognition, and 
motivation (Mishra et al., 2018).  Previous DIO studies in mice have found an inverse 
relationship between dopamine signaling with body weight (Zilkha et al., 2017) and DIO-
induced anxiety with dopamine turnover in the brain (Krishna et al., 2015).  In both the 
dorsal and ventral striatum, the regulation of dopamine neurotransmission is implicated 
as a modulator of DIO and food reward (Baik, 2013).  For example, in a study with male 
B6J mice fed a high fat/high sugar Western style diet for 16 weeks, dopamine release in 
the dorsal striatum was increased and dopamine clearance in the dorsal striatum was 
decreased in mice fed the Western style diet (Fritz et al., 2018).  In the nucleus 
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accumbens (NAc) core of the ventral striatum, dopamine release assessed by fast scan 
cyclic voltammetry was increased in male Sprague-Dawley rats when exposed to a 
sucrose-based food reward (Roitman, 2004).  In a study with male B6J mice fed a HFD 
for six weeks, voltammetry measurements revealed a significant decrease in dopamine 
reuptake in the NAc core (Fordahl and Jones, 2017).  The NAc core of the ventral 
striatum is involved in the mediation of reward, satisfaction, and motivation, and has 
been implicated in numerous behavioral disorders, such as anxiety, obsessive-
compulsive disorder, and addiction (Salgado and Kaplitt, 2015).  The dorsal striatum is 
involved in habitual and compulsive behaviors such as food-seeking and binge eating, 
and plays a role in homeostatic energy consumption (Fritz et al., 2018).  Both regions are 
important to consider when investigating dopamine metabolism as it relates to DIO. 
Sex Factors in Murine Behavior 
Research that includes both sexes in the study of DIO-impact on behavior in mice 
is limited.  In one study using male and female B6 mice fed a HFD (60% kcal fat) for 12 
weeks, males fed a HFD spent less time in the center zone of the open field compared to 
males fed a control diet and compared to all females, indicating increased anxiety-like 
behavior in males only due to HFD (Bridgewater et al., 2017).  Additionally, there was a 
sex difference in ambulation, with male B6 mice showing reduced locomotor activity 
compared to B6 females.  Interestingly, diet had no effect on locomotion for either sex.   
In contrast to these results, a study using male and female B6J mice fed a HFD (60% kcal 
from fat) for approximately 10 weeks found no significant difference in open field center 
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time due to diet or sex (Gelineau et al., 2017).  Male B6J mice fed a HFD had reduced 
locomotion compared to the male LFD group, yet there was no diet impact on female 
locomotion, and no overall sex differences in locomotion.  There was, however, a sex 
difference in protein expression of brain-derived neurotrophic factor (BDNF), with males 
exhibiting lower expression compared to females.  There was no significant impact of 
diet on BDNF expression for either sex.  While both studies report an impact of diet or 
sex on various behaviors, the results are not consistent.  Both studies initiated the HDF 
at a similar age (6-7 weeks), but the diet treatment duration was different (12 weeks 
versus 10 weeks).  The anxiety-like behavior in males was revealed after the 12-week 
diet treatment, which could be a result of increased body weight, older age, or extended 
exposure to the HFD.  
Gene Expression Dysregulation in the Brain 
 DIO has been associated with gene expression dysregulation in the brain, with 
implications for the development of ND or behavior impairments (Han et al., 2019; 
Huang et al., 2005; Lee et al., 2010).  There is also potential for a bidirectional 
relationship between gene expression alterations and trace element dysregulation.  The 
genes or proteins described here are relevant for the investigation of the impact of DIO 
on the brain, together with the sex and genetic factors that may influence the outcome. 
Divalent Metal Transporter 1  
Divalent metal transporter 1 (DMT1) acts as a transporter for several ions, 
including ferrous ion (Fe2+), manganese II (Mn2+), cobalt II (Co2+), cadmium II (Cd2+), 
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nickel II (Ni2+), lead II (Pb2+), and to a lesser extent zinc (Zn2+) (Mackenzie et al., 2007).  
Both cuprous (Cu+) and cupric ion (Cu2+) are transported by DMT1, although Cu+ has a 
higher affinity and can compete with Fe2+  (Arredondo et al., 2003).  There are four 
known isoforms of DMT1 with similar function, all of which transport Fe2+ with similar 
efficiency (Skjørringe et al., 2015).  DMT1 is mainly expressed in neurons, but the level 
of expression and compartmentalization of DMT1 within non-neuronal cells, such as 
astrocytes, is still controversial (Ingrassia et al., 2019; Skjørringe et al., 2015).  
Investigations are needed to learn more about the gene expression of DMT1 in the brain 
under DIO conditions, as the dysregulation of DMT1 and trace element homeostasis is 
associated with various NDs (Ingrassia et al., 2019; C.-W. Zhang et al., 2017). 
Several studies in rodents have shown an association between dysregulated 
DMT1 expression and alterations in Fe or Cu homeostasis in a brain region-specific 
manner.  A study using male Sprague-Dawley rats found that Fe-related protein 
expression changes with age at different rates depending on the brain area (Lu et al., 
2017).  In the striatum, substantia nigra, hippocampus, and cortex, the Fe importer 
DMT1 was upregulated with age.  While the increase in DMT1 in the striatum and 
hippocampus occurred mainly between three-12 months of age, the increase in the 
substantia nigra and cortex occurred between 12-24 months.  The accumulation of Fe in 
each region occurred over the entire time period (three–24 months), suggesting that 
DMT1 upregulation may influence Fe build up to some degree, but is not the only factor 
involved in Fe accumulation.  Unlike DMT1, transferrin receptor 1 (TfR1) was 
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downregulated with age.  These differences suggest that Fe accumulation over time is 
more likely to depend on the expression of DMT1 versus TfR1.  In a study using male +/b 
(control) and b/b (DMT1 mutated) Belgrade rats, DMT1-mutated rats displayed a 
reduction of Fe in the striatum, hippocampus, olfactory bulb, and cortex, as well as an 
increase in Cu in the striatum and hippocampus (Han et al., 2016).  It was found that 
transgenic mice overexpressing DMT1 in multiple brain regions (striatum, substantia 
nigra, hippocampus, olfactory bulb, and cortex) accumulated Fe in the substantia nigra 
when fed an Fe-supplemented diet (C.-W. Zhang et al., 2017).  Interestingly, there was 
no corresponding increase in alpha synuclein, and motor function was similar between 
the treatment group and control mice.  The results of this study show that an increase in 
Fe is only one factor that may contribute to the development of neurodegeneration, 
increasing the challenge of elucidating the pathological mechanisms of ND.   
The effect of DIO on DMT1 expression in the context of Fe metabolism has been 
studied systemically, yet there is limited research focused on the brain.  A recent study 
showed that DIO did not induce DMT1 gene expression changes in various brain regions 
in male B6J mice (Han et al., 2019).  In the system, it was found that male B6 mice fed a 
HFD (60% kcal fat) for eight weeks showed reduced plasma Fe and increased DMT1 
mRNA and protein expression in the duodenum compared to control mice, indicating a 
systemic Fe deficiency caused by DIO (Sonnweber et al., 2012).  In contrast, another 
study found that B6J male mice fed a HFD (54% kcal fat) for 30 weeks resulted in no 
change in duodenal DMT1 mRNA or protein expression, but had Fe accumulation in the 
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liver and spleen (Citelli et al., 2015).  In male Swiss mice fed a HFD (60% kcal fat), DMT1 
expression in adipose tissue was not affected (Gotardo et al., 2013).  Collectively, these 
results show that gene expression alterations and Fe dysregulation due to DIO may be 
tissue-specific, and may depend on the length of time exposed to HFD.  The effects of 
DIO on DMT1 gene expression reported in the literature have focused primarily on male 
rodents and the system, leaving a knowledge gap on DIO impact in the brain and the 
effect of sex on potential gene expression alterations. 
Iron Regulatory Protein 
Iron regulatory protein (IRP) is integral in the regulation Fe absorption, 
transportation, and storage at the cellular level (Zhou and Tan, 2017a).  The two 
isoforms, IRP1 and IRP2, are both involved in Fe homeostasis.  When intracellular Fe 
levels are low, IRP binds to an iron response element (IRE) on the mRNA transcripts of 
Fe-metabolism proteins, such ferritin, ferroportin, transferrin receptor1, and DMT1.  
The binding of IRP inhibits the translation of ferritin and ferroportin, and protects TfR1 
and DMT1 from degradation.  When Fe levels are high, Fe binds to IRP, causing the 
release of IRP from the IRE.  This leads to the synthesis of ferritin and ferroportin to 
stimulate Fe storage or cellular efflux, and promotes the degradation of TfR1 and DMT1 
mRNA transcripts.  Disruptions in gene expression of IRP1 or IRP2 can therefore impact 




It has been discovered that there is an IRE present in alpha synuclein mRNA 
transcripts (Cahill et al., 2009), and one in amyloid precursor protein mRNA transcripts 
that binds specifically with IRP1 (Bandyopadhyay and Rogers, 2014; Cho et al., 2010).  
IRP binding to either of these IREs suppresses protein translation (Cahill et al., 2009; 
Zhou and Tan, 2017a).  Fe overload can therefore lead to the translational upregulation 
of amyloid precursor protein (Cho et al., 2010) or alpha synuclein (Febbraro et al., 2012), 
increasing the risk for ND (Cahill et al., 2009).  An effect of sex for this relationship 
between IRP and alpha synuclein was found in rats, as females expressed more IRP1 in 
the hippocampus compared to males, and had reduced expression of alpha synuclein 
(Thulluri et al., 2012).  There is limited research on the effects of DIO on brain IRP 
expression.  In the system, it was found that IRP1 (but not IRP2) mRNA expression was 
upregulated in adipose tissue of male Swiss mice fed a HFD (60% kcal fat) (Gotardo et 
al., 2013).  Research on the effect of DIO on the gene expression of IRP1 should be 
pursued, as this protein is instrumental in Fe homeostasis through its impact on several 
Fe-related proteins.  Furthermore, the relationship between IRP1 and alpha synuclein or 
amyloid precursor protein may have important implications for the development of ND, 
and should be studied in the context of DIO. 
Ceruloplasmin  
Ceruloplasmin is a Cu-dependent protein that is expressed in astrocytes at the 
blood brain barrier and in dopaminergic neurons in the substantia nigra (Hellman and 
Gitlin, 2002).  It acts as a ferroxidase, allowing for the efflux of Fe from astrocytic cells to 
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neurons via transferrin.  Cu depletion can therefore lead to Fe dyshomeostasis, trapping 
the Fe within astrocytes, and depriving neurons of Fe.  This enzyme also acts as an 
oxidizing agent for Mn, and can function as a general endogenous antioxidant (Hellman 
and Gitlin, 2002; Jursa and Smith, 2009).  Ceruloplasmin is critical for the maintenance 
of Fe homeostasis, and can oxidize 6-hydroxydoapmine without producing reactive 
oxygen species as an end product (Vassiliev et al., 2005).  A deficiency in ceruloplasmin 
can lead to dysregulated Fe and production of reactive oxygen species (ROS) by either 
the Fenton reaction of Fe2+ with hydrogen peroxide to produce the deleterious hydroxyl 
radical, or by the nonenzymatic oxidation of 6-hydroxydopamine to produce hydrogen 
peroxide.  Consequently, aberrations in ceruloplasmin gene expression or protein 
synthesis have been associated with ND.  Murine ceruloplasmin is 90% similar to human 
ceruloplasmin and has similar gene expression patterns, allowing for the use of a mouse 
model to study human ND (Hellman and Gitlin, 2002).   
Ceruloplasmin levels tend to be higher in the plasma of obese individuals (Kim et 
al., 2011; Yang et al., 2019).  Although there is limited research on the impact of DIO on 
ceruloplasmin expression in the brain, there is extensive research using rodent and 
human models to investigate the role of ceruloplasmin in ND.  For example, a study 
using male Sprague-Dawley rats found that ceruloplasmin mRNA expression increased 
with age, with a more extensive induction in the midbrain and striatum compared to the 
hippocampus and cortex (Chang et al., 2005).  In male Wistar rats, ischemia led to 
decreased mRNA expression of ceruloplasmin in the hippocampus, with corresponding 
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accumulation of Fe in neurons (Li et al., 2008).  In mice, ceruloplasmin mRNA and 
protein was upregulated in the retinas of glaucomatous D2 mice, but not B6 control 
mice (Stasi et al., 2007).  A study using postmortem brain tissue from ND patients found 
increased levels of ceruloplasmin protein in AD striatum, HD midbrain, and the 
hippocampus for AD, PD, and HD tissue compared to elderly controls (Loeffler et al., 
1996).  Moreover, it was discovered that ceruloplasmin was depleted in the 
hippocampus of AD postmortem tissue and in an AD mouse model, and that restoration 
of ceruloplasmin alleviated neuronal damage (Zhao et al., 2018).  Collectively, these 
studies show that dysregulated ceruloplasmin expression is associated with the aging 
process and various forms of neurodegeneration.  It is possible that DIO may also 
disrupt the normal expression of ceruloplasmin in the brain.  
Ceruloplasmin dysregulation may also be related to behavior changes.  In 
ceruloplasmin knockout mice, Fe was reduced in the hippocampus and mice exhibited 
higher anxiety-like behavior in an open field test (Texel et al., 2012).  These mice also 
had a reduction in BDNF expression in the hippocampus.  In male and female patients 
with obsessive compulsive disorder (OCD), serum ceruloplasmin levels were found to be 
elevated, suggesting a potential association between ceruloplasmin homeostasis and 
OCD (Virit et al., 2008).  In a study with patients diagnosed with aceruloplasminemia, a 
serious ND involving the lack of synthesis of ceruloplasmin, nearly half of the patients 
presented with anxiety and depression (Vroegindeweij et al., 2017).  While none of 
these studies definitively tie ceruloplasmin to a specific behavior, the evidence suggests 
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that ceruloplasmin dysregulation and concomitant Fe accumulations may be associated 
with various psychotic disorders, warranting more research to be performed.   
Copper Transporter 1 
Copper transporter 1 (CTR1) is a plasma membrane protein expressed in the 
blood brain barrier (BBB), the blood cerebrospinal fluid barrier (BCB), neurons, and 
astrocytes (Skjørringe et al., 2012).  Through CTR1, Cu import occurs mainly at the BBB, 
and Cu export mainly at the BCB (Montes et al., 2014).  Previously, it has been shown 
that CTR1 expression correlates with increased Cu level in the substantia nigra in PD.  
Since Cu dysregulation has been implicated in the development of various NDs (Genoud 
et al., 2017; Mezzaroba et al., 2019; Sensi et al., 2018), the effect of DIO on gene 
expression of CTR1 and its potential link to DIO-induced neurodegeneration should be 
investigated. 
Although there is limited information available regarding the impact of DIO on 
CTR1 expression, studies using various models have shown connections between the 
dysregulation of CTR1 expression and Cu homeostasis with neurodegeneration.  In 
postmortem substantia nigra brain tissue from PD and AD patients, there were 
significant reductions in Cu, CTR1 protein, and superoxide dismutase 1 (SOD1) (Davies et 
al., 2014).  The reductions in SOD1 were positively correlated with Cu reductions, and Cu 
decline occurred before neuronal death.  This study provides evidence that the 
dysregulation of Cu and CTR1 are associated with oxidative stress and 
neurodegenerative damage.  Lang et al. used a Drosophilia AD model to evaluate the 
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impact of Cu and CTR1 gene expression on neurodegeneration (Lang et al., 2013).  
Downregulation of CTR1 resulted in reduced levels of Cu, but not Fe, Mn, and Zn.  Flies 
with higher Cu levels experienced more beta amyloid toxicity as assessed by locomotion 
and mortality.  CTR1 gene expression and Cu concentration did not, however, have an 
impact on memory.  Zheng et al. found that mouse BV-2 microglial cells treated with 
IFN-, a proinflammatory cytokine, resulted in Cu accumulation and induction of CTR1 
mRNA gene expression (Zheng et al., 2010).  The implications of this study are significant 
to the health field, as inflammation is associated with ND (Heneka et al., 2015; 
Ransohoff, 2016) and with DIO (Saltiel and Olefsky, 2017).  CTR1 and Cu homeostasis 
can also be influenced by Mn exposure.  In a study using the Z310 choroidalepithelial 
cell line from murine choroid plexus, exposure to Mn resulted in increased cellular Cu 
and upregulated CTR1 and DMT1 gene and protein expression (Zheng et al., 2010).  This 
study highlights the interplay between trace elements and their effect on gene 
expression and homeostasis.  Collectively, these studies provide evidence for the 
potential impact of CTR1 expression and Cu regulation in the development of ND.  The 
potential impact of DIO on CTR expression in the brain has not thus far been 
investigated.   
Alpha Synuclein 
Alpha synuclein, encoded by the SNCA gene (Fitzgerald et al., 2019), is expressed 
throughout several brain regions and is enriched within presynaptic terminals (Bridi and 
Hirth, 2018).  It acts as a negative modulator of dopamine by inhibiting enzymes that 
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synthesize dopamine, such as tyrosine hydroxylase.  The overexpression of alpha 
synuclein mRNA transcripts may lead to the aggregation of alpha synuclein protein 
(Fields et al., 2019), and can disrupt the function of the presynaptic SNARE complex, 
interfering with the positioning and fusion of synaptic vesicles (Bridi and Hirth, 2018).  
Additionally, accumulated alpha synuclein in the form of Lewy bodies can lead to the 
dysregulation of dopamine, synaptic dysfunction, and damaged neurons, provoking the 
development of neurodegenerative diseases such as PD (Bridi and Hirth, 2018; Fields et 
al., 2019; Fitzgerald et al., 2019). 
There are several biochemical interactions between alpha synuclein and Fe in 
the brain (B. Chen et al., 2019; Lingor et al., 2017).  Fe can regulate alpha synuclein 
levels post transcriptionally through the binding of IRP on the alpha synuclein IRE, and 
post translationally by interfering with the normal ubiquitination process of alpha 
synuclein protein (B. Chen et al., 2019).  It has been proposed that alpha synuclein can 
also regulate Fe levels through its ferroreductase activity, a process that depends on Cu 
as a cofactor.  Over expression of alpha synuclein in both cell and animal models 
increases the intracellular reduction of ferric ion to ferrous ion, thereby increasing the 
risk for ROS generation through the Fenton reaction.  Furthermore, the overexpression 
of alpha synuclein in midbrain neurons was reported to increase intracellular Fe (Ortega 
et al., 2016) and intracellular Mn (Dučić et al., 2015), but had no effect on Zn 




Recent studies in rodents and cells demonstrate the impact of DIO on alpha 
synuclein expression and neuropathology.  For example, male B6J mice fed a HFD (60% 
kcal fat) for 20 weeks showed increased alpha synuclein mRNA and protein expression 
in the midbrain compared to LFD control mice (Han et al., 2019).  Additionally, Fe and 
F2-isoprostane (a biomarker for oxidative damage) levels were also elevated in this 
brain region.  A study using female C57BL/6J/129SVJ mice fed a HFD (58% kcal fat) for 12 
weeks found an upregulation of alpha synuclein mRNA in the hypothalamus (Lee et al., 
2010).  In a study using male ApoE-/- and ApoE-/-/Tollip-/- mice, HFD (42% kcal fat) led to 
the accumulation of alpha synuclein and beta amyloid protein in the hippocampus and 
increased neuronal death (Chen et al., 2017).  Together, these studies provide evidence 
that both male and female mice are prone to dysregulated alpha synuclein expression 
due to DIO.  Additionally, a HFD may instigate alpha-synucleinopathy in mice that are 
genetically predispositioned to age-dependent alpha synuclein pathology.  For example, 
a study using male B6 transgenic mice expressing human mutant [A30P] alpha synuclein 
fed a HFD (45% kcal fat) demonstrated that HFD-induced obesity accelerates alpha-
synucleiopathy and astrogliosis (Rotermund et al., 2014).  Cell studies also show a 
potential relationship between alpha synuclein dysregulation and HFD.  In a study using 
SH-SY5Y human neuroblastoma cells as a neuronal model, and T98G human 
glioblastoma cells as an astrocytic model, alpha synuclein unexpectedly reduced the 
cytotoxic effects of palmitic acid, a long chain saturated fatty acid (Ng and Say, 2018).   
In contrast, a study using U373 MG human astrocytoma cells found that overexpression 
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of alpha synuclein triggered oxidative stress and cell death in these glial cells (Stefanova 
et al., 2001).  While these cell studies show direct effects of saturated fat or alpha 
synuclein overexpression on brain cell viability, further studies are required to 
understand the effect of HFD-feeding on the mRNA expression of alpha synuclein and its 
potential connection to trace element dysregulation and neurodegeneration. 
The dysregulation of alpha synuclein, particularly in the hippocampus,  has been 
implicated in the disruption of normal behavior.  Alpha synuclein pathology in the 
hippocampus was associated with memory loss in patients with Dementia with Lewy 
Bodies (Adamowicz et al., 2017).  In rodents, it was found that when comparing Lewis 
rats to spontaneously hypertensive rats, the Lewis rats expressed higher levels of 
anxiety in an open field test and had higher concentrations of alpha synuclein and beta 
amyloid in the hippocampus (Chiavegatto et al., 2009).  Moreover, alpha synuclein was 
inversely correlated to dopamine turnover.  This study suggests that alpha synuclein 
may be involved in regulating anxiety-like behaviors in rodents through dopaminergic 
mechanisms. 
PD is characterized by intracellular aggregates of alpha synuclein in the form of 
Lewy bodies, localized in the substantia nigra (Ubeda-Bañon et al., 2013).  It has been 
discovered recently that alpha synuclein accumulates in the olfactory bulb long before it 
does in the substantia nigra, and is associated with the loss of olfactory sense in PD 
(Adler and Beach, 2016; Fullard et al., 2017) and AD (Attems et al., 2014).  Analysis of 
postmortem brain tissue revealed that alpha synuclein was accumulated in male and 
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female olfactory bulbs in patients with PD patients and confirmed Lewy body formation 
(Braak et al., 2003; Mazurskyy and Howitt, 2019).  Additionally, the olfactory bulb was 
determined in autopsy studies to be the first brain region affected by Lewy type alpha 
synucleinopathy (Adler and Beach, 2016).  The effect of DIO on alpha synuclein 
expression or trace element dysregulation in the olfactory bulb is unknown, but could 
potentially provide valuable information regarding the development of ND in the 
context of obesity.   
Amyloid Precursor Protein 
Amyloid precursor protein (APP) is a transmembrane protein associated with 
several biological functions, including cellular proliferation and differentiation, cell-fate 
specification, and neurite outgrowth (S. Wang et al., 2016).  The overexpression of APP, 
however, has been implicated in the progression of AD (Roher et al., 2017).  Common 
features of AD include extracellular accumulation of senile plaques, intracellular 
neurofibrillary tangles, and loss of neurons and synapses in the brain (Zhang et al., 2011; 
Zheng and Koo, 2011).  The senile plaques consist mainly of beta amyloid protein, which 
is derived from the proteolytic cleavage of APP.  Disruptions in normal gene expression 
of APP can therefore lead to the potential buildup of beta amyloid, promoting the 
conditions for neurodegeneration. 
APP is highly expressed in both the hippocampus and olfactory bulb in rodents 
(S. Wang et al., 2016).  The hippocampus is particularly vulnerable to beta amyloid 
protein aggregation and senile plaque formation (Zhang et al., 2011).  While there are 
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several studies examining the effects of aging on APP gene expression and beta amyloid 
production in the brain, only a few studies have focused on the effects of diet and 
obesity.  In one report using male B6J mice fed a HFD based on palmitic acid for 16 
months, beta amyloid protein was found to accumulate in the hippocampus (Busquets 
et al., 2017).  The authors suggest that the beta amyloid accretion may be due to 
impeded autophagy of this protein.  In another study using male B6J mice fed a HFD 
based on milk fat for 22 weeks, mice fed the HFD had elevated APP expression in the 
hippocampus (Puig et al., 2012).  Beta amyloid aggregation in the olfactory bulb is also 
implicated in the progression of neurodegenerative disorders based on post mortem 
studies (Attems et al., 2014).  In a study using Tg2576 AD mice, APP gene overexpression 
in the olfactory bulb impaired the function of protein kinase A between 6-18 months 
(Lachen-Montes et al., 2019).  The authors speculate that this dysregulation of 
biochemical activities in the olfactory bulb supports the early progression of AD.  There 
is limited data for the expression of APP in the human olfactory bulb (Rey et al., 2018), 
and no reports on the effect of obesity or diet on APP expression in the olfactory bulb.  
There are conflicting reports concerning the relationship between Cu 
concentration in the brain with APP gene expression.  In mouse neuroblastoma N2a 
cells, Cu treatments promoted an increase in APP mRNA expression and beta amyloid 
synthesis in a dose-dependent manner (Hou et al., 2015).  Cu overload was associated 
with APP upregulation in fibroblast cells from B6 mutants (Armendariz et al., 2004), and 
depleted Cu was correlated to reduced APP expression in human fibroblast cells with 
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MNK deletion (Bellingham et al., 2004).  In contrast, a study using SH-SY5Y neuronal 
cells found that a Cu surplus causes a delocalization of APP by increased exocytosis and 
reduced endocytosis, but not via APP gene expression (Acevedo et al., 2011).  
Additionally, this study showed that Fe and Zn did not impact APP homeostasis.  Taken 
together, these studies provide evidence that APP and beta amyloid homeostasis can be 
disrupted by different mechanisms, warranting more research to understand the 
neuropathology behind DIO and APP dysregulation.   
Brain-Derived Neurotrophic Factor 
Brain-derived neurotrophic factor (BDNF) is a protein and growth factor involved 
in neuronal survival and brain plasticity (Bathina and Das, 2015; Miranda et al., 2019).  
The role of this neurotrophin in brain plasticity is correlated with learning, memory, and 
cognition in humans and rodents (Miranda et al., 2019).  Protein and mRNA expression 
of BDNF has been identified in brain regions such as the hippocampus, cortex, and 
olfactory bulb (Bathina and Das, 2015).  High levels of BDNF are associated with 
neuronal protection (Almeida et al., 2005), while low levels have been associated with 
normal aging and pathological conditions such as AD, PD, and HD (Bathina and Das, 
2015; Miranda et al., 2019).  In a study using postmortem brain tissue from AD patients, 
BDNF mRNA expression was downregulated in the hippocampus and cortex compared 
to age-matched controls (Hock et al., 2000).  Furthermore, BDNF is involved in the 
regulation of energy balance, and may act as an anorexigenic signaling molecule (Liu et 
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al., 2014; Rios et al., n.d.).  As such, decreased levels of BDNF have been associated with 
obesity (Genzer et al., 2016). 
Several reports using male rodents indicate that BDNF expression can be 
influenced by a HFD.  One study using B6 male mice fed two types of HFD (41% kcal fat 
for 21 weeks or 60% kcal fat for 16 weeks) discovered that while BDNF expression and 
cognition were not impacted with the 41% HFD treatment, mice fed the 60% HFD had 
reduced levels of BDNF protein in the cortex and poor cognition performance compared 
to mice fed a control diet (Pistell et al., 2010).  Another study using B6 males fed a HFD 
(42% kcal fat) for 12 weeks found deceased BDNF expression in whole brain tissue, but 
found no change in cognition or memory (Wang et al., 2017).  In contrast, some rodent 
studies show an upregulation of BDNF due to HFD.  For example, a study using male B6 
mice fed a HFD (42% kcal fat) for eight weeks found that BDNF mRNA and protein was 
upregulated in whole brain tissue and in HT-4 hippocampal neurons (Genzer et al., 
2016).  In a study using male Long-Evans rats fed a HFD (45% kcal fat) for a short time 
frame of 72 hours, the mRNA expression of BDNF was upregulated in the hippocampus 
(Gan et al., 2015).  Although there are discrepancies revealed here showing either 
induction or repression of BDNF, overall there is a consistent dysregulation in BDNF 
expression when rodents are fed a HFD.  Likewise, behavior tests show that cognition is 
not always impacted by HFD and may depend on the age of the rodents, duration of the 
HFD, and type of assessment used. 
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Fewer investigations have been performed with female rodents.  One study 
using female Fisher 344 rats fed a diet high in fat (39% kcal fat) and sugar evaluated 
BDNF expression in the hippocampus and caudal cerebral cortex after two months, six 
months, and two years of diet treatment (Molteni et al., 2002).  At all three time points, 
mRNA expression was reduced in the hippocampus for rats fed a high fat and sugar diet 
compared to the control diet.  Protein was also repressed in the hippocampus after six 
months of diet treatment.  There was no impact of diet on mRNA or protein expression 
in the cortex.  Additionally, rats fed the high fat and sugar diet had poor performance in 
spatial learning tasks. 
There are notable sex differences in the distribution of BDNF within different 
brain structures (Chan and Ye, 2017).  In rats, females have higher levels of BDNF in the 
hippocampus and cortex.  In humans, there is no difference in BDNF levels in the 
hippocampus, but females have higher levels of BDNF in the prefrontal cortex compared 
to males.  A study using Long-Evans male and female rats fed a control diet or HFD (45% 
kcal fat) for four days and four weeks compared BDNF mRNA expression in the 
ventromedial nucleus of the hypothalamus (Liu et al., 2014).  At both time points, the 
expression of BDNF was higher in females compared to males, regardless of diet.  After 
four days of HFD-feeding, there was no impact on BDNF expression.  However, after 
four weeks, BDNF mRNA was repressed only in male rats fed a HFD.    
There are very few studies that address the influence of strain and sex on DIO-
induced BDNF gene expression dysregulation, and no reports describing the effects of 
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HFD on BDNF expression in the olfactory bulb.  An evaluation of HFD impact on BDNF 
mRNA expression in the hippocampus and olfactory bulb in male and female mice of 
different strains would address these gaps in the literature. 
Tyrosine Hydroxylase  
Tyrosine hydroxylase (TH) is a rate limiting enzyme that requires Fe as a cofactor 
for the synthesis of catecholamines such as dopamine, epinephrine, and norepinephrine 
(Daubner et al., 2011).  These catecholamines serve brain functions such as attention, 
memory, and cognition.  TH is present within the neurons of the dopaminergic pathway 
that extends from the substantia nigra to the striatum, which is imperative for proper 
motor function (Jang et al., 2017).  Obesity has been shown to have a negative impact 
on mobility (Forhan and Gill, 2013) and has been associated with changes in TH gene 
expression in different brain regions (Huang et al., 2005a; Lee et al., 2010; Ong et al., 
2013; Wu et al., 2017). 
Several studies have used animal models to investigate the impact of DIO on TH 
mRNA and protein expression.  In a study using male B6 mice fed a HFD (40% kcal fat) 
for 20 weeks, there was an upregulation of TH mRNA in the midbrain for mice fed a 
HFD, and a positive correlation between final body weight and TH gene expression in 
this brain region (Huang et al., 2005a).  In contrast, a study that also used B6 males fed a 
HFD (40% kcal fat) for 14 weeks found that mice fed a HFD had downregulated TH in the 
midbrain (Li et al., 2009).  Both studies originated from the same lab and both began the 
diet treatment at 12 weeks of age, but the duration of HFD feeding differed (20 weeks 
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versus 14 weeks), as well as the age of mice at the time of tissue analysis.   Another 
study using male B6 mice fed a HFD (60% kcal fat) for 13 weeks found that TH protein 
expression was downregulated in the midbrain and striatum for mice fed a HFD (Jang et 
al., 2017).  Additionally, these mice had 60% reduced movement in the open field test.  
Corroborating these results, B6J male mice fed a HDF (58% kcal fat) for just 6 weeks also 
showed a decrease in TH protein expression in the striatum and midbrain, along with 
increased anxiety-like behavior in mice fed a HFD (Sharma et al., 2013).  A study using 
female C57BL6/129SVJ mice fed a HFD (58% kcal fat) for 12 weeks discovered an 
induction of TH mRNA expression in the hypothalamus using microarray analysis and 
real time polymerase chain reaction techniques (Lee et al., 2010).   
TH gene expression dysregulation has also been examined in humans with 
overweight and obesity.  In a study using postmortem brain tissue from male and 
female Caucasians and African Americans, TH mRNA was downregulated in the 
substantia nigra in obese tissue, but not overweight or control tissue (Wu et al., 2017).  
Additionally, TH mRNA was negatively correlated with BMI, but not with age, sex, or 
race.  In this same study, there was no significant change in dopamine receptor D2 
mRNA expression. 
Sex differences have been reported for the dysregulation of TH gene expression 
due to HFD.  In male and female Albino Wistar rats fed a cafeteria style HFD (43% kcal 
fat), there was a diet by sex interaction for the expression of TH mRNA in the NAc core 
(Ong et al., 2013).  TH was downregulated in males but upregulated in females.  
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Additionally, there was no significant difference in dopamine receptor D2 expression for 
males, but a repression in females was approaching statistical significance.  
While several reports provide information about DIO-induced dysregulation of 
TH mRNA expression in the midbrain or TH protein expression in the striatum and 
midbrain, there is very little information regarding TH mRNA expression in the striatum, 
or other brain regions such as the olfactory bulb in the context of HFD.  Furthermore, 
most studies with rodents are focused on males, and sex and strain differences are 
generally not addressed. 
Dopamine Receptor D2 
There are five major dopamine receptor subtypes, D1-D5, which belong to either 
the D1-like or D2-like receptor family (Baik, 2013; Gallo, 2019).  Dopamine receptor D2 
(DRD2) is a member of the D2-like receptor family, along with D3 and D4.  DRD2 is 
expressed both pre- and postsynaptically in various brain regions, such as the striatum, 
midbrain, cortex, and olfactory bulb (Gallo, 2019; Mishra et al., 2018).  The main 
function of DRD2 is to modulate dopamine synthesis and release through the 
intracellular inhibition of cAMP (Baik, 2013).  In the striatum, DRD2 mediates the actions 
of dopamine that control both movement and reward-seeking (Gallo, 2019). 
Excessive energy consumption and DIO may be contributed in part to 
dysregulated dopamine metabolism and food reward systems in the brain (Berridge et 
al., 2010).  Reduced DRD2 activity or expression is often, but not always, associated with 
DIO (Baik, 2013).  For example, an imaging study in men and women discovered that 
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striatal DRD2 receptor availability was reduced in obese individuals compared to 
controls, and that BMI was negatively correlated with DRD2 concentration (Wang et al., 
2001).  In corroboration using similar test methods, striatal DRD2 receptor availability 
was reduced in obese women compared to controls (van de Giessen et al., 2014).  
However, another imaging study in obese women found no change in DRD2 receptor 
availability when examining several brain regions, including the striatum, and found no 
correlation between DRD2 and BMI (Karlsson et al., 2015).  In a study using male 
Sprague-Dawley rats fed a HFD (32% kcal fat) for eight weeks, there was a 42% decrease 
in DRD2 density in the dorsal striatum (Narayanaswami et al., 2013).  Furthermore, 
when male and female offspring of female B6J mice bred with D2J males were fed a HFD 
(60% kcal fat) for 12 weeks, both males and females showed a downregulation of DRD2 
mRNA in the NAc core (Carlin et al., 2013).   
In contrast to these reports, there is also evidence that DRD2 may be 
upregulated due to DIO.  In a study using male B6 mice fed a HFD (40% kcal fat) for 20 
weeks, there was an induction of DRD2 mRNA in the NAc core for mice fed a HFD, and a 
positive correlation between final body weight and DRD2 gene expression in this brain 
region (Huang et al., 2005b).  Another study using male B6 mice fed a HFD (58% kcal fat) 
for 12 weeks showed that mice fed a HFD had increased DRD2 protein expression in the 
NAc (Sharma and Fulton, 2013).  Furthermore, when male B6 mice were fed a HFD (40% 
kcal fat) for only 20 days, the DRD2 binding density was increased in the dorsal and 
ventral striatum (South and Huang, 2008).  Interestingly, a human imaging study 
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demonstrated that DRD2 binding potential was positively correlated to BMI in the dorsal 
striatum, yet negatively correlated to BMI in the ventral striatum (Guo et al., 2014).  
Collectively, these studies provide evidence that DRD2 dysregulation is involved as 
either a cause or consequence of DIO, however the direction of DRD2 alteration and 
pathophysiological mechanisms are poorly understood.  Furthermore, the ability to 
measure the precise location of DRD2 dysregulation within specific brain regions and 
cell compartments would be ideal for elucidating these neurophysiological mechanisms. 
Conclusion 
 The impact of DIO on neurobiology dysregulation and behavior changes has been 
described in the current literature.  There is evidence that DIO can alter gene expression 
and trace element homeostasis in the brain.  Furthermore, DIO can disrupt dopamine 
biology and can lead to unfavorable behaviors such as a reduced physical activity, 
anxiety, and compromised memory.  Sex and genetic factors that influence these DIO-
associated alterations in the brain are not well understood.  Further research is needed 
to elucidate the influence of sex and genetic factors on neurobiological and behavioral 
disturbances induced by an energy dense diet and a state of DIO.  The development of 
future treatment and rehabilitation programs could become more effective when 






THE INFLUENCE OF SEX AND STRAIN ON TRACE ELEMENT DYSREGULATION AND GENE 




Diet-induced obesity (DIO) can disrupt trace element homeostasis and gene 
expression in the brain, increasing the risk for neurodegeneration.  Genetics and sex are 
biological factors that can influence these disruptions.  The aim of this study was to 
identify main effects and interaction effects between diet, sex, and mouse strain on 
trace element dysregulation and gene expression due to DIO.  Male and female 
C57BL/6J (B6J) and DBA/2J (D2J) mice were fed either a low fat diet (10% kcal from fat) 
or a high fat diet (60% kcal from fat) for 16 weeks, then assessed for gene expression 
patterns and trace element concentrations in four brain regions.  In the striatum, iron 
was significantly elevated in B6J female mice and ceruloplasmin mRNA was significantly 
upregulated in D2J female mice due to DIO.  In the hippocampus, zinc was substantially 
increased in D2J males fed a high fat diet, but substantially deceased in D2J females fed 
a high fat diet.  There was also a dramatic induction of divalent metal transporter 1, 
alpha synuclein, and amyloid precursor protein for the B6J strain in this brain region due 
to DIO.  In the olfactory bulb, there was a significant elevation of iron and manganese in 
male B6J mice, and an upregulation of divalent metal transporter 1, amyloid precursor 
protein, and alpha synuclein mRNA in male D2J mice.  In the midbrain, copper was    
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depleted in D2J males and females fed a high fat diet.  In summary, we found that the 
disruption of trace element homeostasis and gene expression due to DIO was brain-
region dependent, and was highly influenced by sex and strain.  These results emphasize 
the importance of considering sex and genetics as biological factors when investigating 
potential associations between DIO and neurodegenerative disease. 
Introduction 
The World Health Organization defines obesity as abnormal or excessive fat 
accumulation that may impair health.  Approximately 13% of the global adult population 
was obese in 2016, and worldwide prevalence of obesity has nearly tripled since 1975 
(“WHO | Obesity”).  Biochemical consequences of obesity include inflammation, 
oxidative stress, and mitochondrial dysfunction, all of which are common pathologies of 
neurodegenerative disease (ND) (Mazon et al., 2017).  Increasing evidence implicates 
obesity as a risk factor for two of the most common forms of ND: Alzheimer’s disease 
and Parkinson’s disease (Martin-Jiménez et al., 2017; Mazon et al., 2017).  The risk of 
developing a ND depends on a combination of genetics and the environment (Brown et 
al., 2005).  Our lab seeks to determine the mechanisms by which environmental factors, 
such as diet-induced obesity (DIO), can lead to ND. 
Dysregulation of trace element homeostasis (Ferreira and Gahl, 2017) and gene 
expression (Hwang et al., 2017) in the brain is associated with neurodegeneration.  For 
example, iron (Fe) accumulation and copper (Cu) deficiency are commonly found in the 
substantia nigra pars compacta of Parkinson’s disease patients (Genoud et al., 2017).  
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Disruptions in Fe and manganese (Mn) homeostasis can lead to several NDs, such as 
Parkinson’s disease and Huntington’s disease (P. Chen et al., 2019).  Trace elements Fe, 
Cu, and Mn share some common transporters and enzymes, such as divalent metal 
transporter 1 (DMT1) and ceruloplasmin, allowing their uptake mechanisms to interact 
(Skjørringe et al., 2012; Ye et al., 2017).  Therefore, a disruption in homeostasis of one 
element can impact the other elements, leading to potentially detrimental effects on 
the brain (Herrera et al., 2014; Skjørringe et al., 2012; Ye et al., 2017).  Disruptions in 
gene expression are also evident in ND, such as the upregulation of amyloid precursor 
protein (APP) in Alzheimer’s disease (Roher et al., 2017), and induction of alpha 
synuclein in Parkinson’s disease (Tagliafierro and Chiba-Falek, 2016).  Interestingly, it 
has been discovered that alpha synuclein accumulates in the olfactory bulb long before 
it does in the substantia nigra, and is associated with the loss of olfactory sense (Adler 
and Beach, 2016).  Loss of olfaction is an early symptom of Alzheimer’s disease (Attems 
et al., 2014) and Parkinson’s disease (Fullard et al., 2017), and usually occurs years 
before disease onset.  While trace element homeostasis and gene expression in the 
context of ND have been studied extensively in the substantia nigra (Dusek et al., 2015; 
Friedman and Galazka-Friedman, 2012), hippocampus (Fjell et al., 2014), and striatum 
(Mezzaroba et al., 2019) using human and animal models, it has not received the same 
attention in the olfactory bulb.  Therefore, we included an examination of the olfactory 
bulb in this study, along with other Fe-rich brain regions. 
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Our lab recently published two articles related to the effects of DIO on Fe 
dysregulation and gene expression in Fe-rich brain regions in C57BL/6J (B6J) male mice 
(Han et al., 2019; Liu et al., 2016).  DIO significantly reduced Fe in the striatum, but had 
no impact on the hippocampus or midbrain for mice fed a high fat diet (HFD) in one 
study (Liu et al., 2016).  In another study, DIO resulted in elevated Fe and upregulated 
alpha synuclein in the midbrain, with no effect in hippocampus or striatum (Han et al., 
2019).  In the present study, we evaluated multiple trace elements in the context of DIO, 
including Fe, Mn, Cu, and Zn.  Additionally, we assessed gene expression of mRNA 
transcripts for proteins involved in trace element homeostasis, such as DMT1 and 
ceruloplasmin (Lu et al., 2017), and proteins that have been implicated in the 
development of ND, such as alpha synuclein (Bridi and Hirth, 2018) and amyloid 
precursor protein (Roher et al., 2017). 
The influence of sex and genetics on trace element dysregulation and gene 
expression has been reported in recent literature.  For example, when B6J and D2J mice 
were exposed to paraquat, the B6J strain had elevated Fe in the midbrain and more 
differentially expressed genes compared to the D2J strain (Yin et al., 2011).  A DIO study 
using female B6J and D2J mice revealed distinct trends in gene expression fed a HFD, 
with an upregulation of glutathione peroxidase I in B6J mice and a downregulation of 
glutathione reductase in D2J mice (Norris et al., 2016).  A study that examined 
neurodegeneration and brain connectivity in a group of suspected Alzheimer’s disease 
patients found that the effect of obesity on brain metabolism was more significant in 
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females versus males (Malpetti et al., 2018).  Differences in gene expression between 
males and females can impact susceptibility to disease in a sex-dependent manner 
(Torres-Rojas and Jones, 2018), which is important to recognize when studying the 
biochemical mechanisms of ND development.  To address these important sex and 
genetic factors, our obesity model will include male and female B6J and D2J mouse 
strains.  These widely used inbred strains are commonly studied based on their defined 
genetic profiles and unique response to environmental stress (Jellen et al., 2012; Yin et 
al., 2011), and have proven to be appropriate models for DIO (Alexander et al., 2006; 
Montgomery et al., 2013; West et al., 1992). 
The objective of this study was to identify interaction effects between diet, sex, 
and strain on trace element dysregulation and gene expression due to DIO in specific 
brain regions.  Based on a pilot study of trace element dysregulation in B6J and D2J mice 
in our lab (results not published), we hypothesized that the influence of sex on DIO 
would impact the B6J strain more than the D2J strain, and trace element dysregulation 
would be region-specific.  We also hypothesized that DIO would cause increases in Fe, 
zinc (Zn), and alpha synuclein gene expression in the olfactory bulb, as these 
physiological changes have been implicated in the pathogenesis of Parkinson’s and 
Alzheimer’s disease (Adler and Beach, 2016; Gardner et al., 2017; Samudralwar et al., 
1995).  To test these hypotheses, we evaluated gene expression and trace elements Fe, 
Mn, Cu, and Zn in the following brain regions due to their importance to trace element 
neurobiology: hippocampus, midbrain, striatum, and olfactory bulb.  The specific genes 
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evaluated in our study were selected based on their role in trace element regulation in 
the brain and their potential connection to neurodegeneration. 
Materials and Methods 
Animals and Diet 
A total of 72 male and female mice from the C57BL/6J (B6J) and DBA/2J (D2J) 
strains were purchased from Jackson Laboratory (Bar Harbor, ME, USA) at post-natal 
day 21.  After a three-day acclimation period in the animal care facility, mice were 
randomly assigned a control low fat diet (LFD) with 10% kcal fat/g (Research Diets, 
D12450J) or mineral-matched high fat diet (HFD) with 60% kcal fat/g (Research Diets, 
D12492) for 16 weeks (see Supplementary Table A1).  Previously, it was established that 
a diet high in fat is successful for inducing obesity in both the B6J and D2J strains (Hu et 
al., 2018).  Similarity in trace element content for each diet was confirmed using 
graphite furnace atomic absorption spectrometry (GFAAS) (Model AA240, Agilent 
Technologies Inc, USA).  Each treatment group comprised n=9 (Table 3.1).  
Determination of the number of animals required for each experiment in this study was 
based on a power analysis using an estimated variance from preliminary studies from 
our laboratory.  Ad libitum feeding of the assigned diets was provided with free access 
to deionized water 24 hours/day.  For the duration of the 16-week treatment, mice 
were weighed once per week, and food weight was recorded three days/week.  Mice 
were housed three per cage with males and females stationed on opposite sides of a 
temperature-controlled room (25°C) maintained on a 12-hour light/dark cycle. 
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This study was conducted in an American Association for Laboratory Animal Care 
accredited facility following a protocol approved by the Institution of Animal Care and 
Use Committee at the University of North Carolina Greensboro.  Procedures were 
performed by the principles and guidelines established by the National Institutes of 
Health for the ethical care and use of laboratory animals.  One mouse was humanely 
euthanized during week 10 of the diet treatment due to lack of movement and food 
consumption.   
 
Table 3.1.  Study Design Based on Strain, Sex, and Diet 
 B6J D2J 
Diet Male Female Male Female 
LFD 9 9 9 9 
HFD 9 9 9 9 
 
Tissue Collection 
At the end of the 16-week dietary treatment, 44 mice were humanely 
anesthetized with isoflurane followed by rapid decapitation.  The remaining mice were 
reserved for a separate behavioral study (data reported elsewhere).  Brains were 
dissected sagitally into right and left hemispheres on an ice-cold stainless-steel platform 
into the following brain regions: olfactory bulb, hippocampus, midbrain, and striatum.  
Brain tissues were snap frozen in liquid nitrogen, placed on dry ice, then stored in the -
80°C freezer until further processing.  Right and left hemispheres were randomly 




Trace Element Analysis 
Trace elements Fe, Cu, Mn, and Zn were evaluated using GFAAS with 
concentrations reported as micrograms of metal per gram of protein.  A sample size of 
n=5 per group was used based on a power analysis from our previous studies (Han et al., 
2019; Liu et al., 2016). Total protein was analyzed using a Pierce™ bicinchoninic acid  
(BCA) protein quantitation assay (Thermo Fisher Scientific, Inc., USA).  Brain samples 
were sonicated in cold radioimmunoprecipitation assay buffer (RIPA) containing 
protease inhibitors.  Homogenates were digested in ultrapure nitric acid as a 1:1 ratio 
for 24 hours in a sand bath between 60-80°C.  Aliquots were diluted with 2% nitric acid 
for use on the GFAAS.  Bovine liver (NBS standard reference material, USDC, Washington 
DC, USA) digested in ultrapure nitric acid was used as an internal standard.   
RNA Isolation and cDNA Synthesis 
RNA was isolated from frozen tissue (n=3-5 per group) with the RNeasy® Plus 
Mini Kit (Qiagen Inc., Germantown, MD, USA) following manufacturer’s protocol.  RNA 
concentration and purity were confirmed with a NanoDrop™ 1000 spectrophotometer 
(Thermo Fisher Scientific, Inc., USA).  Reverse transcription of RNA was performed on 
Applied Biosystems GeneAmp® PCR System 9700 using Applied Biosystems High 
Capacity cDNA Reverse Transcription Kit (Life Technologies, Carlsbad, CA, USA) to 
prepare 20 L samples for the thermocycler.  Reaction conditions were as follows: 25°C 
for 10 minutes, 37°C for 120 minutes, 85°C for five seconds, and 4°C holding 
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temperature at completion.  Samples were stored at -20°C until further evaluation.  
Specific mRNA transcripts measured in this study are listed in Table 3.2. 
 
Table 3.2.  mRNA Transcripts Related to Trace Elements and Neurodegeneration 
mRNA Transcript mRNA Abbreviation Gene  
Divalent Metal Transporter 1  DMT1 SLC11A2 
Iron Regulatory Protein 1  IRP1 ACO1 
Ceruloplasmin  Cp CP 
Copper Transporter 1 CTR1 SLC31A1 
Alpha Synuclein aSyn SNCA 
Amyloid Precursor Protein  APP APP 
Genes were selected for evaluation based on their relevance to the neurobiology of Fe, Mn, Cu, and Zn 
and their implication in neurodegeneration. 
 
 
Real Time Polymerase Chain Reaction (RT-PCR) 
Relative gene expression was determined by RT-PCR on a 7500 Fast Real-Time 
PCR System from Applied Biosystems under the following conditions: incubation for two 
minutes at 50°C, polymerase activation for two minutes at 95°C, and 40 cycles of PCR 
(denature for three seconds at 95°C and anneal/extend for 30 seconds at 95°C).  Gene 
assays were supplied from Life Technologies (Carlsbad, CA, USA) and are listed in Table 
3.2.  Each assay was prepared for RT-PCR using Applied Biosystems™ Taqman™ Fast 
Advanced Master Mix.  Expression of each gene was normalized using 18S as the 
endogenous control.  Normalized cycle threshold (Ct) values were used to determine 
interactions and main effects of diet, sex, and strain.  The comparative Ct method was 
used to determine fold change in gene expression comparing LFD (control) to HFD for 





The effects of diet, sex, and strain on trace element concentration and gene 
expression were assessed using a three-way analysis of variance (ANOVA).  Statistically 
significant interaction effects were evaluated further for simple main effects.  In cases of 
no interactions, statistically significant main effects are reported.  Differences between 
treatment groups at each level were determined by pairwise comparisons with a 
Bonferroni adjustment applied. Normality and homogeneity of variance of data were 
confirmed using the Shapiro-Wilk test and Levene’s test respectively.  Pearson 
correlations were used to determine relationships between final body weight and trace 
element concentrations or gene expression.  If equal variances could not be achieved to 
perform a three factor ANOVA, independent t tests were used to compare differences 
between groups.  Statistical significance was accepted at p<0.05 and differences were 
considered approaching significance between p=0.05-0.10.  Data are reported as means 
± standard error of the mean (SEM). Statistical analysis was performed using IBM SPSS 
Statistics 26. 
Results 
A HFD Causes Significant Weight Gain in Male and Female B6J and D2J Mice 
The 16-week HFD treatment led to significant weight gain for both strains and 
sexes.  At the start of the dietary treatment (approximately three weeks old), there 
were no significant differences between body weight when comparing the LFD group 
and the HFD group for each sex and strain (Table 3.3).  By the end of the 16-week diet 
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treatment (approximately 18 weeks old), there was a significant difference between 
body weight when comparing the same groups (Table 3.3).  Since there are natural body 
weight differences between the two sexes and strains, independent t tests were used 
for this comparison between diet treatment groups.                                                 
 
Table 3.3.  Initial and Final Body Weight 
 
Strain/Sex Initial Body Weight (3 weeks old) Final Body Weight (18 weeks old) 
 LFD HFD Significance LFD HFD Significance 
BM 14.30 ± 0.32 14.37 ± 0.54 p = 0.917 28.72 ± 0.41 48.16 ± 0.36 p < 0.0001 
BF 13.38 ± 0.38 12.80 ± 0.26 p = 0.231 21.58 ± 0.21 41.16 ± 1.38 p < 0.0001 
DM 13.14 ± 0.57 13.24 ± 0.38 p = 0.855 28.14 ± 0.78 43.91 ± 1.81 p < 0.0001 
DF 12.38 ± 0.30 11.51 ± 0.37 p = 0.089 23.26 ± 0.75 34.53 ± 1.45 p < 0.0001 
Body weight comparisons are between LFD groups and HFD groups for male and female B6J and D2J mice 
at the beginning and end of the 16-week diet treatment.  Data are represented as mean ± SEM.  Weight is 
in units of grams. BM = B6J males, BF = B6J females, DM = D2J males, DF = D2J females. 
 
Changes in body weight over the full 16-week diet treatment for each strain and 
sex are shown in Figure 3.1.  The percent weight gain over the 16-week diet treatment 
was significantly higher for mice in the HFD treatment groups compared to the LFD 
treatment groups for each strain and sex.  Since equal variances could not be achieved 
to run a three-factor ANOVA, comparisons between week-1 weight and week-16 weight 
were made using independent t tests.  B6J males fed a LFD gained 102% ± 17% grams in 
weight while the HFD group gained 246% ± 26% (t15=14.019, p < 0.0001).  For the B6J 
females, mice fed a LFD gained 62% ± 12% weight and mice fed a HFD gained 225% ± 
32% weight (t14=14.211, p < 0.0001).  D2J males fed a LFD gained 117% ± 27% weight 
while the HFD group gained 235% ± 27% weight (t15=8.951, p < 0.0001).  The D2J female 
group fed a LFD gained 88% ± 17% weight and the HFD group gained 181% ± 37% weight 
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(t14=6.693, p < 0.0001).  There was no significant difference between grams of food 
eaten when comparing the LFD and HFD groups, indicating that any alterations in trace 
element concentration would not be due to differences in dietary intake. 
 
 
Figure 3.1. Weight Gain by Strain.  Weight gain for B6J mice (A) and D2J mice (B) throughout the diet 
treatment.  Letter codes are as follows: M=male, F=female, L=low fat diet, H=high fat diet. Data are 
represented as mean ± SEM. ****p<0.0001.  Statistical significance refers to between-group differences. 
 
 
Female Mice Fed a HFD Have Increased Fe in the Striatum 
 There was a significant interaction between diet and sex on Fe in the striatum 
(F1,16= 4.584, p=0.048), with a simple main effect of diet for female mice (F1,16= 8.140, 
p=0.012), but not for males (F1,16= 0.031, p=0.863) (Figure 3.2A).  Female mice (B6J and 
D2J combined) fed a HFD show a 27% increase in Fe.  Pairwise diet comparisons for each 
strain and sex showed a significant increase in striatum iron by 27% for B6J female mice 
(F1,16= 7.064, p=0.017) and a 20% increase for D2J mice, although not statistically 







Figure 3.2.  The Effect of HFD on Striatum Fe in B6J and D2J Male and Female Mice.  A diet by sex 
interaction (A) and pairwise diet comparisons (B) both show an increase in striatum Fe in females.  Data 
are represented as mean ± SEM. *p<0.05. 
 
 
There were no statistically significant differences in Mn, Cu, or Zn in the striatum 
due to DIO.  However, a 20% increase in Mn in female B6J mice was approaching 
significance (F1,32= 2.845, p=0.101).  Trace element concentrations for all treatment 
groups in this study can be found in the appendix as Supplementary Table A2.  
 Midbrain Cu Decreases in D2J Mice Fed a HFD 
There was a significant main effect of diet on Cu in the midbrain (F1,30=13.645, 
p=0.001). When fed a HFD, D2J males had a 48% reduction in Cu compared to the LFD 
group (F1,30=7.759, p=0.009), and D2J females had a 37% reduction in Cu compared to 
the control group (F1,30=5.139, p=0.031) (Figure 3.3A).  Although diet did not have a 
significant impact on Fe, Mn, and Zn in the midbrain, the D2J strain had 24% higher Mn 






Figure 3.3. Midbrain Cu and Mn Concentrations in B6J and D2J Mice.  Midbrain Cu was reduced in male 
and female B6J and D2J mice fed a HFD (A). The effect of strain on midbrain Mn (B) shows elevated Mn 
levels in the D2J strain compared to the B6J strain.  Data are represented as mean ± SEM. *p<0.05, **p<0.01. 
 
 
B6J Mice Fed a HFD Have Increased Fe, Mn, Cu, and Zn in the Hippocampus, While D2J 
Mice Fed a HFD Show Opposite Trends in Zn Alterations 
 
 For the B6J strain, there was an overall trend of increasing Fe, Cu, Mn, and Zn 
concentration in the hippocampus for mice fed a HFD (Figure 3.4A-D), with a substantial 
increase in Cu by 39% in B6J female mice (F1,29 = 9.192, p=0.005) (Figure 3.4C).  
Additionally, there was a diet by strain interaction on Cu (F1,29 = 6.704, p=0.015) which 
showed a 27% increase in Cu for B6J mice fed a HFD compared to the control LFD (F1,29 = 
7.056, p=0.013), and an 11% decrease in Cu for D2J mice fed a HFD, although not 
statistically significant (F1,29 = 1.059, p=0.312).  There was a three-way interaction effect 
between diet, sex, and strain on Zn in the hippocampus (F1,28 = 9.849, p=0.004), which 
comprised a significant simple two-way interaction between diet and sex for the D2J 
strain (F1,28 = 12.281, p=0.002), but not for the B6J strain.  The simple main effects from 
this interaction show a significant 48% increase in Zn for D2J males fed a HFD (F1,28 = 
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5.443, p=0.027) and a significant 44% decrease in Zn for D2J females fed a HFD (F1,28 = 




Figure 3.4. Hippocampus Trace Elements.  The effect of diet, sex, and strain on hippocampus Fe (A), Mn 
(B), Cu (C), and Zn (D).  Data are represented as mean ± SEM. *p<0.05, **p<0.01 
 
 
It was also discovered that female mice have higher levels of Fe and Cu in the 
hippocampus, regardless of strain or diet.  Specifically, female mice had 13% higher 
levels of Fe (F1,30 = 6.750, p=0.014) and 16% higher levels of Cu (F1,29 = 5.384, p=0.028) in 





Male B6J Mice Fed a HFD Have Increased Fe and Mn in the Olfactory Bulb 
There was a significant two-way interaction between diet and sex on Fe in the 
olfactory bulb (F1,29= 6.241, p=0.018), with a simple main effect of diet in male mice only 
(F1,29= 9.169, p=0.005).  Male mice (B6J and D2J combined) fed a HFD diet had an overall 
increase in Fe by 41% while female mice showed a decrease in Fe by 6%.  The impact of 
diet on Fe in this brain region was greatest for B6J male mice, with an estimated 75% 
increase in Fe (F1,29 = 12.987, p=0.001) (Figure 3.5A).  There were no interaction effects 
for Mn in the olfactory bulb, however, there was a statistically significant increase in Mn 
by 50% in B6J male mice fed a HFD (F1,30 = 4.675, p=0.039) (Figure 3.5B).  Cu in the 
olfactory bulb was not significantly impacted by DIO.  However, the Cu/Zn ratio in B6J 
females was 24% higher in the HFD group.  This result was approaching statistical 




Figure 3.5. Olfactory Bulb Iron and Manganese.  The effect of diet, sex, and strain on olfactory bulb Fe 
and Mn in male and female B6J and D2J mice.  Male B6J mice fed a HFD have increased levels of both Fe 




The Effect of HFD on Olfactory Bulb Zn Shows Opposite Trends by Strain and Sex 
An evaluation of Zn in the olfactory bulb revealed a significant three-way 
interaction between diet, sex, and strain on Zn concentration (F1,30 = 6.329, p=0.017) 
(Figure 3.6).  Zinc increased by 21% in B6J male mice fed a HFD, but decreased by 28% in 
B6J female mice.  The opposite trend occurred in D2J mice, with a 26% decrease in Zn 
for D2J male mice fed a HFD, but a 17% increase for D2J females.  While this three-way 
interaction was statistically significant, individual differences based on pairwise diet 




Figure 3.6. Olfactory Bulb Zinc Three-Way Interaction.  Three-way interaction between diet, sex, and 




Body Weight is Correlated to Striatal Fe and Hippocampal Zn in Females 
 The relationship between final body weight and trace element concentration 
was measured using the Pearson product-moment correlation.  In the striatum, there 
was a strong positive correlation between Fe and female body weight (R=0.70, p=0.011) 
Figure 3.7A).  In the hippocampus, there was a strong negative correlation between Zn 
and D2J female body weight (R= -0.80, p=0.009) (Figure 3.7B).  The corresponding 
coefficient of determination (R2) for each correlation is shown in Figure 3.7.  In the 
striatum of female B6J and D2J mice, 49% of the variance in Fe concentration can be 
explained by body weight.  In the hippocampus, 64% of the variance in Zn for D2J 
females can be explained by body weight. 
 
 
Figure 3.7. Final Body Weight and Trace Element Concentration Correlations.  Body weight after the 16-
week diet treatment is positively correlated to striatum Fe in female mice (A) and negatively correlated to 






D2J Female Mice Fed a HFD Have Increased Expression of Ceruloplasmin in the Striatum 
 The influence of diet, sex, and strain on gene expression in the striatum was 
evaluated for DMT1, IRP1, ceruloplasmin, and alpha synuclein.  The expression of 
ceruloplasmin mRNA in the striatum was significantly impacted by HFD  (Figure 3.8A).  
Specifically, ceruloplasmin was upregulated 1.6-fold for female D2J mice fed a HFD 
(F1,30=6.511, p=0.016) compared to mice fed a LFD.  The influence of diet was not 
significant for B6J mice or D2J male mice.  When evaluating sex and strain as factors that 
may influence gene expression, there was a significant sex difference in mRNA 
expression for DMT1, alpha synuclein, and ceruloplasmin in the striatum.  Compared to 
B6J males, female B6J mice had 1.3-fold increased expression of DMT1 mRNA 
(F1,30=7.848, p=0.009) and nearly 20-fold decreased expression of alpha synuclein mRNA 
(F1,30=916.922, p<0.0001).  While the sex effect was not significant in D2J mice for DMT1 
and alpha synuclein, there was a significant sex effect in the D2J strain for the 
expression of ceruloplasmin.  Compared to D2J males, ceruloplasmin expression in D2J 
females is 1.4-fold less (F1,30=11.685, p=0.002).  When examining the impact of sex by 
diet for ceruloplasmin, this repression was only significant for female D2J mice fed a 
LFD, with a 1.9-fold reduction in mRNA compared to males (F1,30=13.014, p=0.001).  The 
effect of sex on DMT1 and alpha synuclein expression was not analyzed separately by 
diet since there was no diet effect for either gene.  IRP1 showed no significant 
difference in mRNA expression by diet, sex, or strain.  Gene expression data for the 
striatum is included in the appendix as Supplementary Table A3.  
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DIO Significantly Impacts Gene Expression in the Hippocampus of B6J Male Mice 
 There were significant three-way interaction effects between diet, sex, and 
strain for the mRNA expression of DMT1 (F1,30=31.955, p<0.0001) , ceruloplasmin 
(F1,32=4.629, p=0.039), alpha synuclein (F1,28=6.988, p=0.013), and APP (F1,30=31.322, 
p<0.0001).  The impact of the HFD on the expression of these genes is shown in Figure 
3.8B.  For DMT1, there was an upregulation by 5-fold for B6J male mice fed a HFD 
(F1,30=77.306, p<0.0001), but only a slight downregulation for D2J male mice, and no 
change in expression for females of either strain due to diet.  For ceruloplasmin, there 
was a downregulation of mRNA expression in B6J male mice fed a HFD by 1.5-fold 
(F1,32=6.911, p=0.013), a slight induction for D2J male mice, and no change for females.  
For alpha synuclein, both male and female B6J mice fed a HFD showed a significant 
upregulation in mRNA, with a 7-fold increase in B6J males (F1,28=41.805, p<0.0001) and a 
1.7-fold increase for B6J females (F1,28=4.486, p=0.043).  The expression of alpha 
synuclein in D2J mice was not impacted by the HFD.  For APP, only the B6J male mice 
were significantly impacted by the HFD, with a 10-fold upregulation (F1,30=96.038, 
p<0.0001).  Female mice of both strains showed a slight upregulation in APP.  Although 
diet did not have an impact on any of the mice for the expression of CTR1 (Figure 3.8B), 
there was a significant two-way interaction between sex and strain (F1,32=21.415, 
p<0.0001) for the expression of this gene.  The effect of strain was only significant for 
females, with D2J female mice showing a 2-fold decrease in expression compared to 
female B6J mice (F1,32=28.570, p<0.0001).  The effect of sex was only significant in the 
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D2J s, with D2J females showing a 2-fold decrease in expression compared to D2J males 
(F1,32=23.768, p<0.0001).  Gene expression data for the hippocampus is included in the 
appendix as Supplementary Table A4. 
DIO Significantly Impacts Gene Expression in the Olfactory Bulb of D2J Male Mice 
 The expression of mRNA in D2J male mice was influenced by exposure to a 
chronic high fat diet.  DMT1 mRNA expression increased by 2-fold (F1,23=4.608, p=0.043), 
alpha synuclein was upregulated by 1.5-fold (F1,22=4.805, p=0.039), and APP was 
upregulated by nearly 3-fold ((F1,23=7.436, p=0.012) (Figure 3.8C).  Each gene measured 
in this brain region also showed a significant sex by strain interaction effect.  For DMT1, 
the effect of sex was significant for B6J mice only (F1,23=23.708, p<0.0001), with B6J 
females expressing 3-fold higher mRNA compared to B6J males.  Alpha synuclein 
showed a similar pattern of a sex effect that was evident in B6J mice only (F1,22=32.455, 
p=0.0001), with B6J females expressing 2.4-fold higher mRNA compared to B6J males.  
The sex by strain interaction was different for APP mRNA expression, with a significant 
sex effect for D2J mice only (F1,23=158.745, p<0.0001).  In this case, D2J males had a 23-
fold higher expression level compared to D2J females.  Gene expression data for the 





Figure 3.8.  Gene Expression Related to Trace Element Regulation and ND.  Fold change comparisons by 
diet for these genes are shown for the striatum (A), hippocampus (B), and olfactory bulb (C). The LFD 
mRNA expression was established as the control (set to 1).  Fold change compared to each control was 
determined using the 2-Ct method. Data are represented as mean ± SEM. *p<0.05, ****p<0.0001. 
DMT1=divalent metal transporter 1, IRP1=iron regulatory protein 1, Cp=ceruloplasmin, aSyn=alpha 
synuclein, CTR1=copper transporter protein 1, APP = amyloid precursor protein, BM=B6J males, BF=B6J 





Body Weight is Correlated with mRNA Expression of DMT1, Alpha Synuclein, and APP in 
Female D2J Mice 
 
 To understand the relationship between body weight and gene expression in the 
brain, Pearson correlations were evaluated using the final weight of each mouse after 
the 16-week diet treatment with delta Ct values from the RT-PCR experiment.  Since 
there is an inverse relationship between delta Ct values and gene expression, positive R 
values indicate a decrease in mRNA expression and negative R values indicate an 
increase in mRNA expression.  Correlation data with statistical significance for DMT1, 
alpha synuclein, and APP in the striatum, hippocampus, and olfactory bulb for both 
strains and sexes are summarized in Table 3.4.  Correlations were only statistically 
significant for D2J females after examining scatter plots for linearity.  In the striatum, 
DMT1 expression increases as body weight increases for D2J females (p=0.001).  In the 
hippocampus, as body weight increases for D2J females, gene expression increases for 
DMT1 (p=0.042), alpha synuclein (p=0.045), and APP (p=0.002).  Furthermore, in the 
striatum there were no significant correlations found for IRP1 or ceruloplasmin with 
body weight.  In the hippocampus, there were no significant correlations found for CTR1 




Table 3.4.  Correlation Between Final Body Weight and Gene Expression  
Gene Strain/Sex Striatum Hippocampus Olfactory Bulb 
  R p R p R p 
DMT1 BM 0.38 0.283 -0.86 0.026 0.43 0.291 
BF 0.30 0.396 -0.04 0.922 -0.06 0.885 
DM 0.02 0.973 0.60 0.088 -0.89 0.018 
DF -0.91 0.001 -0.65 0.042 -0.44 0.277 
aSyn BM 0.47 0.168 -0.92 0.004 0.88 0.009 
BF 0.65 0.044 -0.63 0.072 0.21 0.619 
DM 0.10 0.824 -0.17 0.658 -0.77 0.044 
DF 0.22 0.577 -0.64 0.045 -0.24 0.567 
APP BM   -0.92 0.001 -0.040 0.925 
BF   -0.58 0.080 0.149 0.726 
DM   0.33 0.382 -0.984 0.0004 
DF   -0.84 0.002 0.134 0.752 
Positive correlations indicate a decrease in gene expression and negative correlations indicate an increase 
in gene expression.  Blue text indicates no correlation due to clustering of data or nonlinear scatterplot.  
Red text indicates a statistically significant correlation.  BM = B6J males, BF = B6J females, DM = D2J 





The goal of our study was to understand the impact of DIO on trace element 
homeostasis and mRNA gene expression in multiple brain regions, and to identify 
interactions between diet, sex, and strain.  Dysregulation of trace element homeostasis 
and gene expression in the brain has been associated with a number of NDs, such as 
Alzheimer’s disease and Parkinson’s disease (Cicero et al., 2017; Cristóvão et al., 2016; 
Ferreira and Gahl, 2017; Hwang et al., 2017).  We have shown here that DIO disrupts Fe, 
Mn, Cu, and Zn concentrations and mRNA gene expression in the brain in a sex and 
strain-dependent fashion.  Additionally, we found that obesity-induced alterations in 
trace element concentrations and gene expression were brain region-dependent, which 
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is consistent with our previous work (Han et al., 2019; Liu et al., 2016).  The impact of 
DIO on each brain region was unique, ranging from simple cases of no effect (e.g., 
hippocampus Mn) to complex three-way interactions between diet, sex, and strain (e.g., 
olfactory bulb Zn).  Although we hypothesized that the factor of sex would be more 
prominent in the B6J strain based on our previous pilot study, we found that sex was 
often a critical factor for both strains.  We also hypothesized that Fe, Zn and alpha 
synuclein mRNA expression would increase in the olfactory bulb due to DIO.  We found 
that Fe was in fact elevated, but for males only.  The Zn outcome in this brain region 
depended on both sex and strain, and alpha synuclein was upregulated only in D2J 
males.  As DIO provoked differerent responses in trace element homeostasis and gene 
expression based on sex and strain, we speculate that these biological factors are 
instrumental in elucidating the precise mechanisms of neurodegeneration, with 
potential for targeted  therapeutics based on sex or genetic profile.  Our research 
provides a snapshot of DIO effects at a particular timepoint in mice (18 weeks old), and 
lays the foundation for future sex and strain based DIO studies.   
Effect of HFD on DIO 
Our experimental design included male and female B6J and D2J mouse strains 
which were randomly assigned to a LFD or HFD for the duration of the study.  As with 
our previous studies, there was a marked difference in the volume of adipose tissue 
while harvesting organs from our mice, with HFD mice consistently exhibiting greater 
volumes of fat tissue.  Males and females from both the B6J and D2J strains fed a HFD 
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had significantly higher body weight at the end of the diet treatment (Figure 3.1).  This 
weight gain corroborates previous reports of DIO in B6J and D2J mouse strains 
(Alexander et al., 2006; Montgomery et al., 2013; West et al., 1992).  In contrast, there 
are previous reports that indicate D2J mice as responding less efficiently to a HFD, 
including lack of weight gain (Kirk et al., 1995), delayed weight gain (Norris et al., 2016), 
or similar weight gain compared to a control LFD (Funkat et al., 2004).  These studies 
either initiated their diet treatments later than three weeks of age (typically 8-10 weeks 
old), or used a fat source other than lard in their HFD.  Our male and female D2J mice 
fed a HFD all gained significantly more weight compared to mice fed a LFD, likely due to 
early initiation of the HFD treatment at approximately three weeks old and the 
incorporation of 60% lard as the source of fat.  The DIO model used in our study allowed 
us to fully determine the influence of sex and genetics on brain regional trace element 
homeostasis and gene expression in the obese state. 
Effect of DIO in Striatum 
In the striatum, a brain region involved in controlling movement, responding to 
environmental stimuli (Rolls, 1994), and learning (Graybiel and Grafton, 2015), we 
report increased concentrations of Fe in female mice (Figure 3.2A) and upregulated 
gene expression of ceruloplasmin in D2J female mice (Figure 3.8A) due to DIO. To the 
best of our knowledge, our study is the first to show that a persistent HFD is associated 
with an accumulation of Fe in the female striatum.  This significant increase in Fe for 
females strongly supports the role of DIO in the disruption of trace element homeostasis 
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(Figures 3.2A, 3.7A).  While both the B6J and D2J female strains did show an increase in 
Fe, the results were more significant in the B6J strain (Figure 3.2B).  Previous reports 
comparing C57BL/6 and DBA/2 strains have shown differences in biological response 
due to Fe-rich or Fe-poor diets.  For example, in a study using male C57BL/6Ibg and 
DBA/2JIbg strains fed a high-Fe diet for four months, the C57BL/6Ibg strain experienced 
increased hepatic lipid hyrdoperoxide levels and increased glutathione S-trasnferase 
activity compared to the DBA/2JIbg strain (Tjalkens et al., 1998).  In a study using male 
and female mice from the BXD recombinant inbred strains and their parental strains 
(B6J and D2J) fed an Fe-deficient diet for approximately 3.5 months, there was a 
significant diet by strain interaction on Fe concentrations in the striatum and midbrain 
ranging from no change to 37% change across strains (Jellen et al., 2012). In contrast to 
these findings in females, we found no significant change in striatum Fe status in B6J 
males, which is consistent with our previous work using exclusively male B6J mice (Han 
et al., 2019).  Interestingly, it has been reported that Fe can accumulate in the striatum 
of multiple sclerosis patients due to inflammation of brain tissue and the attraction of 
Fe-rich microglia (Mezzaroba et al., 2019).  During a state neuroinflammation, microglia 
become activated to sequester extracellular iron to protect surrounding tissues, thereby 
increasing intracellular iron in this mode of defense (Nnah and Wessling-Resnick, 2018).  
Triggers for neuroinflammation can include proinflammatory cytokines, pathogens 
(Nnah and Wessling-Resnick, 2018), or protein deposits such as beta amyloid (Gold and 
El Khoury, 2015) or alpha synuclein (Ferreira and Romero-Ramos, 2018; Q.-S. Zhang et 
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al., 2017).  Systemically, it has been reported that DIO elicits a redistribution of Fe 
(increased Fe in adipose tissue and decreased Fe in liver), accompanied by upregulation 
of inflammatory cytokine and reduced ferromagnetic adipose tissue macrophages (Orr 
et al., 2014).  As obesity is related to a heightened state of inflammation, it is possible 
that the increase in Fe that we see in our study may be related to this attraction and 
activation of microglia, with females being more susceptible than males for reasons that 
should be futher investigated.   
Based on these striatal Fe alterations in females, we predicted that the gene 
expression of DMT1 or IRP1 would be impacted by DIO in the female striatum.  Although 
ANOVA showed no difference in mRNA expression of either gene due to DIO (Figure 
3.8A), there was a significant positive correlation between body weight and DMT1 
mRNA expression in D2J females (Table 3.4).  Furthermore, there was a significant sex 
effect for the expression of DMT1, with B6J females expressing 1.3-fold higher levels of 
this gene compared to males.  DMT1 is a ubiquitous transporter for several trace 
elements, including Fe, Mn, and Cu (Mezzaroba et al., 2019; Skjørringe et al., 2015).  The 
higher expression levels of DMT1 in B6J females may explain the susceptibility of female 
mice to increases in striatal Fe particularly due to HFD.  While the specific mechanism 
driving HFD-associated increased Fe is unknown, these data provide a platform to direct 
future studies designed to identify the mechanism(s).  Our previous study examining 
DIO in B6J males looked at an array of Fe-regulating proteins such as hepcidin, 
ferroportin, transferrin receptor and ferritin and found no effect of HFD on any of them.  
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Due to limited tissue in the current study, we selected DMT1, IRP1, and ceruloplasmin 
based on their contribution to Fe homeostasis (Lu et al., 2017; Skjørringe et al., 2015; 
Zhou and Tan, 2017), as well as their relationship to other trace elements (Cu, Mn, and 
Zn) (Han et al., 2016; Jursa and Smith, 2009; Martelli and Moulis, 2004).  Additionally, 
we evaluated alpha synuclein in the striatum, as this protein is known to aggregate with 
Fe during the process of neurodegeneration (B. Chen et al., 2019).  Consistent with our 
previous work with male B6J mice fed a HFD (Han et al., 2019), alpha synuclein gene 
expression in males was not impacted in the striatum.  Our data support that future 
studies looking at the impact of DIO on brain iron metabolism should include both sexes 
and a wider array of Fe-regulating genes to further our understanding of Fe-related 
neurodegenerative processes. 
The gene expression of ceruloplasmin was also evaluated in the striatum.  
Ceruloplasmin is a Cu-dependent protein that acts as a ferroxidase, enabling cellular 
export of Fe into the blood via the binding to transferrin in the Fe3+ oxidation state 
(Hellman and Gitlin, 2002).  This protein also acts as an oxidizing agent for Mn (Hellman 
and Gitlin, 2002; Jursa and Smith, 2009).  Although DIO did not have an impact on the 
gene expression of DMT1 or IRP1 in the striatum, we found that DIO disrupted mRNA 
expression of ceruloplasmin in D2J female mice (Figure 3.8A), with a statistically 
significant upregulation by 1.6-fold.  Previous studies have shown evidence of 
ceruloplasmin upregulation associated with neurodegenerative disease in humans and 
rodents.  For example, postmortum brain tissue ceruloplasmin levels were elevated in 
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the striatum of Alzheimer’s disease patients compared to young adult and elderly 
controls (Loeffler et al., 1996).  Moreover, ceruloplasmin mRNA and protein was 
upregulated in the retinas of glaucomatous DBA/2 mice, but not C57BL/6 control mice 
(Stasi et al., 2007).  In this same study, ceruloplasmin concentration was elevated in 
human eye tissue of patients with glaucoma.  Further studies are needed to determine if 
the induction of ceruloplasmin that we found in the striatum of D2J females with DIO 
could impact Fe or Mn homeostasis with age and continued HFD feeding, or if this 
upregulation is associated with neurodegeneration.   
In addition to the sex effect that we found on DMT1 mRNA expression, there 
was also a sex effect for the expression of ceruloplasmin and alpha synuclein.  D2J 
females expressed 1.4-fold lower levels of ceruloplasmin than D2J males, and B6J 
females expressed 20-fold lower levels of alpha synuclein compared to male B6J mice.  
Collectively, these results show that the impact of DIO on trace element homeostasis 
and gene expression in the striatum is influenced by sex and strain.  Furthermore, even 
when diet had no impact on biochemical parameters, the sex and strain differences that 
we have discovered here are important to consider when studying the 
pathophysiological mechanisms of ND. 
Effect of DIO in Midbrain 
The midbrain is of particular interest for the study of Parkinson’s disease, as this 
brain region is known to accumulate Fe and alpha synuclein as neurodegeneration 
progresses (P. Chen et al., 2019; Lingor et al., 2017).  Furthermore, Cu depletion in the 
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midbrain is a hallmark of this disease (Dusek et al., 2015; Liddell and White, 2018).  In 
our previous work, we found that both Fe and alpha synuclein increased in the midbrain 
of B6J male mice fed a HFD (Han et al., 2019).  In our current study using male and 
female B6J and D2J mice, we report that Cu was significantly reduced in male and 
female D2J mice, but only slightly reduced in B6J mice (Figure 3.3A).  This decline in Cu is 
consistent with characteristics of Parkinson’s disease, supporting the role of DIO as a 
potential trigger for trace element dysregulation and neurodegeneration. Although Cu 
homeostasis was altered, the mice in our study did not show significant changes in Fe, 
Mn, or Zn due to DIO.  This may be due to the age of our mice (18 weeks old) at the time 
of trace element analysis, compared to our previous study that examined mice at 24 
weeks old.  Fe is known to accumulate in the brain with normal aging and during cases 
of neurodegeneration (Ward et al., 2014), and we propose that DIO can exacerbate this 
accumulation with time.  Since mRNA concentrations were unusually low in our 
midbrain samples, gene expression data were limited to males only.  We found that 
ceruloplasmin and alpha synuclein gene expression was slightly upregulated due to DIO, 
however these differences were not statistically significant.  Gene expression data for 
the midbrain is included in the appendix as Supplementary Table A6.  Taken together, 
our trace element and gene expression results show that at 18 weeks of age, B6J and 
D2J mice fed a HFD do not yet experience significant Fe accumulation nor alpha 
synuclein induction in the midbrain.  Additionally, the substantial Cu reductions in D2J 
mice due to DIO emphasize the importance of evaluating genetics as a factor in trace 
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element dysregulation, and indicate that D2J mice may be impacted at an earlier age 
compared to the B6J strain.   
Effect of DIO in Hippocampus 
Several interactions between diet, sex, and strain on trace element homeostasis 
were discovered in the hippocampus.  The hippocampus is a brain region involved in 
learning, memory, and cognition (Toda et al., 2019).  Alterations in Cu and Zn due to DIO 
were more prevalent in this brain region compared to Fe and Mn.  For example, female 
B6J mice fed a HFD had a significant 39% increase in Cu (Figure 3.4C), and there was a 
three-way interaction between diet, sex, and strain for Zn, affecting mainly the D2J 
strain (Figure 3.4D).  The effect of DIO revealed a striking difference between Zn levels 
within the D2J strain.  D2J males had a significant 48% increase in Zn, while females had 
a significant 44% decrease in Zn (Figure 3.4D).   Additionally, D2J female body weight 
was negatively correlated to Zn concentration (Figure 3.7B).  In the literature, there are 
several conflicting reports of Zn concentration in the hippocampus of Alzheimer’s 
disease patients, with some showing increases and others reporting decreases (Panayi 
et al., 2002).  We speculate that the sex-dependent dysregulation of Zn could be due to 
altered gene expression provoked by DIO.  In a study that evaluated Zn-related gene 
expression patterns in the cortex of post mortem tissue, ZNT3 and ZNT4 mRNA 
expression was downregulated, while ZIP1, ZIP9, and ZIP3 were upregulated in brain 
tissue of obese individuals (Olesen et al., 2016).  Additionally, BMI was correlated with 
repression of both ZNT1 and ZNT6.  This study also measued the effects of sex and race, 
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and found that men had a higher expression of ZNT4, women had lower expression of 
ZIP1, and African Americans had higher expression of ZIP14 compared to Caucasians.   
Although these results are for cortex, it is possible that Zn dysregulation in the 
hippocampus may also depend on ZIP and ZNT gene expression.  The activity of Cu-Zn 
superoxide dismutase (SOD) in postmortem brain tissue of Alzheimer’s patients was also 
found to be sex-dependent (Schuessel et al., 2004).  Cu-Zn SOD activity was higher 
overall in Alzheimer’s brain tissue versus control tissue, but females with Alzheimer’s 
disease had higher activity of Cu-Zn SOD than males with Alzheimer’s.  No sex difference 
in Cu-Zn SOD activity was found in the control samples.  Dysregulation of Cu and Zn 
homeostasis is a hallmark of Alzheimer’s disease, as both ions can interact with beta 
amyloid protein in the formation of senile plaques (Mezzaroba et al., 2019; Sensi et al., 
2018), occurring mainly in the hippocampus (Cristóvão et al., 2016; Deibel et al., 1996; 
Tamano and Takeda, 2019).  In the current study, we found a diet by strain interaction 
for Cu in this brain region, with B6J mice showing an increase in Cu while D2J mice 
showed a decrease in concentration.  These strain differences suggest that genetics 
have a strong influence on biochemical response to DIO, and may help to explain the 
disparity in results regarding Cu increases or decreases reported in the literature 
(Mezzaroba et al., 2019).  Furthermore, the opposite effects in Zn concentration for D2J 
males and females emphasize that sex is a critical factor when studying the impact of 
DIO on trace element dysregulation. 
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Gene expression in the hippocampus was also influenced by diet, sex, and strain.  
Based on our results of increased Cu levels, we speculated that there may be 
disturbances in CTR1 expression, a major transporter for Cu in the brain (Sharp, 2003).  
Contrary to our prediction, there was no impact of DIO on CTR1 expression (Figure 
3.8B), however, there were significant three-way interactions between diet, sex, and 
strain for the mRNA expression of ceruloplasmin, DMT1, alpha synuclein, and APP.  
These interactions showed a greater impact on males compared to females.  For 
example, the expression of DMT1 and ceruloplasmin had opposite effects, with DMT1 
expression increasing for B6J males but decreasing for D2J males, while ceruloplasmin 
showed a decrease in expression for B6J males and an increase in D2J males.  Expression 
of these two genes for females of both strains was unaffected by DIO.  This leads us to 
infer that the increase in Cu for B6J females that we found is not directly related to the 
mRNA gene expression of DMT1 or ceruloplasmin.  Future studies will include protein 
expression measurement to investigate other potential mechanisms of Cu dysregulation 
in B6J female mice.  For alpha synuclein, there was an upregulation for both male and 
female B6J mice due to DIO (Figure 3.8B), but no change in D2J mice, highlighting the 
influence of genetics on gene expression.  In the hippocampus, alpha synuclein can form 
protein aggregates called Lewy bodies, which are characteristic of dementia and 
Alzheimer’s disease (Adamowicz et al., 2017).  Our results suggest that the B6J strain is 
more susceptible to Lewy body formation in the hippocampus when fed a HFD.  The 
effect of DIO on APP expression had the most significant impact on B6J males, with a 10-
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fold increase in mRNA expression (Figure 3.8B).  Amyloid precursor protein (APP) is a 
transmembrane protein associated with several biological functions, including cellular 
proliferation and differentiation, cell-fate specification, and neurite outgrowth (S. Wang 
et al., 2016).  The overexpression of APP, however, has been implicated in the 
progression of Alzheimer’s disease (Roher et al., 2017) since the senile plaques in this 
disease consist mainly of beta amyloid protein, which is derived from the proteolytic 
cleavage of APP.  Disruptions in normal gene expression of APP can therefore lead to the 
potential build-up of beta amyloid, promoting the conditions for neurodegeneration.  
The hippocampus is particularly vulnerable to beta amyloid protein aggregation and 
senile plaque formation (Zhang et al., 2011).  Our results are consistent with other DIO 
studies involving male B6J mice fed a HFD that found either beta amyloid accumulation 
(Busquets et al., 2017) or APP induction (Puig et al., 2012) in response to DIO.   
Overall, our findings in the hippocampus demonstrate that sex and strain 
strongly influence the impact of DIO on Cu and Zn homeostasis and gene expression 
alterations in DMT1, ceruloplasmin, alpha synuclein, and APP.  Sex differences were 
prominent in the D2J strain for Zn, while strain differences are highly pronounced for 
DMT1 and ceruloplasmin expression in males.  Genes related to neurodegenerative 
pathologies, alpha synuclein and APP, show a dramatic upregulation only in male B6J 
mice and corroborate with previous studies in male B6 mice (Busquets et al., 2017; Puig 
et al., 2012).  These data provide a foundation for future studies examining sex and 
strain influences on the effects of DIO and neurodeneration.    
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Effect of DIO in Olfactory Bulb 
The impact of diet, sex, and strain was also evident in the olfactory bulb, a brain 
region involved in the detection of odor (Nagayama et al., 2014).  Compared to other 
brain regions, it has less protection by the blood brain barrier and more exposure to the 
environment through the nasal cavity, providing a potential route for toxins, or a 
beneficial entry for therapeutics (Crowe et al., 2018).  In our study, we found a diet by 
sex interaction for Fe that showed an increase in Fe in males but a decrease in Fe in 
females due to DIO.  The impact of DIO was greatest in B6J males, which showed a 75% 
higher concentration of Fe (Figure 3.5A) and a 50% elevation in Mn (Figure 3.5B) in the 
HFD group versus the LFD group.  Although there were no differences in Cu 
concentrations in the olfactory bulb due to DIO, the Cu/Zn ratio for female B6J mice was 
24% higher for the HFD group compared to the LFD group and was trending toward 
statistical significance (p=0.097).  Elevated blood Cu/Zn ratios have been reported 
previously in cases of autism spectrum disorders (Bjørklund, 2013), aging (Giacconi et 
al., 2017), and inflammation (Malavolta et al., 2015).  For Zn, there was a significant 
three-way interaction between diet, sex, and strain in the olfactory bulb (Figure 3.6).  
Concentrations of Zn were increased in B6J males and D2J females but were decreased 
in B6J females and D2J males by a similar magnitude.  Interestingly, the Zn results in D2J 
mice in the olfactory bulb were opposite of the Zn results in the hippocampus (Figure 
3.4D).  It is possible that Zn may be redistributed within brain regions during obesity-
induced dysregulation, causing increases in one region and decreses in others.  This 
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highlights the importance of evaluating individual brain regions versus whole brain 
analysis.  Our trace element results were similar in some aspects to a study using post-
mortem male and female human brain tissue, which found that Fe concentration was 
25% higher in Parkinson’s disease olfactory bulbs compared to controls (Gardner et al., 
2017).  In another study using brain tissue from Alzheimer’s disease patients, Fe and Zn 
were significantly elevated in the olfactory bulb (Samudralwar et al., 1995).  Collectively, 
these studies demonstrate that DIO and common neurodegenerative diseases may be 
associated with trace element dysregulation in the olfactory bulb. 
Alterations in gene expression due to DIO in the olfactory bulb were assessed for 
DMT1, alpha synuclein, and APP (Figure 3.8C).  Considering the significant Fe and Mn 
alterations due to DIO found in male B6J mice, we expected to find an impact on gene 
expression in B6J males as well.  Unexpectedly, only the D2J males were highly 
impacted, with a significant upregulation in all three genes due to DIO.  Previous studies 
have also shown B6 and D2 strain differences in APP and DMT1 expression.  For 
example, one study found that under conditions of stress, APP mRNA in the 
hypothalamus was upregulated in D2J mice but not in B6J mice (Tsolakidou et al., 2010).  
Another study found that APP protein levels were upregulated in D2J glaucomatous 
retinas, but not in B6 controls (Goldblum et al., 2007).  In the duodenum, there were 
significant diet by strain interactions on the mRNA expression of DMT1 for D2 and B6 
mice which showed that mRNA was upregulated more in D2 mice fed an Fe-deficient 
diet compared to B6 mice, while an Fe-supplemented diet resulted in a downregulation 
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of DMT1 in D2 mice, but had no effect on B6 mice (Dupic, 2002).  In future studies, we 
will examine both mRNA and protein expression together to understand the 
downstream effects of gene expression alterations.  In the current study, the increase in 
Fe that we found in B6J males in the olfactory bulb were not associated with an 
induction of alpha synuclein mRNA in B6J males.  Although Fe overload is known to 
promote alpha synuclein aggregation (B. Chen et al., 2019), and alpha synuclein 
upregulation has been associated with synucleinopathies (Tagliafierro and Chiba-Falek, 
2016), other studies have shown that alpha synuclein mRNA expression is unchanged or 
reduced in Parkinson’s disease brains, with Fe inducing alpha synuclein protein synthesis 
at the translational level rather than the transcriptional level (Febbraro et al., 2012; 
Zhou and Tan, 2017).  This helps to explain why we did not see an upregulation of alpha 
synuclein mRNA in the olfactory bulb of B6J mice fed a HFD, even though Fe was 
elevated in this brain region. 
To summarize our results in the olfactory bulb, we found that DIO led to 
alterations in trace element homeostasis predominantly in male B6J mice, and gene 
expression dysregulation mainly in male D2J mice.  While these changes in 
neurobiological conditions due to DIO may not be related, our results show that DIO has 
the potential to disrupt homeostasis by various methods in the olfactory bulb, with 





In conclusion, our study provides unique information regarding the impact of 
DIO on trace element homeostasis and mRNA gene expression in multiple brain regions, 
with sex and genetic factors influencing the outcome.  In the striatum, Fe was 
significantly increased in B6J females and ceruloplasmin was significantly upregulated in 
D2J females.  In the midbrain, there was a substantial decrease in Cu for the D2J strain 
only.  In the hippocampus, there was a dramatic upregulation of DMT1, alpha synuclein, 
and APP for B6J males.  Moreover, there was an opposite trend of Zn dysregulation in 
this brain region for the D2J strain that showed a significant increase in Zn for males but 
a major decrease in Zn for females.  In the olfactory bulb, Fe and Mn were significantly 
increased for B6J males and there was a significant induction of DMT1, alpha synuclein, 
and APP for D2J males.  A major strength of our study includes the use of two murine 
strains and both sexes, allowing for the evaluation of sex and genetics as biological 
variables.  Additionally, we examined the effects of DIO in a brain region-specific 
manner.  Limitations of our study include the lack of protein expression data and mRNA 
expression data for the midbrain.  Although we processed the midbrain to collect mRNA, 
the concentrations were too low for RT-PCR analysis for most samples.   
Overall, our findings provide evidence that sex and strain factors influence the 
effect of DIO on the brain.  While we hypothesized that the effect of sex would be 
greater in the B6J strain, we found that sex was often a significant factor for both 
strains.  Our hypothesis for elevated Fe levels and alpha synuclein gene expression in 
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the olfactory bulb was confirmed in male B6J mice and male D2J mice respectively.  
Consistent with our previous work (Han et al., 2019; Liu et al., 2016), we found that 
trace element dysregulation and gene expression alterations due to DIO were brain 
region-specific.  The biochemical disruptions that we discovered in each brain region 
often differed in magnitude and direction depending on sex and strain, highlighting the 
important influence of sex and genetics on the impact of DIO in the brain.  Considering 
the staggering escalation of obesity prevalence for males and females with various 
genetic backgrounds, these data have important health implications regarding the 








THE IMPACT OF SEX AND STRAIN ON THE DYSREGULATION OF BEHAVIOR, DOPAMINE 




Obesity is linked to several adverse behavioral and biochemical changes, such as 
reduced physical activity, increased anxiety, and compromised memory.  Furthermore, 
diet induced obesity (DIO) can lead to gene expression alterations in the brain and 
dysregulated dopamine biology.  The objective of our study was to determine the 
impact of DIO on behavior, dopamine biology, and gene expression in male and female 
C57BL/6J (B6J) and DBA/2J (D2J) mice.  Mice were fed either a low fat diet with 10% kcal 
from fat or a high fat diet (HFD) with 60% kcal from fat for 16 weeks.  Behavior 
assessments demonstrated that B6J male mice fed a HFD were impacted the most 
through their display of significantly reduced locomotion, reduced rate of habituation to 
a novel environment, lack of motivation, and elevated anxiety levels in the open field.  
Dopamine clearance in the dorsal striatum was significantly reduced in both male and 
female D2J mice due to DIO, while in the nucleus accumbens core, reductions in 
dopamine clearance occurred for male mice of both strains fed HFD.  Our evaluation of 
mRNA gene expression showed that dopamine receptor D2 (DRD2) was significantly  
upregulated in the striatum of B6J males.  In the olfactory bulb, DIO caused a significant
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upregulation of DRD2 and tyrosine hydroxylase in D2J males, and an induction of brain-
derived neurotrophic factor expression in B6J females.  In summary, our study provides 
evidence for important sex and strain differences on the impact of DIO-induced 
behavior alterations and neurobiology dysregulation.  As the incidence of obesity 
continues to rise worldwide, these data have key health implications related to 
debilitating behavior disorders that can be triggered by a HFD and a state of DIO. 
Introduction 
Obesity and overweight prevalence is escalating worldwide, with an estimated 
39% of adults classified as obese or overweight (Chooi et al., 2019).  The adverse effects 
of obesity have been linked to various behavioral and biochemical changes, such as 
reduced physical activity (Sanyaolu et al., 2019), increased anxiety (Baker et al., 2017), 
and compromised memory (Davidson et al., 2014).  Furthermore, diet induced obesity 
(DIO) can lead to gene expression alterations in the brain (Gan et al., 2015; Huang et al., 
2005a; Wu et al., 2017) and dysregulated dopamine biology (Leite and Ribeiro, 2019).  
As conditions of overweight and obesity are increasing in both males and females 
worldwide, these alterations in behavior and biochemistry due to obesity can have 
serious consequences related to declining health, reduced productivity, and increased 
health care costs (Trogdon et al., 2008). 
It has been demonstrated that physical activity or mobility can be impacted by a 
state of obesity in humans and rodents.  In humans, obesity has been associated with 
decreased fine motor control and speed (C. Wang et al., 2016), reduced functional 
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mobility in adults (Forhan and Gill, 2013; Trivedi et al., 2015), and decreased physical 
activity in children and adolescents (Sanyaolu et al., 2019).  In rodents, there are mixed 
results.  In some studies, C57BL/6J (B6J) and C57BL/6 (B6) mice fed a high fat diet (HFD) 
show reduced locomotion due to HFD (Almeida-Suhett et al., 2017; Krishna et al., 2016; 
Tsai et al., 2018; Wu et al., 2018), while other studies show no impact of diet on physical 
activity (Bridgewater et al., 2017; Zilkha et al., 2017).  Sex differences in physical activity 
or locomotion in the context of obesity have also been reported.  In a cross-sectional 
study in 964 community dwelling older adults, obese women were found to be less 
active than obese men (Gretebeck et al., 2017).  In B6J and B6 mice, male mice fed a 
HFD are frequently reported as having reduced locomotion in an open field (Almeida-
Suhett et al., 2017; Gelineau et al., 2017; Tsai et al., 2018; Wu et al., 2018), while female 
mice show mixed results, with some having decreased locomotion (Krishna et al., 2016), 
some increased locomotion (Krishna et al., 2015), and others with no effect 
(Bridgewater et al., 2017; Gelineau et al., 2017).  These discrepancies may be due to the 
duration of dietary treatment, age of behavioral testing, and diet composition.  
Although the precise mechanisms of how DIO can impact mobility are not clear, it is 
possible that DIO may disrupt the expression of genes such as dopamine receptor D2 
(DRD2) and tyrosine hydroxylase (TH), which are associated with dopamine biology and 
physical activity (Gallo, 2019; Jang et al., 2017).  Furthermore, it is possible that DIO may 
disrupt dopamine release and clearance in the striatum, as this brain region is known to 
be a primary regulator of spontaneous physical activity (Rosenfeld, 2017).   
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Obesity has been associated with a higher prevalence of anxiety, as 
demonstrated in several human studies (Baker et al., 2017; Gariepy et al., 2010; Strine 
et al., 2008) and rodent studies (Almeida-Suhett et al., 2017; Krishna et al., 2016).  For 
example, a cross-sectional study of 217,379 adults in the United States found a positive 
association between obesity and anxiety (Strine et al., 2008).  Similarly, a study in the 
United States with 9125 adults found that obesity lead to an approximate 25% increase 
in odds of having an anxiety disorder (Simon et al., 2006).  A meta-analysis in China that 
included 17,894 children and adolescents found a significantly higher incidence of 
anxiety in obese and overweight subjects (40%) compared to normal weight subjects 
(14%) (Wang et al., 2019).  In rodent DIO studies, B6J male mice (Almeida-Suhett et al., 
2017) and B6 female mice (Krishna et al., 2016) fed a HFD displayed higher anxiety-like 
behavior in an open field as assessed by decreased center time.  Additionally, male 
Fischer 344 rats (Buchenauer et al., 2009) and female Long Evans rats (Sivanathan et al., 
2015) fed a HFD also exhibited more anxiety-like behavior compared to normal weight 
rats fed a control diet.  In contrast, there are other reports in humans and rodents that 
found no link between obesity and anxiety (Araujo et al., 2017; Gelineau et al., 2017; 
Tsai et al., 2018).  The relationship between obesity and anxiety is complex, often due to 
comorbidities and a potential bidirectional association (Baker et al., 2017).  More 
research is needed to understand the physiological mechanisms that may connect 
obesity to anxiety.  
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Research that includes both sexes in the study of DIO-impact on behavior in 
rodents is limited.  In one study using male and female B6 mice fed a HFD for 12 weeks, 
males fed a HFD spent less time in the center zone of the open field compared to males 
fed a control diet and compared to all females, indicating increased anxiety-like 
behavior in males only due to HFD (Bridgewater et al., 2017).  Additionally, there was a 
sex difference in ambulation, with male B6 mice showing reduced physical activity 
compared to B6 females.  Interestingly, diet had no effect on locomotion for either sex.   
In contrast to these results, a study using male and female B6J mice fed a HFD for 
approximately 10 weeks found no significant difference in open field center time due to 
diet or sex (Gelineau et al., 2017).  Moreover, male mice fed a HFD had reduced 
locomotion compared to the male low fat diet (LFD) group, yet there was no diet impact 
on female locomotion, and no overall sex differences in locomotion.  In this same study, 
males expressed less brain-derived neurotrophic factor (BDNF) compared to females, 
but there was no significant impact of diet on BDNF expression for either sex.  While 
both studies report an impact of diet or sex on various behaviors, the results are 
inconsistent, which may be due to genetic differences between B6 and B6J mice.  Both 
studies initiated the HDF at a similar age (6-7 weeks), but the diet treatment duration 
was different (12 weeks versus 10 weeks).  The anxiety-like behavior in males was 
revealed after the 12-week diet treatment, which could be a result of increased body 
weight, older age, or extended exposure to the HFD.  
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Obesity can also have a negative impact on memory.  In human studies, a high 
body mass index (BMI) was associated with poor memory in adolescents (Tee et al., 
2018) and adults (Coppin et al., 2014).  Seniors with obesity were also found to have 
compromised memory when compared to a normal weight group (Clark et al., 2016).  
An extensive review of the impact of HFD on learning and memory in rodent studies 
using various test measures found that most studies, but not all, found an association 
between HFD or DIO and memory decline (Cordner and Tamashiro, 2015).  Collectively, 
most of these studies show a pattern of obesity with reduced memory, but few 
distinguish between males and females or differences in genetics that may cause 
discrepancies in the results. 
Dopamine plays an important role in regulating motor control, cognition, and 
motivation (Mishra et al., 2018).  Previous DIO studies in mice have found an inverse 
relationship between dopamine signaling with body weight (Zilkha et al., 2017) and DIO-
induced anxiety with dopamine turnover in the brain (Krishna et al., 2015).  In both the 
dorsal and ventral striatum, the regulation of dopamine neurotransmission is implicated 
as a modulator of DIO and food reward (Baik, 2013).  For example, in a study with male 
B6J mice fed a high fat/high sugar Western style diet for 16 weeks, dopamine release in 
the dorsal striatum was increased and dopamine clearance in the dorsal striatum was 
decreased in mice fed the Western style diet (Fritz et al., 2018).  In the nucleus 
accumbens (NAc) core of the ventral striatum, dopamine release assessed by fast scan 
cyclic voltammetry was increased in male Sprague-Dawley rats when exposed to a 
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sucrose-based food reward (Roitman, 2004).  In a study with male B6J mice fed a HFD 
for six weeks, voltammetry measurements revealed a significant decrease in dopamine 
reuptake in the NAc (Fordahl and Jones, 2017).  The NAc of the ventral striatum is 
involved in the mediation of reward, satisfaction, and motivation, and has been 
implicated in numerous behavioral disorders, such as anxiety, obsessive-compulsive 
disorder, and addiction (Salgado and Kaplitt, 2015).  The dorsal striatum is involved in 
habitual and compulsive behaviors such as food-seeking and binge eating, and plays a 
role in homeostatic energy consumption (Fritz et al., 2018).  Both regions are important 
to consider when investigating dopamine biology as it relates to DIO. 
DIO has been associated with gene expression dysregulation in the brain, with 
implications for the development of various behavior impairments, such as increased 
anxiety, reduced motor function, or compromised memory (Almeida-Suhett et al., 2017; 
Krishna et al., 2016; Lee et al., 2010).  In our study, we examined the impact of DIO on 
the mRNA expression of BDNF, TH, and DRD2.  The role of BDNF in brain plasticity is 
correlated with learning, memory, and cognition in humans and rodents (Miranda et al., 
2019).  In previous rodent studies, a HFD was associated with reduced BDNF expression 
in some cases (Molteni et al., 2002; Pistell et al., 2010; Wang et al., 2017), but showed 
an increase in expression in other cases (Gan et al., 2015; Genzer et al., 2016).  TH is a 
rate limiting enzyme required for the synthesis of catecholamines such as dopamine, 
epinephrine, and norepinephrine (Daubner et al., 2011).  These catecholamines serve 
brain functions such as attention, memory, and cognition.  TH is present within the 
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neurons of the dopaminergic pathway that extends from the substantia nigra to the 
striatum, which is imperative for proper motor function (Jang et al., 2017).  Obesity has 
been shown to have a negative impact on mobility (Forhan and Gill, 2013) and has been 
associated with changes in TH gene expression in different brain regions (Huang et al., 
2005a; Lee et al., 2010; Ong et al., 2013; Wu et al., 2017).  DRD2 is a member of the D2-
like receptor family, and is expressed both pre- and postsynaptically in various brain 
regions, such as the striatum, midbrain, cortex, and olfactory bulb (Gallo, 2019; Mishra 
et al., 2018).  The main function of DRD2 is to modulate dopamine synthesis and release 
through the intracellular inhibition of cAMP (Baik, 2013).  In the striatum, DRD2 
mediates the actions of dopamine that control both movement and reward-seeking 
(Gallo, 2019).  Reduced DRD2 activity or expression has been associated with DIO in 
some human studies (van de Giessen et al., 2014; Wang et al., 2001) and rodent studies 
(Carlin et al., 2013; Narayanaswami et al., 2013).  However, conflicting reports show an 
increase in DRD2 in mice (Huang et al., 2005a; Sharma and Fulton, 2013; South and 
Huang, 2008), or no change in humans (Karlsson et al., 2015).  Interestingly, a human 
imaging study demonstrated that DRD2 binding potential was positively correlated to 
BMI in the dorsal striatum, yet negatively correlated to BMI in the ventral striatum (Guo 
et al., 2014).  Collectively, these studies provide evidence that BDNF, TH, and DRD2 
dysregulation may be involved as either a cause or consequence of DIO, however the 
direction of alteration and pathophysiological mechanisms are poorly understood.  
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There are very few rodent studies that address the influence of both strain and 
sex on behavior changes and gene expression alterations due to DIO.  The aim of this 
study was to investigate the impact of DIO on behavior change, gene expression, and 
dopamine release and reuptake using male and female B6J and DBA/2J (D2J) mice as a 
model to examine sex and strain influences.  These strains were selected based on their 
frequent use in behavioral neuroscience and prior studies exhibiting differential traits 
(Mozhui et al., 2010).  B6J and D2J mice represent key strains that are represented in 
the Mouse Phenome Project Database (Bogue et al., 2018; Grubb et al., 2014) and are 
used as parental strains in the BXD recombinant inbred strain set used as genetic 
reference populations to evaluate genetic determinants of correlated phenotypes for 
the GeneNetwork open source project (Philip et al., 2010).  Furthermore, these strains 
have been validated as appropriate models for DIO (Alexander et al., 2006; Montgomery 
et al., 2013; West et al., 1992).  In the current study, gene expression was evaluated in 
the striatum, hippocampus, and olfactory bulb, and dopamine release and reuptake 
were assessed in the dorsal and ventral striatum.  We hypothesized that DIO would have 
a greater impact on males compared to females, and that D2J mice would be more 
resistant to behavior and biochemical changes compared to the B6J strain based on 
previous studies (Bridgewater et al., 2017; Gelineau et al., 2017; Kulesskaya et al., 2014; 




Materials and Methods 
Animals and Diet 
Male and female mice from the C57BL/6J (B6J) (n=36) and DBA/2J (D2J) (n=36) 
strains were purchased from Jackson Laboratory (Bar Harbor, ME, USA) at post-natal 
day 21.  After three days of acclimation in the animal care facility, mice were randomly 
assigned a control LFD with 10% kcal fat/g (Research Diets, D12450J) or mineral-
matched HFD with 60% kcal fat/g (Research Diets, D12492) for 16 weeks (see 
Supplementary Table A1).  Each diet treatment group comprised n=9, with a total of 
n=72.  Ad libitum feeding of the assigned diets was provided with free access to 
deionized water 24 hours per day.  All mice were weighed once per week during the 16-
week diet treatment, and food weight was recorded three days per week.  Mice were 
housed three per cage by strain with males and females positioned on opposite sides of 
a temperature-controlled room (25°C) maintained on a 12-hour light/dark cycle.  Sample 
size for the analysis of behavior, gene expression, and voltammetry (Table 4.1) was 
determined based on a power analysis from previous studies in our lab.   
This study was conducted in an American Association for Laboratory Animal Care 
accredited facility following a protocol approved by the Institution of Animal Care and 
Use Committee at the University of North Carolina Greensboro.  Procedures were 
performed by the principles and guidelines established by the National Institutes of 
Health for the ethical care and use of laboratory animals.  One mouse was humanely 
euthanized during week 10 of the diet treatment due to failure to thrive. 
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Table 4.1.  Study Design for Behavior, Gene Expression, and Voltammetry 
Test 
B6J D2J 
Male Female Male Female 
Behavior 18 18 17 18 
Gene Expression 14 10 10 10 
Voltammetry 4 8 7 8 
Sample size for each group was determined using a power analysis based on previous data from our lab.  
Behavior testing occurred during weeks 14-15 of the diet treatment.  Gene expression was measured 
after 16 weeks of diet treatment.  Voltammetry experiments were conducted over a 14-day period after 
the 16-week diet treatment.  
 
 
Open Field   
The open field test was conducted during week 14 of the diet treatment and was 
used to evaluate locomotion and anxiety.  Our test design for open field was based on 
published protocols (Gellért and Varga, 2016; Seibenhener and Wooten, 2015) and 
current literature (Almeida-Suhett et al., 2019; Bridgewater et al., 2017; Krishna et al., 
2016).  Mice were acclimated to the behavior test room for a minimum of 30 minutes 
before each experiment.  Clear acrylic 29 cm x 29 cm x 38 cm cubes covered with 
opaque white paper on all sides were used as the test arena.  Cubes were cleaned with a 
disinfectant spray after each test and allowed to dry for 10 minutes before starting the 
next test.  Recording software (TopScan Lite Version 2.00, Clever Systems, Inc.) and 
video camera equipment were used for each recording.  There were four separate test 
arenas (cubes) in the behavior test room, allowing for four mice to be tested at one time 
(see Supplementary Figures B1 and B2).  Cube assignments were rotated to prevent 
proximity to the door from being a confounding factor.  Mice had free access to food 
and water in their home cages, but did not have access to food or water in the testing 
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arena.  All open field testing was conducted between 9am-1pm.  Mice were placed in 
the center of the cube at the start of each test, and activity was recorded for 30 
minutes.  At the end of each test, mice were transferred from the test cube to a 
separate polycarbonate cage to avoid inducing anxiety in the cage of remaining mice.  
Fecal boli were counted manually at the end of each test as an additional measure of 
anxiety.  
Open field videos were analyzed using TopScan Lite Version 2.00, Clever 
Systems, Inc.  Five-minute intervals were analyzed for each 30-minute video to measure 
changes in behavior over time.  Data from these videos were used to evaluate 
differences in total distance travelled (TDT), velocity, habituation, and center entries.  
Rate of habituation was calculated by regressing distance travelled versus time during 
each five-minute interval with regression coefficients (slopes) used to determine the 
rate.  A center zone of 30% was delineated to measure center entries (center entries are 
inversely proportional to anxiety-like behavior).  The first five-minute time segment (0-5 
minutes in the open field) was used for center entry analysis for the B6J strain, and the 
second five-minute time segment (5-10 minutes in the open field) was used for center 
entry analysis for the D2J strain.  These specific time frames were selected based on the 
activity level of each strain. 
Novel Object Recognition  
The novel object recognition (NOR) test was used to evaluate memory, and was 
designed based on published protocols (Antunes and Biala, 2012; Paola, 2011).  This test 
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comprised of three phases:  habituation, familiarization, and testing.  The open field test 
described above was used as the habituation phase (phase I).  All NOR testing was 
conducted between 1pm-6pm, with each test starting approximately 24 hours after the 
corresponding open field test.  The objects used were nonporous figures with similar 
size and color, but distinct shape (Supplementary Figure B3).  Objects were placed five 
centimeters from the back and side wall of each cube (Supplementary Figure B4).  Mice 
were placed in the cubes facing away from the objects on the opposite wall.  During the 
familiarization phase (phase II), mice were introduced to two identical objects and 
allowed to explore for five minutes.  Cubes and figures were cleaned with a disinfectant 
after each test.  The testing phase (phase III) began two hours after the familiarization 
phase.  During this last phase, one of the familiar objects was replaced with a new 
object.  Placement of the new object was alternated between left and right side of the 
cube to counterbalance any preference for cube location.  Mice were given five minutes 
to explore the new and familiar objects during this testing phase. 
Videos were analyzed manually for the entire five-minute video per mouse.  
Hand counters were used to determine the amount of time spent exploring each object.  
The mouse was considered exploring the object when the nose was touching the object.  
Results are reported here using the discrimination index as recommended in NOR 
protocols (Antunes and Biala, 2012; Krishna et al., 2015).  The formula used to calculate 
discrimination index is as follows: (Tnew - Tfamiliar)/(Tnew + Tfamiliar).  Rodents are naturally 
curious animals and will explore new objects as a normal process.  Therefore, a positive 
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discrimination index  value indicates normal behavior (exploring the new object more 
than the familiar object). 
Nestlet Shredding  
Nestlet shredding tests were conducted during week 15 of the diet treatment for 
the evaluation of motivation (Nichols et al., 2016), compulsivity (Angoa-Pérez et al., 
2013), and overall welfare (Gaskill et al., 2013).  All mice were acclimated to the 
behavior test room for 30 minutes prior to assessment.  Each nestlet was made from 
standard cotton material and measured 5.8 cm x 5.8 cm x 0.2 cm.  Nestlets were 
acclimated to the behavior room for three days prior to testing to allow for adjustments 
to humidity.  Each nestlet was then weighed on an analytical balance on the day that 
testing began.  Polycarbonate mouse cages with a fitted filter-top cover were filled with 
fresh bedding to a depth of 0.5cm (Supplementary Figure B5).  One nestlet was placed in 
the center of each cage.  Screening dividers were placed between test cages to avoid 
distractions from other mice.  Each mouse was placed in a cage by itself with a nestlet 
and allowed to shred for 30 minutes.  After each test, shredded nestlet material was 
carefully removed from each nestlet square.  Nestlets were dried for 24 hours, then 
reweighed to determine the degree of shredding.  Results are reported here as percent 
nestlet shredded.   
Tissue Collection 
After the 16-week diet treatment, 44 mice were humanely anesthetized with 
isoflurane followed by rapid decapitation.  Brains were dissected sagitally into right and 
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left hemispheres on an ice-cold stainless-steel platform.  The following brain regions 
were isolated for this study: olfactory bulb, hippocampus, and striatum.  Brain tissues 
were snap frozen in liquid nitrogen, placed on dry ice, then stored at -80°C.  Brain tissue 
for the remaining 27 mice was obtained over a 14-day period after the 16-week diet 
treatment for voltammetry experiments (described below).   
RNA Isolation and cDNA Synthesis 
RNA was isolated from brain tissue samples (n=3-5 per group) with the RNeasy® 
Plus Mini Kit (Qiagen Inc., Germantown, MD, USA) following manufacturer’s protocol.  
RNA concentration and purity were determined using a NanoDrop™ 1000 
spectrophotometer (ThermoFisher Scientific, Inc., USA).  Reverse transcription of RNA 
was conducted on Applied Biosystems GeneAmp® PCR System 9700 using Applied 
Biosystems High Capacity cDNA Reverse Transcription Kit (Life Technologies, Carlsbad, 
CA, USA) to prepare 20 L samples for the thermocycler.  Reaction conditions were 
applied as follows: 25°C for 10 minutes, 37°C for 120 minutes, 85°C for five seconds, and 
4°C holding temperature at completion.  Samples were stored at -20°C until further 
evaluation of relative gene expression.  Specific mRNA transcripts measured in this 






Table 4.2.  mRNA Transcripts Related to Behavior and Dopamine 
mRNA Transcript mRNA Abbreviation Gene  
Brain derived neurotrophic factor BDNF BDNF 
Dopamine receptor D2 DRD2 DRD2 
Tyrosine hydroxylase TH Th 
Genes were selected for evaluation based on their relevance to behavior and dopamine biology. 
 
 
Real Time Polymerase Chain Reaction (RT-PCR) 
Relative gene expression was determined by RT-PCR on a 7500 Fast Real-Time 
PCR System from Applied Biosystems using the following conditions: incubation for two 
minutes at 50°C, polymerase activation for two minutes at 95°C, and 40 cycles of PCR 
(denature for three seconds at 95°C and anneal/extend for 30 seconds at 95°C).  Gene 
assays were purchased from Life Technologies (Carlsbad, CA, USA) and are listed in 
Table 4.2.  Each assay was prepared for RT-PCR using Applied Biosystems™ Taqman™ 
Fast Advanced Master Mix.  The endogenous control 18S was used to normalize the 
expression of each gene.  Normalized cycle threshold (Ct) values were used to 
determine interactions and main effects of diet, sex, and strain.  The comparative Ct 
method (2-ΔΔCt ) was used to determine fold change in gene expression comparing LFD 
(control) to HFD for each sex and strain, or to compare males (control) to females. 
Dopamine and Voltammetry 
Dopamine release and uptake were evaluated using ex-vivo fast scan cyclic 
voltammetry.  This technique has been used previously to determine dopamine terminal 
function in mice fed a HFD (Fordahl and Jones, 2017).  Male and female B6J (n=12) and 
D2J (n=15) mice were evaluated over a two-week time period after the 16-week diet 
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treatment.  During this time, mice were fed their respective LFD or HFD.  Mice were 
rendered unconscious using isoflurane, decapitated, and the brain quickly removed.  
The brain was sliced (300µm width) on the coronal plane, and slices containing the 
dorsal and ventral striatum were incubated in artificial cerebral spinal fluid until and 
throughout voltammetry recordings. The remaining brain tissue was dissected into 
olfactory bulb, cortex, dorsal striatum, and ventral striatum, and stored at -80°C.  
Carbon fiber electrodes were used to record dopamine release and pre-synaptic uptake 
in the following regions: dorsal striatum, NAc core, and NAc shell.  Dopamine release 
was evoked with either a single pulse (1P) stimulation (350µA) to measure tonic activity 
or a phasic burst of five stimulations (350µA, each at a frequency of 20Hz) (5P) to 
simulate physiological firing rate of dopamine neurons.  Data was recorded as the 
maximal rate of dopamine uptake (Vmax), 1P dopamine release, and 5P dopamine 
release.  The percent 5P to 1P dopamine release was calculated to provide information 
about the dynamic capacity to release dopamine from specific brain regions.  Our lab 
used data from the dorsal striatum and NAc core to determine relationships among DIO-
impacted dopamine biology and behavior.   
Statistical Analysis 
Statistical analysis was conducted using IBM SPSS Statistics 26.  A three-factor 
mixed plot analysis of variance (ANOVA) for each strain was used to assess behavior 
changes over time, with time as the within subject factor and sex and diet as between 
subject factors.  This test was applied to TDT and velocity.  A three-factor ANOVA with 
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diet, sex, and strain as between subject factors was used to evaluate gene expression 
(with Ct values), Vmax, dopamine release, and fecal boli.  Since ambulatory 
characteristics of each strain differed significantly, a two-factor ANOVA was used for 
each strain with diet and sex as between subject factors for the evaluation of 
habituation rate, center entries, and NOR.  Statistically significant interactions were 
evaluated for simple main effects.  If no interactions were present, significant main 
effects are reported.  Differences between treatment groups at each level were 
determined by pairwise comparisons with a Bonferroni adjustment applied.  
Independent t tests were used to compare weight gain and weight differences between 
the LFD and HFD groups for each strain and sex.  A Welch’s test for unequal variances 
was used for nestlet shredding.  Pearson correlations were used to determine 
relationships between final body weight and TDT or velocity.   
Normality was confirmed using the Shapiro-Wilk test, and homogeneity of 
variance was assessed using Levene’s test.  Statistical significance was accepted at 
p<0.05 and differences were considered approaching significance between p=0.05-0. 10.  
Data are reported as means ± standard error of the mean (SEM).   
Results 
Mice Fed a HFD Gained a Significant Amount of Weight Compared to Mice Fed a LFD 
All male and female B6J and D2J mice fed a HFD gained a significant amount of 
weight by the end of the 16-week diet treatment.  Since there are natural body weight 
differences between the two sexes and strains, independent t tests were used to 
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compare weight gain between diet treatment groups of the same sex and strain.  Before 
starting the diet treatment (approximately three weeks old), there were no significant 
differences between body weight when comparing the LFD group and the HFD group for 
each sex and strain.  At the end of the 16-week diet treatment (approximately 18 weeks 
old), there was a significant difference between body weight (Table 4.3).   
 
Table 4.3.  Final Body Weight 
 
Strain/Sex Final Body Weight (g) Significance 
 LFD Group HFD Group  
BM 28.72 ± 0.41 48.16 ± 0.36 p < 0.0001 
BF 21.58 ± 0.21 41.16 ± 1.38 p < 0.0001 
DM 28.14 ± 0.78 43.91 ± 1.81 p < 0.0001 
DF 23.26 ± 0.75 34.53 ± 1.45 p < 0.0001 
Body weight comparisons are between LFD groups and HFD groups for male and female B6J and D2J mice 
at the end of the 16-week diet treatment.  Data are represented as mean ± SEM.  BM = B6J males, BF = 
B6J females, DM = D2J males, DF = D2J females. 
 
 
Changes in body weight over the 16-week diet treatment for male and female 






Figure 4.1. Weight Gain by Strain and Sex.  Weight gain throughout the 16-week diet treatment for B6J 
males (A), B6J females (B), D2J males (C), and D2J females (D).  Letter codes are as follows: B=B6J, D=D2J, 
M=male, F=female, L=low fat diet, H=high fat diet. Data are represented as mean ± SEM. ****p<0.0001. 
 
 
The percent weight gain for each group over the 16-week diet treatment was 
described previously in a companion study.  Briefly, percent weight gain was 
significantly higher for mice in the HFD treatment groups compared to the LFD 
treatment groups for each strain and sex (p<0.0001 for each comparison: CML vs CMH, 
CFL vs CFH, DML vs DMF, DFL vs DFH).  There was no significant difference between 
grams of food eaten when comparing the LFD and HFD groups, indicating that all groups 




B6J and D2J Mice Fed a HFD Travel Less Distance in the Open Field  
 A three-factor mixed ANOVA was used to evaluate the effects of time, diet, and 
sex on TDT, with diet and sex as the between subject factors and time as the within 
subject factor.  B6J and D2J strains were analyzed separately due to differences in 
ambulation.  Distance traveled was analyzed in six 5-minute time intervals for a total of 
30 minutes.  In the repeated measures within-subject analysis, there was a statistically 
significant two-way interaction between time and sex in B6J mice (F5,160=2.408, 
p=0.039).  B6J males and females travel a similar distance for the first 15 minutes in the 
open field, however, after 15 minutes, the sex differences become apparent with 
females traveling more than males (Fig 4.2A).  Between 15-20 minutes, B6J females 
travel 1.74m ± 0.57m more than B6J males (F1,32=9.407, p=0.004), and between 25-30 
minutes, B6J females travel 1.69m ± 0.070m more than B6J males (F1,32=5.931, p=0.021).  
Overall, there is a steady decline in TDT over the 30-minute time period for both sexes.  
For the D2J strain, there was a statistically significant three-way interaction between 
time, sex, and diet in D2J mice (F5,145=2.930, p=0.015).  Unlike the B6J strain, the D2J 
strain increased their TDT between 5-10 minutes in the open field, then displayed a 
steady decline in TDT after 10 minutes (Figure 4.2B).  Differences between D2J males 
and females emerge between 10-15 minutes in the open field, with males traveling 
more distance overall than females.  Specifically, between 10-15 minutes in the open 
field, D2J males traveled 2.05m ± 0.80m more than D2J females (F1,29=6.493, p=0.016), 
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Figure 4.2.  Total Distance Traveled Sex Effect with Time.  The effect of sex on TDT for B6J mice (A) and 
D2J mice (B).  * p<0.05, ** p<0.01.  Abbreviations: B=B6J, D=D2J, M=male, F=female. 
 
 
For the between-subjects analysis, there was a main effect of diet for both the 
B6J strain (F1,32=42.648, p<0.0001) and the D2J strain (F1,29=13.700, p=0.001).  For B6J 
males, there was a statistically significant decrease in TDT for mice fed a HFD at each 
recorded time interval (Figure 4.3A).   For B6J female mice fed a HFD, TDT was 
significantly reduced at all time points except for the first 5 minutes, which was 
approaching significance (Figure 4.3B).  For D2J males, there was an overall reduction in 
TDT for mice fed a HFD, but the reduction was not as significant compared to B6J males 
(Figure 4.3C).  For D2J females, only the last five minutes in the open field revealed a 
statistically significant decrease in TDT for mice fed a HFD, although the time period of 
10-15 min was approaching significance (Figure 4.3D).  Mean TDT data for each 




Figure 4.3.  Total Distance Traveled Diet Effect with Time.  The effect of diet on TDT for B6J male mice 
(A), B6J female mice (B), D2J male mice (C), and D2J female mice (D).  * p<0.05, ** p<0.01, *** p<0.001, 




B6J and D2J Mice Fed a HFD Have Reduced Velocity in the Open Field 
 A three-factor mixed ANOVA was used to evaluate the effects of time, diet, and 
sex on velocity, with diet and sex as the between subject factors and time as the within 
subject factor.  Velocity was analyzed in six 5-minute time intervals for a total of 30 
minutes.  In the repeated measures within-subject analysis, there was a statistically 
significant main effect of time on velocity in B6J mice (F5,160=51.492, p<0.0001).  Two 
interactions for the B6J strain were approaching significance: time by diet (F5,160=2.053, 
p=0.074) and time by sex (F5,160=1.971, p=0.086).  B6J females traveled 5.67 mm/s ± 1.90 
mm/s faster than B6J males between 15-20 minutes in the open field (F1,32=8.936, 
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p=0.005) and 5.39 mm/s ± 2.33 mm/s faster than B6J males between 25-30 minutes 
(F1,32=5.374, p=0.027) (Figure 4.4A).  For the D2J strain, there was a statistically 
significant three-way interaction between time, sex, and diet on velocity (F5,140=3.358, 
p=0.007).   In contrast to the B6J strain, D2J males traveled 6.06 mm/s ± 2.62 mm/s 
faster than D2J females between 10-15 minutes in the open field (F1,28=5.362, p=0.028) 
and 6.69 mm/s ± 2.83 mm/s faster than D2J females between 20-25 minutes 
(F1,28=5.605, p=0.025) (Figure 4.4B). 
 
 
Figure 4.4.  Velocity Sex Effect with Time.  The effect of sex on velocity for B6J mice (A) and D2J mice (B).  
* p<0.05, ** p<0.01.   
 
 
For the between subject analysis, there was a significant effect of diet for both 
the B6J strain (F1,32=42.956, p<0.0001) and the D2J strain (F1,28=10.674, p=0.003).  
Additionally, an interaction between diet and sex that was approaching significance for 
the B6J strain (F1,32=2.939, p=0.096).   B6J males fed a HFD had a substantial reduction in 
velocity at each time interval in the open field (Figure 4.5A).  B6J females fed a HFD also 
had a reduction in velocity at most time intervals, although not as significant of a change 
compared to male B6J mice (Figure 4.5B).  D2J male mice fed a HFD had reduced 
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velocities for three time intervals midway through testing (Figure 4.5C).  Female D2J 
mice fed a HFD only had a significantly reduced velocity during the last time interval (25-
30 minutes), although reductions in velocity between 5-15 min were approaching 
significance (Figure 4.5D).  Mean velocity data for each treatment group at each time 
interval are included as Supplementary Table A8. 
 
 
Figure 4.5.  Velocity Diet Effect with Time.  The effect of diet on velocity for B6J male mice (A), B6J female 
mice (B), D2J male mice (C), and D2J female mice (D).  * p<0.05, ** p<0.01, *** p<0.001, **** p<0.0001, † 





Final Body Weight is Correlated to TDT and Velocity for Females Fed a HFD 
 Pearson correlation tests were used to assess relationships between final body 
weight and TDT or velocity.  When evaluating all mice combined, there was a moderate 
negative correlation between body weight and TDT (R= -0.40, p=0.001) (Figure 4.6A) and 
a moderate negative correlation between body weight and velocity (R= -0.38, p=0.001) 
(Figure 4.6B).  However, when splitting the data by strain, sex, and diet, the correlations 
are only significant for females fed a HFD.  D2J females fed a HFD had a strong negative 
correlation between weight and TDT (R= -0.82, p=0.007) (Figure 4.6C) and a strong 
negative correlation between weight and velocity (R= -0.79, p=0.011) (Figure 4.6D).  A 
similar trend was approaching significance for B6J females with a strong negative 
correlation between weight and TDT (R= -0.66, p=0.054) (Figure 4.6E) and a strong 





Figure 4.6.  Relationships between Weight and Total Distance Traveled or Velocity.  Pearson correlations 
are pictured here for body weight with the following variables: TDT for all mice (A), velocity for all mice 
(B), TDT for D2J females fed a HFD (C), velocity for D2J females fed a HFD (D), TDT for B6J females fed a 





Male B6J Mice Fed a HFD Have a Slower Habituation Rate  
The habituation rates in the open field were analyzed separately for each strain 
due to major differences in locomotion.  For the B6J strain, there was a significant main 
effect of diet on habituation rate.  B6J mice fed a HFD had a 35% lower habituation rate 
compared to B6J mice fed a LFD (F1,32=4.289, p=0.047).  Pairwise comparisons showed 
that the simple main effect of diet was significant for B6J male mice (F1,32=5.446, 
p=0.026) with a 47% reduction in habituation rate for the HFD group (Figure 4.7A).  
Additionally, there was a main effect of sex on habituation rate for the B6J strain.  B6J 
female mice had a 42% lower habituation rate compared to B6J males (F1,32=5.928, 
p=0.021).  The simple main effect for sex was significant at the level of LFD (F1,32=6.713, 
p=0.014) with B6J females displaying a 53% lower habituation rate compared to males.  
For the D2J strain, there were no main effects or interactions.  Mean habituation rates 
for each treatment group are provided in Supplementary Table A9. 
Male B6J Mice Fed a HFD Show Higher Anxiety-like Behavior Through Fecal Boli 
 Fecal boli were counted at the end of each open field test as a measure of 
anxiety level.  A three-way ANOVA was used to evaluate differences.  Male B6J mice fed 
a HFD had 37% higher fecal boli compared to B6J mice fed a LFD (F1,63=5.620, p=0.021) 
(Figure 4.7B).  There was a significant main effect of sex (F1,63=5.377, p=0.024), with 
males showing 22% greater fecal boli counts compared to females.  This effect of sex 
was greatest for B6J mice fed a HFD, with a 50% difference between sexes (F1,63=9.103, 
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p=0.004).  There was no impact of diet or sex on fecal boli for the D2J strain.  Mean fecal 
boli counts for each treatment group are provided in Supplementary Table A9. 
DIO Did Not Impact Center Entries in the Open Field 
 A two-way ANOVA was used to evaluate the impact of sex and diet on 
the number of center entries in the open field.  Center entries are inversely proportional 
to anxiety-like behavior in rodents.  There were no interaction effects on center entries.  
For B6J mice, the main effect of diet was approaching significance (F1,32=3.232, p=0.082), 
as was the main effect of sex (F1,32=3.759, p=0.061).  Center entries for each treatment 
group are shown in Figure 4.7C.  Data for mean center entries for each treatment group 
are provided in Supplementary Table A9. 
Male B6J Mice Fed a HFD Have Significantly Lower Levels of Nestlet Shredding 
Nestlet shredding was measured as an assessment of motivation, compulsivity, 
and general welfare.  An example of a shredded nestlet square is provided as 
Supplementary Figure B6.  Since the data within each treatment group was normal but 
did not pass the test for homogeneity of variance, an unequal variance t test (Welch’s 
test) was used to compare differences in shredding between diet groups.  Male B6J mice 
fed a HFD had 183% less nestlet shredding compared to male B6J mice fed a LFD 
(t8.041=3.001, p=0.017) (Figure 4.7D).  Female D2J mice fed a HFD had 79% less shredding 
compared to the LFD group, which was approaching statistical significance (t15=1.963, 
p=0.068).  Data for mean percent nestlet shredding for each treatment group are 




Figure 4.7.  DIO Impact on Various Behaviors in B6J and D2J Mice.  Behavior testing was assessed using 
habituation rate (A), fecal boli in the open field (B), center entries into the open field (C), and nestlet 
shredding (D).  Graphs A and B show a sex effect in the B6J strain and a diet effect in male B6J mice for 
both habituation and fecal boli.  Graph C shows trends in center entries with no statistically significant 
differences.  Graph D shows a diet effect for nestlet shredding in B6J males and a diet effect that is 
approaching significance in D2J females.   Data are represented as mean ± SEM. *p<0.05, **p<0.01, 
†approaching significance. LF=low fat diet, HF=high fat diet. 
 
 
DIO Did Not Impact Memory in NOR  
 The NOR test was performed to assess memory in male and female B6J and D2J 
mice.  A two-factor ANOVA was used to evaluate the effects of diet and sex within each 
strain separately due to heterogeneity of variance between strains.  There were no 
statistically significant main effects or interactions for either strain.  All treatment 
groups except for the D2J females fed a HFD had a positive discrimination index score 
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Figure 4.8.  Novel Object Recognition in Male and Female B6J and D2J Mice.  Positive discrimination 
index values indicate normal behavior.  Data are represented as mean ± SEM. 
 
 
Dopamine Release in the Dorsal Striatum is Increased in B6J Females Fed a HFD 
Dopamine biology was evaluated in the dorsal striatum, a brain region involved 
in locomotion and habitual behaviors.  There was a statistically significant three-way 
interaction between diet, sex, and strain on relative dopamine release in the dorsal 
striatum (F1,40=5.426, p=0.025).  Upon further analysis, there was a statistically 
significant simple two-way interaction between diet and sex for B6J mice (F1,40=7.125, 
p=0.011), with a 24% increase for B6J females and a 10% decrease for B6J males due to 
HFD.  Pairwise comparisons reveal that this 24% increase for female B6J mice was 
statistically significant (F1,40=10.142, p = 0.003) but the 10% decrease for male B6J mice 
was not (F1,40=0.954, p=0.335) (Figure 4.9A). 
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Dopamine Reuptake in the Dorsal Striatum is Reduced for D2J Mice Fed a HFD  
A three-factor ANOVA was used to evaluate differences between strain, sex, and 
diet on dopamine transporter Vmax to assess dopamine reuptake.  There was a 
statistically significant two-way interaction between diet and strain on Vmax in the 
dorsal striatum (F1,40=4.880, p=0.033).  For the D2J strain, mice fed a HFD had a 
significant 33% reduction in Vmax compared to D2J mice fed a LFD (F1,40 =8.505, 
p=0.006).  However, the B6J strain Vmax differed by only 0.5% (F1,40=0.096, p=0.758).  
Pairwise comparisons show that the DIO-induced reduction in Vmax for D2J mice was 
significant for both males and females, with a 34% reduction for male D2J mice 
(F1,40=4.122, p = 0.049) and a 32% reduction for female D2J mice (F1,40=4.431, p=0.042) 
(Figure 4.9B).  Dopamine release and reuptake data in the dorsal and ventral striatum 
are reported in Supplementary Table A10. 
Dopamine Reuptake in the NAc Core is Reduced for Male Mice Fed a HFD  
Dopamine biology was also evaluated in the NAc core of the ventral striatum, a 
brain region involved in motivation, anxiety, and addictive behaviors.  Dopamine release 
in the NAc was not significantly impacted by DIO, however there was a main effect of 
strain (F1,44=4.891, p=0.032), with D2J mice showing an 11% greater dopamine release 
compared to B6J mice.  Dopamine release in the NAc core for each treatment group is 
shown in Figure 4.9C.  There was a significant diet by sex interaction on Vmax 
(F1,44=4.645, p=0.037), with males showing a significant reduction in Vmax (F1,44=9.252, 
p=0.004) compared to females (F1,44=0.059, p=0.810) due to HFD.  Pairwise comparisons 
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show that this obesity-induced decrease is statistically significant in D2J males with a 
49% reduction in Vmax (F1,44=6.932, p=0.012) and approaching significance for B6J 
males with a 56% reduction (F1,44=3.300, p=0.076) (Figure 4.9D).  Furthermore, there 
was a main effect of strain (F1,44=7.209, p=0.010), with D2Js exhibiting a 26% higher 
Vmax compared to the B6J strain.   
 
 
Figure 4.9.  Dopamine Release and Reuptake in the Striatum.  This figure shows the impact of diet on 
dopamine release in the dorsal striatum (A), DAT-mediated dopamine reuptake (Vmax) in the dorsal 
striatum (B), dopamine release in the NAc core (C), and DAT-mediated dopamine reuptake (Vmax) in the 
NAc core (D).  Data are represented as mean ± SEM. *p<0.05, †approaching significance. DA = dopamine, 





In the Striatum, DRD2 Gene Expression was Upregulated in B6J Males Due to DIO and TH 
Gene Expression was Significantly Higher in the B6J Strain Compared to the D2J Strain 
 
 DRD2 and TH mRNA expression were measured in the striatum.  Male B6J mice 
fed a HFD showed a 2.40 ± 0.70 fold increase in gene expression compared to B6J males 
fed a LFD (F1,24=4.241, p=0.049) (Figure 4.10A).  DIO did not have an impact on mRNA 
expression of DRD2 in the other treatment groups.  Furthermore, DIO had no impact on 
tyrosine hydroxylase mRNA expression in the striatum (Figure 4.10A).  However, there 
was a significant main effect of strain (F1,30=173.528, p<0.0001), with B6J mice 
expressing 8.08 ± 0.76 fold more tyrosine hydroxylase compared to D2J mice (4.10B).  Ct 




Figure 4.10.  Striatum DRD2 and TH Gene Expression.  The effect of diet on DRD2 and TH mRNA gene 
expression (A) and the effect of strain on TH mRNA gene expression (B) in the striatum as fold change 
compared to a reference.  Fold change compared to each control was determined using the comparative 
Ct method. For the diet effect, the LFD mRNA expression was established as the control (LFD reference = 1 
as indicated by the horizontal bar).  For the strain effect, the D2J strain was set as the control.  Data are 
represented as mean ± SEM. *p<0.05, ****p<0.0001.  DRD2 = dopamine transporter D2, TH = tyrosine 





In the Hippocampus, Female D2J Mice Express Significantly More BDNF Compared to D2J 
Males 
 
 In the hippocampus, the mRNA expression of BDNF was evaluated.  There was 
no effect of DIO on BDNF expression in this brain region.  However, D2J females 
expressed 2.54 ± 0.19 fold more BDNF compared to D2J males (F1,30=32.677, p<0.0001) 
(Figure 4.11).  Ct values for BDNF gene expression in the hippocampus are provided in 
Supplementary Table A4. 
 
 
Figure 4.11.  Influence of Sex on BDNF Gene Expression in the Hippocampus.  Fold change comparisons 
by sex are shown for BDNF in the hippocampus.  Male mRNA expression for each strain was established as 
the control.  Fold change in female mRNA expression compared to each control was determined using the 
comparative Ct method.  Data are represented as mean ± SEM. ****p<0.0001.  BDNF = brain-derived 






In the Olfactory Bulb, DIO Caused an Upregulation of DRD2 and TH Gene Expression in 
Male D2J Mice and Induced BDNF Gene Expression in Female B6J Mice 
 
 In the olfactory bulb, mRNA expression was evaluated for DRD2, TH, and BDNF.  
There was a statistically significant induction of DRD2 in D2J male mice fed a HFD by 
3.52 ± 1.03 fold (F1,24=5.879, p=0.025) and a downregulation of DRD2 in B6J male mice 
fed a HFD by 0.48 ± 0.16 relative to control (approximately 2-fold decrease) was 
approaching significance (F1,24=3.868, p=0.064) (Figure 4.12).  For TH gene expression, 
there was a diet by strain interaction in the olfactory bulb (F1,16=7.213, p=0.016).  
Pairwise comparisons showed that the diet effect was significant only for D2J males, 
with a 3.78 ± 1.26 fold upregulation due to HFD (F1,16=6.444, p=0.022) (Figure 4.12).  For 
BDNF expression, there was a diet by sex interaction (F1,24=4.378, p=0.047).  Female 
mice fed a HFD had 1.87 ± 0.39 fold higher BDNF expression compared to female mice 
fed a LFD (F1,30=7.811, p=0.10), but there was no significant difference in expression for 
males.  Pairwise comparisons revealed that B6J females fed a HFD were impacted the 
greatest, with an upregulation of BDNF by 2.08 ± 0.39 fold (Figure 4.12).  Ct values for 
DRD2, TH, and BDNF gene expression in the olfactory bulb are provided in 







Figure 4.12.  DIO Impact on Olfactory Bulb DRD2, TH, and BDNF Gene Expression.  Fold change 
comparisons by diet for these genes are shown for the olfactory bulb. The LFD mRNA expression was 
established as the control (LFD reference = 1 as indicated by the horizontal bar).  Fold change compared 
to each control was determined using the comparative Ct method. Data are represented as mean ± SEM. 
*p<0.05, †approaching significance. DRD2 = dopamine transporter D2, TH = tyrosine hydroxylase, BDNF = 




 The objective of our study was to determine sex and strain differences on  
behavior, dopamine biology, and gene expression in normal and obese male and female 
B6J and D2J mice.  Our main findings were as follows: 1) mice with DIO had reduced 
motor activity, 2) B6J male mice with DIO displayed reduced habituation, decreased 
motivation, and increased anxiety-like behavior, 3) dopamine clearance in the dorsal 
striatum was reduced in D2J mice with DIO, 4) dopamine clearance in the NAc core was 
reduced in male mice with DIO, 5) DRD2 was upregulated in male B6J mice with DIO in 
the striatum, 6) DRD2 and TH were upregulated in male D2J mice with DIO in the 
olfactory bulb.  Our hypothesis that DIO would have a greater impact on the B6J strain 
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compared to the D2J strain was confirmed for several behavior tests, however, the 
dopamine biology dysregulation and gene expression alterations impacted both strains.   
Likewise, our hypothesis that DIO would impact males more than females was validated 
for behavior testing, dopamine uptake in the NAc core, and gene expression of DRD2 
and TH.    
Weight Gain 
 In the current study, all mice fed a lard-based HFD with 60% kcal from fat gained 
a significant amount of weight compared to mice fed a LFD (Figure 4.1).  This weight 
gain is consistent with previous reports using B6J and D2J strains for DIO investigations 
(Alexander et al., 2006; Montgomery et al., 2013; West et al., 1992) and previous DIO 
studies from our lab using male B6J mice (Han et al., 2019; Liu et al., 2016).  The diet 
treatment was initiated at a young age of approximately three weeks old and continued 
for 16 weeks.  Based on the significant weight gain that we observed and measured in 
both male and female B6J and D2J mice, we can conclude that this diet regimen 
provided a successful model for the study of DIO on brain and behavior dysregulation. 
DIO and Locomotion 
 Obesity has been associated with reduced physical activity in both humans 
(Forhan and Gill, 2013; Trivedi et al., 2015) and rodents (Almeida-Suhett et al., 2017; 
Krishna et al., 2016).  In our study, we measured TDT and velocity in five-minute time 
bins over a period of 30 minutes in the open field for each treatment group.  Overall, 
TDT and velocity decreased over time for all treatment groups as expected (Figures 4.3 
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and 4.5).  We found a significant time by sex interaction on TDT for B6J mice, with 
females traveling more than males during the last 15 minutes of the test (Figure 4.2A).  
The D2J strain displayed different locomotor behavior compared to the B6J strain.  D2J 
mice travel minimally during the first five minutes, then proceed to travel more 
between 5-10 minutes followed by a steady decline in TDT over the remaining 20 
minutes.  Furthermore, there was a significant three-way interaction between time, sex 
and diet on TDT for D2J mice.  Unlike the B6J strain, male D2J mice traveled more than 
female D2J mice, most notably between 10-15 minutes and 20-25 minutes in the open 
field (Figure 4.2B).  For both strains, there was a main effect of diet on reducing TDT, 
however this effect was more significant for the B6J males and females (Figures 4.3A 
and B) compared to the D2J males and females (Figures 4.3C and 4.3D).  The impact of 
DIO on reducing TDT in male B6J mice in our study (Figure 4.3A) was consistent with 
other DIO studies using male B6J or B6 mice (Almeida-Suhett et al., 2017; Gelineau et 
al., 2017; Tsai et al., 2018; Wu et al., 2018).  TDT was also significantly reduced in our 
female B6J mice fed a HFD at most time intervals (Figure 4.3B).  Additionally, there was 
a negative correlation between body weight and TDT that was significant for female D2J 
mice (Figure 4.6C) and trending toward significance for female B6J mice (Figure 4.6E).  In 
other studies using both male and female B6 or B6J mice fed a HFD (60% kcal fat), there 
was no effect of DIO on TDT in the female mice (Bridgewater et al., 2017; Gelineau et 
al., 2017).  However, these studies initiated their HFD at approximately six weeks of age 
(compared to ours at three weeks of age) with a diet duration of 10-12 weeks 
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(compared to ours for a 16-week duration).  Furthermore, a study using female B6 mice 
fed a 60% HFD starting at 6-7 weeks old found that mice with DIO showed reduced 
locomotion after approximately 32 weeks of HFD feeding, but not at 21 weeks of HFD 
feeding (Krishna et al., 2016).  Again, this study initiated the HFD at a later age, and used 
a substrain of B6 mice with a different genetic background compared to our B6J mice.  
Early initiation of the HFD to produce the DIO state could explain the overall reduction 
in TDT that we see in both sexes and both strains in our study, indicating a more serious 
health threat to physical activity when a HFD begins early in life.  
DIO and Habituation 
 Habituation in rodents represents a natural reduction in locomotor activity after 
an initial period of exploration in a novel environment.  This learning behavior allows 
mice to discriminate between novel and normal stimuli.  Abnormal habituation behavior 
has been associated with lesions in the hippocampus and disruptions in dopamine 
biology (Leussis and Bolivar, 2006).  In our study, B6J and D2J habituation data were 
analyzed separately due to major differences in ambulation and heterogeneity of 
variance.  Habituation was determined using two methods: first by visual inspection of 
TDT over time (Figure 4.3) and second by regressing distance traveled over time and 
using the regression coefficients (slopes) to determine habituation rates (Figure 4.7A).  
Over the 30-minute testing period, both strains and sexes showed an overall reduction 
in locomotion as assessed by total distance traveled (Figure 4.3), indicating normal 
habituation trends.  This is consistent with other studies using male B6J and D2J mice 
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(Anisman et al., 1976; Cabib et al., 1990; Kafkafi et al., 2003) and a combination of male 
and female B6J and D2J mice (Koyner et al., 2000).  One study using a shorter open field 
session found D2J activity to increase over time, while B6J activity decreased (Logue et 
al., 1997).  This is also consistent with our data, which show an increase in activity for 
D2J mice over the first 5-10 minutes.  During the open field test, we observed that the 
D2J strain often remained still for several minutes before starting to explore, explaining 
the rise in activity during the first 10 minutes.  Remaining still is a reflection of anxiety 
when first introduced to the open field environment (Gould et al., 2009).  Nevertheless, 
all mice in our study habituated to the open field when accounting for the full 30-minute 
test session.  Specific habituation rates for each treatment group were calculated based 
on the overall 30-minute open field test (Figure 4.7A).  Our data reveal a main effect of 
diet in B6J mice, with mice fed a HFD displaying a 35% reduction in habituation rate.  
Furthermore, pairwise comparisons showed that the diet effect had the biggest impact 
on male B6J mice, with a 47% reduction in habituation rate due to DIO.  This significant 
result in male B6J mice indicates potential disruptions in the hippocampus, as this brain 
region is associated with the habituation process (Bolivar, 2009; Leussis and Bolivar, 
2006).  In a previous study from our lab using the same mice, we reported a significant 
upregulation in alpha synuclein (7-fold) and amyloid precursor protein (APP) (10-fold) 
mRNA transcripts in the hippocampus of B6J mice fed a HFD.  Although we did not 
measure protein expression in that study, it is possible that the upregulation of alpha 
synuclein and APP could potentiate neurodegeneration in this brain region, thus 
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impacting habituation.  In addition to the diet effect on habituation in our current study, 
we also found a significant sex effect in B6J mice, with females habituating at a 42% 
reduced rate compared to males.  There were no significant diet or sex effects within 
the D2J strain, indicating that the D2J strain is more resistant to sex and diet effects 
compared to the B6J strain when comparing the rate of habituation. 
DIO and Anxiety-like Behavior 
There is evidence in humans (Baker et al., 2017; Gariepy et al., 2010; Strine et al., 
2008) and in rodents (Almeida-Suhett et al., 2017; Krishna et al., 2016) that suggests a 
relationship between obesity and anxiety.  In the current study, we assessed anxiety in 
the open field arena by measuring avoidance of center entries and fecal boli quantity.  
Evading the center area and fecal boli are common behavioral assays for determining 
anxiety-like behavior in mice that are introduced to a novel environment (Seibenhener 
and Wooten, 2015).  Our data revealed a significant 37% increase in fecal boli produced 
by male B6J mice fed a HFD compared to mice fed a LFD (Figure 4.7B).  There was also a 
significant sex effect in the B6J strain, with males producing 50% more fecal boli 
compared to females (Figure 4.7B).  The impact of DIO on the B6J strain is consistent 
with another study that reported an increase in fecal boli for male and female SM/J 
mice fed a HFD, however, this study showed no sex effect with the SM/J strain (Keleher 
et al., 2018).  In our study, there was no sex or diet effect on fecal boli in the D2J strain, 
which highlights the influence of genetics on the impact of DIO on specific types of 
behavior.  Evaluation of center entries in the present study showed only a slight 
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decrease for mice fed a HFD in most treatment groups.  It is interesting to note the 
disparities in the literature regarding center entries and percent center time for the 
assessment of DIO impact on anxiety-like behavior in B6J or B6 mice.  For example, one 
study in male B6J mice found a negative correlation between weight gain and center 
entries (Almeida-Suhett et al., 2017), while others using B6 (Tsai et al., 2018) or B6J 
(Zilkha et al., 2017) mice found no effect of DIO on center entries.  In a study with 
female B6 mice, there was no impact of DIO on center entries after 12 and 21 weeks of 
HFD feeding, but DIO mice had reduced center entries after 32 weeks of HFD feeding 
(Krishna et al., 2016, 2015).  There are several factors that may explain these different 
results, such as the size of the open field, the age at which HFD is initiated, diet 
duration, and the use of different substrains of B6 mice.  Although it is recommended by 
some protocols to test for anxiety within the first 5-10 minutes of the open field test 
(Gould et al., 2009; Seibenhener and Wooten, 2015), a wide variety of time frames are 
used in DIO studies.  In our study, we used the first five-minute time bin (0-5min) for the 
B6J strain and the second five-minute (5-10) for the D2J strain in order to capture the 
most active time for each strain, as shown in the TDT and velocity plots (Figures 4.3 and 
4.5).  Considering the discrepancies in center time or center entry results in DIO studies 
listed here, it is possible that other behavioral assays for anxiety in rodents may be more 
accurate predictors of anxiety in obese mice, such as the elevated plus maze, which has 




While there is extensive published research on sex differences regarding 
associations between obesity and depression, less is known about sex factors involved 
in relationships between obesity and anxiety (Tronieri et al., 2017).  Some studies show 
a more significant relationship between overweight or obesity and anxiety in females 
compared to males (Anderson et al., 2006; Barry et al., 2008; DeJesus et al., 2016; 
Hofmann et al., 2015; Svenningsson et al., 2012).  However, there are other reports that 
suggest a higher incidence of anxiety in obese males compared to obese females 
(Bjerkeset et al., 2007; Bridgewater et al., 2017; Tronieri et al., 2017).  Our fecal boli 
data show that only male B6J mice fed a HFD displayed higher anxiety-like behavior.  
These results indicate that sex is an influential factor regarding the impact of DIO on the 
development of anxiety. 
DIO Effect on Motivation and Welfare 
 The nestlet shredding test has been used to evaluate a variety of behaviors, 
including obsessive-compulsive behavior (Angoa-Pérez et al., 2013), motivation or 
apathy (Nichols et al., 2016), and general welfare (Gaskill et al., 2013).  It has also been 
used to assess the efficacy of anxiolytics (Li et al., 2006).  Nestlet shredding for the 
purpose of nest building, warmth, or protection is a natural, spontaneous behavior in 
laboratory mice of both sexes (Gaskill et al., 2013; Jirkof et al., 2013; Nichols et al., 
2016).  Excessive shredding indicates repetitive, compulsive behaviors (Angoa-Pérez et 
al., 2013), while latency to shred can be a sign of apathy, depression, or poor health 
associated with disease progression (Jirkof, 2014; Nichols et al., 2016).  In the present 
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study, we reveal that DIO caused a significant reduction in shredding behavior for male 
B6J mice (Figure 4.7D).  This latency to shred could indicate a lack of motivation caused 
by chronic exposure to a HFD, or could be a sign of declining nervous system health.  
Impaired nestlet shredding has been associated with hippocampal dysfunction and 
neurodegenerative disease, specifically with mouse models of Alzheimer’s disease 
(Jirkof, 2014).  Furthermore, mice with hippocampal lesions have performed poorly in 
nest building tasks and show a similar latency in shredding (Deacon and Rawlins, 2005).  
Although we did not see any differences in BDNF mRNA expression in the hippocampus 
in the present study, we did see a significant upregulation of alpha synuclein and APP in 
the hippocampi of these mice in a companion study.  As mentioned above with 
habituation deficits in male B6J mice, this upregulation of alpha synuclein and APP may 
be a sign of neurodegeneration in the hippocampus.  Interestingly, a recent study in 
mice exposed to lead (Pb) in drinking water found that the Pb-exposed mice presented 
with latency to shred (Chang et al., 2014), providing more evidence that the nestlet 
shredding test is a potential indicator of hippocampal dysfunction.  Based on the data 
presented here and in our previous work with DIO mice, we propose that DIO generated 
by a HFD acts as an environmental stress that can increase the risk for 
neurodegeneration and negative behavior transformations. 
DIO and Memory 
 There is evidence in humans that a diet high in saturated fat can lead to memory 
impairment and an increased risk for Alzheimer’s disease (Eskelinen et al., 2008; 
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Pasinetti and Eberstein, 2008).  In rodents, there are mixed results regarding the effect 
of DIO or HFD on memory.  For example, memory was compromised in young male B6J 
mice fed a HFD (60% kcal fat) for a short duration of one week, with the diet treatment 
initiated at three weeks old (Kaczmarczyk et al., 2013).  A similar result was reported for 
middle-aged (11 months old) male B6J mice fed a HFD (60% kcal fat) for four months 
(Carey et al., 2014).  In contrast, male B6J mice fed a moderately HFD (32% kcal fat) at 
11 weeks old for 6.5 months showed no difference in short- or long-term memory 
(Tucker et al., 2012).  Female B6 mice at age 6-7 weeks old fed a 60% HFD for 12, 22, 
and 36 weeks also showed that diet had no impact on memory (Krishna et al., 2016, 
2015).  Under normal diet conditions, there are natural strain differences in memory 
which show that the B6J strain has superior memory compared to the D2J strain 
(Lenselink et al., 2015).  Our results show that DIO did not have a statistically significant 
impact on memory as assessed by the novel object recognition test.  It is interesting, 
however, that the discrimination index for female D2J mice fed a HFD was negative, 
indicating a possible disturbance of normal behavior due to DIO.   
Dopamine Release and Reuptake in the Dorsal Striatum 
Fast scan cyclic voltammetry was used to measure real-time dopamine release 
and reuptake by dopamine transporter (DAT) in the striatum.  We found that dopamine 
release in the dorsal striatum was significantly increased by 24% in female B6J mice fed 
a HFD (Figure 4.9A).  Additionally, our data reveal a diet by strain interaction for 
dopamine reuptake in the dorsal striatum, specifically both male and female D2J mice 
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fed the HFD showed a decreased rate of dopamine reuptake whereas the B6J were 
unaffected (Figure 4.9B).  In another study with male B6J mice fed a high fat/high sugar 
Western style diet for 16 weeks, dopamine release in the dorsal striatum was increased 
and dopamine clearance was decreased in mice fed the Western style diet (Fritz et al., 
2018).   Although our results were consistent with this study in the direction of change 
for dopamine release and reuptake, we did not observe these changes in B6J males.  
DIO studies using male and female rats have consistently reported decreases in 
dopamine clearance in this subregion of the striatum (Geiger et al., 2009; Morris et al., 
2011; Patel et al., 2019), which is similar to what we discovered for the D2J strain.  
These same rat studies also report decreases in dopamine release; however, we found 
an increase in release for B6J females, and no change for the other treatment groups.  It 
is possible that the dopamine response is different for mice compared to rats in the 
dorsal striatum, although research in mice on this topic, especially in females, is 
currently limited.    
Dopamine Release and Reuptake in the NAc Core of the Ventral Striatum 
  Dopamine release and reuptake were also assessed in the NAc core.  In this brain 
region, we found no impact of DIO on dopamine release in either strain or sex.  There 
was, however, a diet by sex interaction for Vmax, with male mice fed a HFD exhibiting a 
decreased rate of dopamine clearance compared to female mice.  Although the 
magnitude of reduction was greater in the B6J males (56% less) compared to the D2J 
males (49% less), the D2J male result was statistically significant, while the B6J male 
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result was trending toward significance.  This decrease in NAc Vmax in male mice is 
consistent with several other reports.  For example, in three separate studies using male 
B6J mice fed a HFD for six weeks, the use of fast scan cyclic voltammetry revealed a 
significant decrease in dopamine reuptake in the NAc core (Barnes et al., 2020; Fordahl 
et al., 2016; Fordahl and Jones, 2017).  In the present study, it is interesting that DIO 
only had an impact on dopamine clearance in males from each strain.  It is possible that 
estrogen has a neuroprotective effect on dopamine biology (Dluzen and McDermott, 
2000), specifically in the NAc core of females (Thompson, 1999), which would explain 
the diet by sex interaction.  Our results that show no change in dopamine release in the 
NAc core are consistent with another study in B6J mice fed a 60% HFD for six weeks 
(Fordahl et al., 2016), however, other reports in mice and rats fed a HFD have found a 
decrease in dopamine release in this region (Barnes et al., 2020; Geiger et al., 2009; 
Patel et al., 2019).  It has been reported that DAT may regulate diurnal oscillations of 
dopamine release in mice and rats (Ferris et al., 2014) and that ovarian hormones in rats 
can impact circadian variation of dopamine release in the striatum (Becker et al., 1984), 
which could explain the discrepancies in dopamine release that have been reported in 
the striatum of rodents.  Nevertheless, we show here that DIO has an impact on 





Effect of Diet, Sex, and Strain on DRD2 mRNA Expression 
DRD2 has an important role in dopamine biology, facilitating the actions of 
dopamine that control both movement and reward-seeking (Gallo, 2019).  In the current 
study, we discovered dysregulations in DRD2 mRNA gene expression in the striatum and 
olfactory bulb due to DIO.  For this evaluation, the striatum was not divided into dorsal 
and ventral subregions, but included the entire brain region.  We found a significant 
upregulation of DRD2 by 2.4-fold in the striatum of B6J males (Figure 4.10A).  In the 
olfactory bulb, we found a significant 3.5-fold upregulation in DRD2 mRNA in male D2J 
mice, and a 2-fold downregulation in male B6J that was approaching significance (Figure 
4.12).  DIO did not impact the gene expression in females of either strain.    
There are conflicting reports regarding DRD2 expression dysregulation due to 
DIO, with some reporting downregulation, some upregulation, and a few reporting no 
change.  For example, an imaging study in men and women discovered that striatal 
DRD2 receptor availability was reduced in obese individuals compared to controls, and 
that BMI was negatively correlated with DRD2 concentration (Wang et al., 2001).  In 
corroboration using similar test methods, striatal DRD2 receptor availability was 
reduced in obese women compared to controls (van de Giessen et al., 2014).  However, 
another imaging study in obese women found no change in DRD2 receptor availability 
when examining several brain regions, including the striatum, and found no correlation 
between DRD2 and BMI (Karlsson et al., 2015).  In a study using male Sprague-Dawley 
rats fed a HFD for eight weeks, there was a 42% decrease in DRD2 density in the dorsal 
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striatum (Narayanaswami et al., 2013).  Furthermore, when male and female offspring 
of female B6J mice bred with D2J males were fed a HFD for 12 weeks, both males and 
females showed a downregulation of DRD2 mRNA in the NAc core (Carlin et al., 2013).  
In contrast to these studies demonstrating a downregulation or no change in DRD2 
expression, several labs have reported an upregulation in DRD2 due to DIO.  In a study 
using male B6 mice fed a HFD for 20 weeks, there was an induction of DRD2 mRNA in 
the NAc core for mice fed a HFD, and a positive correlation between final body weight 
and DRD2 gene expression in this brain region (Huang et al., 2005b).  Another study 
using male B6 mice fed a HFD for 12 weeks showed that mice fed a HFD had increased 
DRD2 protein expression in the NAc (Sharma and Fulton, 2013).  Furthermore, when 
male B6 mice were fed a HFD for only 20 days, the DRD2 binding density was increased 
in the dorsal and ventral striatum (South and Huang, 2008).  Collectively, these studies 
provide evidence that DRD2 dysregulation is involved as either a cause (in humans) or 
consequence of DIO, however the direction of DRD2 alteration and pathophysiological 
mechanisms are poorly understood.  The DRD2 upregulation we discovered in male B6J 
mice in the striatum is consistent with reports in B6 mice described here.  Although we 
did not measure protein or binding density, our mRNA expression results are a unique 
and valuable contribution for understanding sex and strain differences in the study of 
DIO impact on neurobiology.  To the best of our knowledge, there are no prior published 
results regarding the impact of DIO on DRD2 expression in the olfactory bulb.  As with 
the striatum, we found that males were susceptible to mRNA dysregulation in the 
129 
 
olfactory bulb, but not females, possibly due to the protective effects of estrogen.  The 
opposite trends in mRNA dysregulation in the olfactory bulb for the B6J and D2J strains 
also highlight the important influence of genetics on the brain’s response to a state of 
DIO.   
Effect of Diet, Sex, and Strain on TH mRNA Expression 
TH is a rate limiting enzyme for the synthesis of dopamine, an important 
neurotransmitter involved in attention, memory, and cognition (Daubner et al., 2011).  
Furthermore, TH is required for proper motor function (Jang et al., 2017).  In the present 
study, we found a significant 3.8-fold upregulation of TH mRNA in the olfactory bulb for 
male D2J mice (Figure 4.12).  In the striatum, there was no impact of DIO on TH gene 
expression (Figure 4.10A).  However, we found a significant 8-fold increase in TH mRNA 
expression in the B6J strain compared to the D2J strain (Figure 4.10B).  Previous rodent 
studies have reported an upregulation in TH mRNA expression due to DIO in other brain 
regions.  For example, in a study using male B6 mice fed a HFD for 20 weeks, there was 
an upregulation of TH mRNA in the midbrain for mice fed a HFD, and a positive 
correlation between final body weight and TH gene expression in this brain region 
(Huang et al., 2005a).  A study using female C57BL6/129SVJ mice fed a HFD for 12 weeks 
discovered an induction of TH mRNA expression in the hypothalamus using microarray 
analysis and real time polymerase chain reaction techniques (Lee et al., 2010).  In 
contrast, other human and rodent studies have found a downregulation of TH 
expression due to DIO in various brain regions.  In a study using postmortem brain tissue 
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from male and female Caucasians and African Americans, TH mRNA was downregulated 
in the substantia nigra in obese tissue, but not overweight or control tissue (Wu et al., 
2017).  A study using male B6 mice fed a HFD for 13 weeks found that TH protein 
expression was downregulated in the midbrain and striatum for mice fed a HFD (Jang et 
al., 2017).  Furthermore, B6J male mice fed a HDF for just 6 weeks showed a decrease in 
TH protein expression in the striatum and midbrain, along with increased anxiety-like 
behavior in mice fed a HFD (Sharma et al., 2013).  The induction of TH mRNA that we 
found in the olfactory bulb of male D2J mice fed a HFD for 16 weeks indicates that the 
impact of DIO in this brain region is influenced by sex and strain.  Moreover, we reveal a 
substantial 8-fold strain effect in the striatum for this gene, emphasizing the influence of 
genetics on the expression of genes that are related to dopamine biology.  While we do 
not fully understand the neurophysiological mechanisms behind these sex and strain 
influences in TH gene expression, our preliminary findings provide a foundation for 
future work involving the impact of DIO on gene expression dysregulation in the brain. 
Effect of Diet, Sex, and Strain on BDNF mRNA Expression  
Brain-derived neurotrophic factor (BDNF) is a protein and growth factor involved 
in neuronal survival and brain plasticity (Bathina and Das, 2015; Miranda et al., 2019).  
The role of this neurotrophin in brain plasticity is correlated with learning, memory, and 
cognition in humans and rodents (Miranda et al., 2019).  High levels of BDNF are 
associated with neuronal protection (Almeida et al., 2005), while low levels have been 
associated with normal aging and pathological conditions such as Alzheimer’s disease 
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and Parkinson’s disease (Bathina and Das, 2015; Miranda et al., 2019).  Furthermore, 
BDNF is involved in the regulation of energy balance, and may act as an anorexigenic 
signaling molecule (Liu et al., 2014; Rios et al., n.d.).  As such, dysregulated levels of 
BDNF have been associated with obesity (Genzer et al., 2016).  In our study, DIO led to a 
2-fold increase in BDNF mRNA expression in B6J females in the olfactory bulb (Figure 
4.12).  Previous studies in rodent models have also shown an upregulation of BDNF 
mRNA or protein due to DIO, however, these results were in males and in different brain 
regions.  For example, a study using male B6 mice fed a HFD for eight weeks found that 
BDNF mRNA and protein was upregulated in whole brain tissue and in HT-4 
hippocampal neurons (Genzer et al., 2016).  In a study using male Long-Evans rats fed a 
HFD for 72 hours, the mRNA expression of BDNF was upregulated in the hippocampus 
(Gan et al., 2015).  In contrast, a study using female Fisher 344 rats fed a diet high in fat 
and sugar found that BDNF protein and mRNA expression in the hippocampus was 
reduced after 6 months of diet treatment (Molteni et al., 2002).  In our mice, we found 
no effect of DIO on hippocampal BDNF gene expression.  However, there was a 
significant sex effect in the D2J strain, with D2J female mice expressing 2.5-fold higher 
levels of BDNF mRNA compared to D2J males (Figure 4.11).  It has been reported 
previously that female rats express higher levels of BDNF in the hippocampus and cortex 
(Chan and Ye, 2017).  A study using Long-Evans male and female rats fed a control diet 
or HFD for four days and four weeks compared BDNF mRNA expression in the 
ventromedial nucleus of the hypothalamus (Liu et al., 2014).  At both time points, the 
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expression of BDNF was higher in females compared to males, regardless of diet.  In a 
study with male and female Wistar rats exposed to an enriched environment, females 
expressed higher levels of BDNF protein compared to males in both the control and 
enrichment-treated groups (Bakos et al., 2009).  The D2J strain in our study follow a 
similar pattern of increased hippocampal BDNF expression in females, however we did 
not observe the same effect in the B6J strain.  To gain a better understanding of these 
sex- and strain-dependent gene expression trends in different brain regions, future 
investigations could include an evaluation of BDNF expression levels for both mRNA and 
protein in several brain regions or subregions.  To the best of our knowledge, our study 
is the first study to reveal DIO-induced alterations in BDNF mRNA expression in the 
murine olfactory bulb.  As BDNF has an important role in neural plasticity and neuronal 
protection in several brain regions, including the olfactory bulb, this could have 
important health implications regarding the development of behavior disorders and 
neurodegenerative disease. 
Conclusion 
 In conclusion, the results from this study provide evidence that the impact of DIO 
on behavior, dopamine biology, and gene expression is influenced by sex and strain.   
Behavior evaluations showed that the B6J male mice fed a HFD were impacted the most 
through their display of reduced TDT throughout the entire open field test, reduced rate 
of habituation to a novel environment, lack of motivation to shred, and elevated anxiety 
levels in the open field.  Furthermore, DRD2 was upregulated only in male B6J mice in 
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the striatum due to DIO.  These results confirmed our hypothesis that male mice would 
be impacted more than females, and that the B6J strain would be less resistant to the 
effects of DIO compared to the D2J strain.  We did find, however, that dopamine biology 
alterations and gene expression dysregulation due to DIO were present in females and 
the D2J strain.  Dopamine clearance in the dorsal striatum was significantly reduced in 
both male and female D2J mice due to DIO, while in the NAc core, reductions in 
dopamine clearance occurred for male mice of both strains.  Our evaluation of mRNA 
gene expression demonstrated that DRD2 in the striatum and olfactory bulb and TH in 
the olfactory bulb were only dysregulated in males due to DIO.  BDNF mRNA expression, 
however, was only impacted by DIO in B6J females in the olfactory bulb.  The major 
strengths of this study were the inclusion of two strains and both sexes for the 
evaluation of sex and genetic influences on DIO impact in the brain, the use of multiple 
performance tests to assess the impact of DIO on a variety of behaviors, and the use of 
real time ex-vivo fast scan cyclic voltammetry to evaluate dopamine biology.  Moreover, 
we have provided novel information regarding the neurobiological impact of DIO on the 
olfactory bulb, a brain region that previously has not been investigated in the context of 
DIO with sex and strain influences.  In terms of study limitations, we measured mRNA 
expression exclusively, but not protein expression due to lack of tissue availability.  
Furthermore, while we carefully planned our behavior tests and tissue collection 
schedule to limit variability due circadian variation and estrous cycle, we could not 
perform all measurements at the same time of day due to the number of mice involved.  
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To account for this, we used a Latin square technique for all measurements and 
procedures to counterbalance potential variations that could impact our data.  In 
summary, our study provides evidence for important sex and strain influences on the 
impact of DIO-induced behavior alterations and neurobiology dysregulation.  As the 
incidence of obesity continues to rise worldwide, these data have key health 
implications related to debilitating behavior disorders.  The development of treatment 
and rehabilitation programs should therefore account for these apparent 









 The overarching goal of this research was to identify sex and strain influences on 
neurobiological and behavioral changes due to DIO.  In our first study (Chapter III), we 
investigated main effects and interactions between diet, sex, and strain on Fe, Mn, Cu, 
and Zn homeostasis and mRNA gene expression for proteins related to trace element 
metabolism and neurodegeneration.  In our second study (Chapter IV), we examined 
main effects and interactions between diet, sex, and strain on behavior, dopamine 
release and reuptake, and mRNA gene expression for proteins related to behavior and 
dopamine biology.  These studies revealed a heterogeneous effect of DIO on many of 
the neurobiological variables that we evaluated.  For example, in the striatum, Fe was 
significantly elevated in B6J female mice but not male mice due to DIO.  Similarly, in the 
hippocampus, Zn was increased in D2J males but deceased in D2J females.  There was 
also a dramatic induction of DMT1, alpha synuclein, and APP in this brain region due to 
DIO, but only in the B6J males.  Behavior assessments demonstrated that B6J male mice 
fed a HFD were impacted the most through their display of significantly reduced 
locomotion, reduced rate of habituation, lack of motivation, and elevated anxiety levels.  
Interestingly, these mice also showed a significant upregulation of DRD2.  Dopamine 
clearance in the dorsal striatum was significantly reduced in both male and female D2J
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mice due to DIO, while in the NAc core, reductions in dopamine clearance occurred for 
male mice of both strains fed HFD.   
In order to establish an effective DIO model in rodents, it is important to select   
appropriate diets and mouse strains.  Our experimental design included male and 
female B6J and D2J mouse strains which were randomly assigned to a LFD (10% kcal fat) 
or HFD (60% kcal lard-based fat) for 16 weeks.  These strains have been shown to 
respond efficiently to a HFD to create the DIO state (Alexander et al., 2006; 
Montgomery et al., 2013; West et al., 1992).  Our data corroborates with these reports, 
as males and females from both the B6J and D2J strains fed a HFD had significantly 
higher body weight and greater volume of adipose tissue at the end of the diet 
treatment.  There are other reports in the literature, however, that show D2J mice  
respond less efficiently to a HFD, including lack of weight gain (Kirk et al., 1995), delayed 
weight gain (Norris et al., 2016), or similar weight gain compared to a control LFD 
(Funkat et al., 2004).  These studies either initiated their diet treatments later than 
three weeks of age (typically 8-10 weeks old), or used a fat source other than lard in 
their HFD.  Using a diet with 60% lard as the source of fat and initiating our diet at 
approximately three weeks old provided a quick and effective DIO model for our study.  
It should be noted that other diets, such as a 45% HFD or a cafeteria style diet may 
mimic the human HFD more closely, however, the 60% HFD is widely used in animal 
research and produces physiological responses that are relevant to human physiology 
(Lutz and Woods, 2012). 
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 A limitation of our study is that our experimental design did not allow for the 
partitioning of effects of DIO versus HFD.  Instead, we can conclude that the impact we 
observed on trace element homeostasis, gene expression, etc., was due to a state of 
DIO induced by a high saturated fat diet, or restated, a combination of HFD and DIO.  To 
determine if the neurobiological and behavioral changes were due to components of 
the HFD and not a state of DIO, a future experimental design using a LFD and HFD 
treatment could incorporate a mouse strain that is resistant to weight gain, such as the 
AJ or Mbd2 -/- strains (Cheng et al., 2016; Surwit et al., 1995).  Furthermore, there are 
alternative methods to induce dietary obesity, such as a 45% HFD, cafeteria style diet, or 
high fat diets containing different unsaturated and saturated fatty acid blends (Barrett 
et al., 2016; Speakman, 2019).  Future experiments could utilize these different diets to 
provide a comparison of DIO states with different origins.   
Reviewing our findings from both studies, it is interesting that B6J male mice 
displayed significant behavior changes, increased Fe and Mn in the olfactory bulb, and 
dysregulation of mRNA expression of genes related to neurodegeneration.  These mice 
had significantly reduced locomotion throughout the open field test, decreased 
motivation in the nestlet shredding test, and increased anxiety-like behavior assessed by 
fecal boli quantity.  Furthermore, B6J males had significantly reduced habituation, a 
measure of learning and memory, which could indicate hippocampal impairment.  It is 
possible that these behavior changes are related to the dysregulated mRNA expression 
that occurred in B6J males due to DIO.  For example, there was a substantial induction 
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of DMT1, alpha synuclein, and APP in the hippocampus for B6J males, and an 
upregulation of DRD2 in the striatum.  The induction of alpha synuclein and APP could 
be a sign of early neurodegeneration, which could manifest as reduced habituation rate.  
A follow up experiment should include protein testing for alpha synuclein and APP in the 
hippocampus.  Furthermore, an evaluation of oxidative stress, such as the F2-
isoprostane test for lipid peroxidation, should be performed in the hippocampus to test 
for signs of neurodegeneration.  The upregulation of DRD2 in the striatum indicates 
dysregulation of dopamine biology, which may be associated with the reduction of 
motor activity in the open field and lack of motivation to shred.  Moreover, B6J males 
had a reduced rate of dopamine reuptake in the NAc core, indicating a disruption of the 
reward circuitry in these mice.  Future work with B6J mice should include behavior 
testing using the elevated plus maze, which may be a more accurate test for anxiety 
compared to center entries in an open field.  The nestlet test for motivation could be 
modified to extend the time from 30 minutes to 1-2 hours, which may provide a better 
determination of latency to shred.  Additionally, this test can be recorded to monitor 
other behaviors such as locomotion, grooming, and rearing.  Since the nestlet shredding 
test is relatively easy to set up and provides a quantitative measurement to reduce 
subjectivity, this test is recommended for future behavior assessments.  The open field 
test also provides several useful behavior assessments; however, our current apparatus 
is not large enough for the obese mice.  Most labs use a 40” x 40” surface area made of 
opaque plastic for easy cleaning.  Our surface measures 29” by 29” and is lined with 
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paper.  Although the paper creates an opaque arena, the mice can dig into the paper, 
which occurred often with the D2J strain.  Furthermore, the sides of our testing cubes 
displayed a reflection, which could impact the behavior of the mice.  Nevertheless, our 
findings demonstrate that B6J male mice are a good model for evaluating the effects of 
DIO on behavior change and neurobiological alterations. 
In Chapters III and IV, our results demonstrate that D2J females have a unique 
response to DIO.  D2J females fed a HFD were the only group to display a decrease in Zn 
in the hippocampus and the only group to have a negative discrimination index in the 
learning and memory test.  For the assessment of correlations with body weight, the D2J 
females had a positive correlation between weight and Fe and weight and DMT1 
expression in the striatum.  In the hippocampus, D2J females showed positive 
correlations between weight and alpha synuclein and weight with APP expression, and 
showed a negative correlation with weight and Zn.  Furthermore, the D2J group had a 
negative correlation between weight and TDT and weight with velocity.  These 
correlations are useful for understanding relationships between weight and 
neurobiological changes, and provide evidence that excess body weight could be a 
direct cause of these alterations.  Although other treatment groups appeared to have 
statistically significant correlations between body weight and different neurobiological 
variables, the data were often clustered and could not be characterized as a linear 
relationship.  The Zn reduction in the hippocampus of female D2J mice with the negative 
discrimination index for learning and memory could be investigated further in future 
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studies.  It is possible that dysregulated Zn due to DIO is associated with reductions in 
cognition.  There are alternative methods for evaluating memory and cognition that 
may provide a better understanding of the effects of DIO on the hippocampus, including 
the Morris water maze test (Cordner and Tamashiro, 2015).  Moreover, the novel object 
test can be modified to change the spatial arrangement of objects rather than 
introducing a new object, which has also been shown to reflect neurobiological changes 
in the hippocampus (Cordner and Tamashiro, 2015).  Future work could also include an 
evaluation of the prefrontal cortex for trace element dysregulation and gene expression 
alterations, as this brain region is also involved in memory, learning, and cognition 
(Cordner and Tamashiro, 2015).  Furthermore, the impact of DIO on gene and protein 
expression for ZIP and ZRT transporters could be investigated in the hippocampus and 
prefrontal cortex to explore potential links to dysregulated Zn in the brain. 
The olfactory bulb is a brain region that has not been studied extensively in the 
context of DIO.  A recent study in Parkinson’s disease patients found that Fe was 
elevated in this brain region (Gardner et al., 2017).  In a study using brain tissue from 
Alzheimer’s disease patients, both Fe and Zn were increased in the olfactory bulb 
(Samudralwar et al., 1995).  Another study reported alpha synuclein upregulation in the 
olfactory bulb in the early development of Parkinson’s disease (Adler and Beach, 2016).  
In our lab, we found previously that DIO in male B6J mice can lead to upregulated alpha 
synuclein and increased Fe in the midbrain, both of which are hallmarks of 
neurodegeneration (Han et al., 2019).  Based on these studies, we were interested in 
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exploring the effects of DIO on olfactory bulb neurobiology.  We found a significant 
increase in Fe and Mn in B6J male mice fed a HFD, but no increases in Zn in this brain 
region.  It is interesting that the dysregulation of trace elements in the olfactory bulb 
only impacted the male B6J mice.  In contrast, the impact of DIO on gene expression 
alterations in the olfactory bulb predominantly affected D2J males.  D2J males fed a HFD 
exhibited significantly upregulated DMT1, alpha synuclein, APP, DRD2, and TH in this 
brain region.  The only other treatment group that was also affected was the B6J 
females with an upregulation of BDNF in the olfactory bulb for mice fed a HFD.  These 
studies provide evidence that the olfactory bulb is a brain region that is impacted by a 
state of DIO in sex and strain dependent manner.  The olfactory bulb is relatively easy to 
separate from the rest of the brain during the dissection process, making it simple to 
isolate and store for future DIO studies.  Future work could include an evaluation of DIO-
associated trace element dysregulation and gene expression alteration over time to 
study the effects of DIO on aging in this brain region.  Since there were clear differences 
in neurobiological disturbances between males and females and between the B6J and 
D2J strain, both sexes of these strains could be used for future work.  However, since 
female mice appeared to be more resistant to DIO-associated alterations in the 
olfactory bulb, it may be justified to use only males for the comparison of strain 
differences. 
In our study of gene expression, we selected the gene that was recommended 
for best coverage to obtain a broad scope understanding of each gene.  However, this 
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does not differentiate between different isoforms that may exist for each gene.  Future 
work in our lab may include an assessment of DIO-associated alterations of specific 
isoforms.  For example, DRD2 has two isoforms, D2L and D2S, with the long D2L 
predominantly expressed in the brain (Baik, 2013).  Recent studies in humans and mice 
show that these isoforms are differentially expressed in addiction studies (Moyer et al., 
2011) and may have different functions in vivo (Usiello et al., 2000; Wang et al., 2000).  
DMT1 has four known isoforms: 1A/(+IRE), 1A/(-IRE),  1B/(+IRE), 1B/(-IRE) that are 
expressed at different levels (Skjørringe et al., 2015), however, the trace element 
transport function of all four isoforms is similar (Mackenzie et al., 2007).  Nevertheless, 
a more comprehensive examination of DMT1 gene expression based on specific 
isoforms may provide a better understanding of the specific mechanisms involved in 
obesity-induced gene expression alteration.  Furthermore, future studies with IRP in the 
brain should include IRP2, which has been found recently to have a critical impact on 
brain iron metabolism (Zhang et al., 2014), neurodegeneration (Ghosh et al., 2015), and 
behavior (Zumbrennen-Bullough et al., 2014).  A case study performed on a 16-year-old 
male with evidence of neurodegeneration was found to lack the gene coding for IRP2 
(Costain et al., 2019), and is the first study to show IRP2 dysregulation in the human 
brain. 
In summary, our findings provide evidence for important sex and strain 
differences on the impact of DIO-associated behavior alterations and neurobiology 
dysregulation.  As the incidence of obesity continues to rise worldwide, these findings 
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have key health implications related to debilitating behavior disorders and the 
development of neurodegenerative disease that can be triggered by an energy dense 
diet and a state of DIO.  Future targeted therapies for obesity, behavior impediments, 
and brain diseases may need to be specifically tailored to account for sex and genetics 
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Supplementary Table A1.  Rodent Diets D12450J and D12492 from Research Diets, Inc. 
Ingredient 
D12450J (10% kcal from fat) D12492 (60% kcal from fat) 
Grams Kilocalories Grams Kilocalories 
Casein, Lactic, 30 mesh 200.00 800.00 200.00 800.00 
L-Cysteine 3.00 12.00 3.00 12.00 
Cornstarch 506.20 2024.80 - - 
Lodex 10 125.00 500.00 125.00 500.00 
Fine granulated sucrose 72.80 291.20 72.80 291.20 
Solka Floc fiber, FCC200 50.00 200.00 50.00 200.00 
Soybean oil, USP 25.00 225.00 25.00 225.00 
Lard 20.00 180.00 245.00 2205.00 
Mineral mix S10026B 50.00 - 50.00 - 
Choline bitartrate 2.00 - 2.00 - 
Vitamin mix V10001C 1.00 - 1.00 - 
Yellow dye FD&C #5 0.04 - - - 
Blue dye FD&C #1 0.01 - 0.05 - 
     
Total 1055.05 4233.00 773.85 4233.20 
Caloric Summary     
Fat  10% kcal  60% kcal 
Carbohydrate  70% kcal  20% kcal 
Protein  20% kcal  20% kcal 
Energy Density  3.82 kcal/g  5.21 kcal/g 
A description of diets used for the 16-week treatment.  D12450J (10% kcal from fat) represents the LFD 
and D12492 (60% kcal from fat) represents the HFD.  Saturated fat in the form of lard is the major source 







Supplementary Table A2.  Trace element Concentrations in Specific Brain Regions of 





Iron Manganese Copper Zinc 
Hippocampus BML 373 ± 3 6.82 ± 0.48  118.5 ± 1.3 367 ± 32 
 BMH 431 ± 32 7.28 ± 0.41 134.3 ± 11.3 409 ± 75 
 BFL 435 ± 22 7.00 ± 0.58 119.4 ± 16.6 350 ± 27 
 BFH 470 ± 35 8.81 ± 1.19 176.7 ± 20.4 473 ± 59 
 DML 357 ± 24 7.41 ± 0.96 122.1 ± 6.3 338 ± 36 
 DMH 386 ± 24 6.95 ± 0.81 118.3 ± 15.8 549 ± 94 
 DFL 452 ± 34 8.03 ± 0.59 157.0 ± 8.3 581 ± 73 
 DFH 405 ± 36 6.76 ± 0.83 131.6 ± 12.6 370 ± 11 
Midbrain BML 479 ± 96 10.00 ± 0.96 109.0 ± 17.0 400 ± 95 
 BMH 369 ± 34 7.72 ± 0.69 82.0 ± 7.2 251 ± 27 
 BFL 444 ± 24 10.58 ± 1.09 98.4 ± 5.5 340 ± 11 
 BFH 443 ± 49 9.43 ± 1.46 88.5 ± 10.0 314 ± 49 
 DML 551 ± 85 12.59 ± 1.83 125.2 ± 16.5 543 ± 118 
 DMH 470 ± 83 11.53 ± 2.27 76.9 ± 3.0 403 ± 118 
 DFL 473 ± 105 12.58 ± 1.49 124.8 ± 13.5 407 ± 81 
 DFH 402 ± 38 11.49 ± 1.30 85.6 ± 11.9 379 ± 103 
Olfactory Bulb BML 572 ± 66 12.33 ± 0.28 102.3 ± 8.3 223 ± 26 
 BMH 1252 ± 282 20.45 ± 4.49 118.3 ± 7.5 275 ± 30 
 BFL 931 ± 31 18.15 ± 1.84 126.1 ± 10.0 278 ± 19 
 BFH 818 ± 116 16.66 ± 2.02 116.2 ± 17.1 209 ± 11 
 DML 758 ± 82 16.78 ± 1.89 127.0 ± 14.6 306 ± 60 
 DMH 844 ± 145 14.99 ± 1.90 108.0 ± 8.4 236 ± 29 
 DFL 887 ± 92 16.76 ± 1.82 113.7 ± 9.8 281 ± 36 
 DFH 885 ± 88 14.45 ± 1.25 121.4 ± 15.3 334 ± 44 
Striatum BML 448 ± 63 10.15 ± 1.04 129.8 ± 17.5 712 ± 157 
 BMH 409 ± 9 9.44 ± 0.45 97.1 ± 0.8 710 ± 141 
 BFL 454 ± 40 8.44 ± 0.70 107.4 ± 12.5 716 ± 175 
 BFH 598 ± 48 10.32 ± 1.30 111.4 ± 28.5 563 ± 100 
 DML 381 ± 35 8.04 ± 0.55 94.5 ± 8.8 696 ± 185 
 DMH 406 ± 6 8.24 ± 0.45 93.1 ± 2.1 569 ± 46 
 DFL 335 ± 32 9.51 ± 0.73 95.6 ± 11.2 731 ± 113 
 DFH 410 ± 39 9.58 ± 0.67 123.7 ± 11.5 552 ± 54 
Data are represented as mean ± SEM in units of g trace element/g protein.  Treatment group letter 




Supplementary Table A3.  Striatum mRNA Gene Expression ΔCt Values 
Treatment 
Group 
DMT1 IRP1 Cp aSyn D2 TH 
BML 17.37 ± 0.06 18.37 ± 0.13 18.44 ± 0.27 9.81 ± 0.12 20.71 ± 0.10 16.75 ± 0.32 
BMH 17.47 ± 0.08 18.36 ± 0.15 18.20 ± 0.24 10.07 ± 0.15 19.68 ± 0.41 16.36 ± 0.18 
BFL 17.00 ± 0.21 18.06 ± 0.23 18.09 ± 0.12 14.07 ± 0.14 18.47 ± 0.28 16.69 ± 0.38 
BFH 17.22 ± 0.07 18.14 ± 0.05 17.92 ± 0.18 14.42 ± 0.07 18.34 ± 0.42 16.43 ± 0.20 
DML 17.43 ± 0.14 18.20 ± 0.16 18.07 ± 0.13 14.38 ± 0.14 16.67 ± 0.57 19.03 ± 0.41 
DMH 17.36 ± 0.15 18.09 ± 0.09 18.10 ± 0.08 14.31 ± 0.19 16.64 ± 0.30 19.33 ± 0.34 
DFL 17.36 ± 0.02 18.14 ± 0.08 19.00 ± 0.16 14.32 ± 0.21 17.72 ± 0.07 19.57 ± 0.25 
DFH 17.17 ± 0.04 18.09 ± 0.06 18.38 ± 0.16 14.43 ± 0.03 17.26 ± 0.15 19.72 ± 0.32 
Data are represented as mean ± SEM.  ΔCt values were normalized using the endogenous control, 18S.  
Higher ΔCt values indicate lower levels of gene expression.  The ΔCt values reported here were used to 
determine fold change in gene expression when comparing LFD (control) to HFD or male (control) to 
female using the comparative Ct method.  Treatment group letter codes: B=B6J, D=D2J, M=male, 
F=female, L=low fat diet, H=high fat diet.  DMT1=divalent metal transporter 1, IRP1=iron regulatory 




Supplementary Table A4.  Hippocampus mRNA gene expression ΔCt values 
Treatment 
Group 
DMT1 Cp CTR1 aSyn APP BDNF 
BML 16.79 ± 0.21 12.91 ± 0.08 18.49 ± 0.17 13.50 ± 0.32 10.55 ± 0.41 19.12 ± 0.28 
BMH 14.56 ± 0.45 13.61 ± 0.20 18.56 ± 0.18 10.74 ± 0.40 7.30 ± 0.37 18.89 ± 0.26 
BFL 17.51 ± 0.06 18.19 ± 0.23 18.18 ± 0.36 15.04 ± 0.39 8.51 ± 0.11 19.11 ± 0.26 
BFH 17.42 ± 0.12 18.05 ± 0.20 18.10 ± 0.22 14.25 ± 0.08 8.09 ± 0.11 18.67 ± 0.08 
DML 16.96 ± 0.12 17.86 ± 0.19 18.23 ± 0.25 14.34 ± 0.35 10.86 ± 0.21 19.16 ± 0.17 
DMH 17.24 ± 0.07 17.51 ± 0.23 18.27 ± 0.10 14.14 ± 0.31 11.03 ± 0.10 19.39 ± 0.43 
DFL 17.18 ± 0.16 18.07 ± 0.19 19.56 ± 0.22 13.98 ± 0.05 11.10 ± 0.13 17.92 ± 0.18 
DFH 17.02 ± 0.10 18.02 ± 0.14 19.20 ± 0.27 13.75 ± 0.90 10.76 ± 0.08 17.95 ± 0.13 
Data are represented as mean ± SEM.  ΔCt values were normalized using the endogenous control, 18S.  
Higher ΔCt values indicate lower levels of gene expression.  The ΔCt values reported here were used to 
determine fold change in gene expression when comparing LFD (control) to HFD or male (control) to 
female using the comparative Ct method.  Treatment group letter codes: B=B6J, D=D2J, M=male, 
F=female, L=low fat diet, H=high fat diet.  DMT1=divalent metal transporter 1, Cp=ceruloplasmin, 
CTR1=copper transporter protein 1, aSyn=alpha synuclein, APP = amyloid precursor protein, BDNF = brain-




Supplementary Table A5.  Olfactory Bulb mRNA Gene Expression ΔCt Values 
Treatment 
Group 
DMT1 aSyn APP BDNF D2 TH 
BML 14.01 ± 0.20  13.40 ± 0.03 11.01 ± 0.23 19.04 ± 0.35 19.55 ± 0.16 14.70 ± 0.74 
BMH 14.40 ± 0.20 13.60 ± 0.04 10.97 ± 0.21 19.01 ± 0.17 20.84 ± 0.46 15.45 ± 0.55 
BFL 12.82 ± 0.36 12.25 ± 0.31 11.40 ± 0.34 19.82 ± 0.28 18.77 ± 0.50 13.82 ± 0.25 
BFH 12.79 ± 0.40 12.50 ± 0.25 11.68 ± 0.40 18.87 ± 0.35 19.86 ± 0.69 14.41 ± 0.47 
DML 18.23 ± 0.05 14.47 ± 0.21 8.89 ± 0.03 19.92 ± 0.19 21.28 ± 0.24 16.34 ± 0.33 
DMH 17.27 ± 0.34 13.83 ± 0.02 7.54 ± 0.29 20.04 ± 0.24 19.68 ± 0.48 14.67 ± 0.66 
DFL 17.85 ± 0.38 14.38 ± 0.23 12.27 ± 0.44 20.55 ± 0.20 20.74 ± 0.25 15.80 ± 0.15 
DFH 17.79 ± 0.15 14.26 ± 0.07 12.62 ± 0.38 20.11 ± 0.11 20.62 ± 0.33 15.27 ± 0.19 
Data are represented as mean ± SEM.  ΔCt values were normalized using the endogenous control, 18S.  
Higher ΔCt values indicate lower levels of gene expression.  The ΔCt values reported here were used to 
determine fold change in gene expression when comparing LFD (control) to HFD or male (control) to 
female using the comparative Ct method.  Treatment group letter codes: B=B6J, D=D2J, M=male, 
F=female, L=low fat diet, H=high fat diet.  DMT1=divalent metal transporter 1, aSyn=alpha synuclein, APP 




Supplementary Table A6.  Midbrain mRNA Gene Expression ΔCt Values 
Treatment Group aSyn Cp TH 
BML 15.34 ± 0.32 18.52 ± 0.27 18.32 ± 1.44 
BMH 15.19 ± 1.14 18.24 ± 0.59 17.95 ± 1.42 
DML 13.76 ± 1.48 17.52 ± 0.20 16.66 ± 0.22 
DMH 12.83 ± 0.46 17.13 ± 0.59 17.30 ± 1.36 
Data are represented as mean ± SEM.  ΔCt values were normalized using the endogenous control, 18S.  
Higher ΔCt values indicate lower levels of gene expression.  The ΔCt values reported here were used to 
determine fold change in gene expression when comparing LFD (control) to HFD or male (control) to 
female using the comparative Ct method.  Treatment group letter codes: B=B6J, D=D2J, M=male, L=low 






Supplementary Table A7.  Total Distance Traveled for Male and Female B6J and D2J 




Total Distance Traveled (m) per Five-min Timeframe 
0-5 5-10 10-15 15-20 20-25 25-30 
BML 18.1 ± 1.2 12.3 ± 0.9 11.6 ± 0.4 10.4 ± 0.5 11.3 ± 0.8 9.7 ± 0.7 
BMH 11.2 ± 0.8 8.3 ± 0.6 8.0 ± 0.5 7.9 ± 0.5 6.7 ± 0.3 6.5 ± 0.3 
BFL 15.7 ± 1.2 11.8 ± 0.7 11.1 ± 0.6 12.3 ± 0.5 10.9 ± 0.6 10.9 ± 0.8 
BFH 12.9 ± 0.7 9.3 ± 0.6 8.8 ± 0.6 9.6 ± 0.7 8.7 ± 0.9 8.6 ± 0.8 
DML 8.7 ± 1.2 9.9 ± 1.4 10.4 ± 0.8 9.8 ± 0.8 7.6 ± 1.2 6.8 ± 1.1 
DMH 5.9 ± 0.6 7.5 ± 0.8 6.3 ± 1.0 4.9 ± 0.7 4.1 ± 0.7 4.2 ± 1.0 
DFL 7.8 ± 0.5 10.2 ± 1.7 7.3 ± 0.7 5.3 ± 1.0 4.5 ± 0.5 6.6 ± 1.3 
DFH 7.1 ± 0.9 7.1 ± 1.0 5.2 ± 0.6 6.9 ± 1.1 3.1 ± 0.4 3.3 ± 0.6 
Data are represented as mean ± SEM. Treatment group letter codes: B=B6J, D=D2J, M=male, F=female, 
L=low fat diet, H=high fat diet. 
 
 





Velocity (mm/s) per Five-min Timeframe 
0-5 5-10 10-15 15-20 20-25 25-30 
BML 60.4 ± 3.8 40.6 ± 3.4 38.6 ± 1.3 35.1 ± 1.8 38.0 ± 2.6 32.6 ± 2.4 
BMH 37.4 ± 2.8 27.9 ± 2.2 25.9 ± 1.5 26.6 ± 1.7 22.4 ± 1.0 21.7 ± 0.9 
BFL 52.7 ± 4.1 39.4 ± 2.2 37.0 ± 1.8 41.1 ± 1.5 36.3 ± 1.8 36.0 ± 2.8 
BFH 43.3 ± 2.6 31.1 ± 2.1 29.2 ± 2.1 31.9 ± 2.4 29.2 ± 2.8 29.0 ± 2.6 
DML 25.8 ± 2.7 29.9 ± 4.4 33.1 ± 2.6 31.5 ± 2.8 25.0 ± 4.6 18.0 ± 3.6 
DMH 19.3 ± 2.0 25.1 ± 2.7 20.9 ± 3.4 16.6 ± 2.1 13.8 ± 2.5 13.9 ± 3.3 
DFL 26.0 ± 1.7 34.3 ± 5.8 24.4 ± 2.2 17.9 ± 3.2 15.1 ± 1.6 21.9 ± 4.4 
DFH 23.8 ± 2.9 23.6 ± 3.4 17.4 ± 2.0 21.4 ± 4.6 10.2 ± 1.4 10.8 ± 2.1 
Data are represented as mean ± SEM. Treatment group letter codes: B=B6J, D=D2J, M=male, F=female, 




Supplementary Table A9.  Behavior Tests for Exploration, Anxiety, Compulsivity, 











BML 263 ± 32 5.33 ± 0.75 25.2 ± 1.6 2.38 ± 0.76 0.057 ± 0.068 
BMH 163 ± 25 7.78 ± 0.60 22.4 ± 1.8 0.11 ± 0.04 0.146 ± 0.067 
BFL 152 ± 32 4.11 ± 0.51 22.2 ± 1.6 0.31 ± 0.14 0.090 ± 0.055 
BFH 127 ± 31 4.67 ± 0.76 19.3 ± 1.3 0.61 ± 0.20 0.166 ± 0.069 
DML 156 ± 45 5.89 ± 0.72 7.9 ± 2.1 3.00 ± 0.74 0.098 ± 0.087 
DMH 101 ± 18 5.38 ± 0.78 9.8 ± 3.3 2.50 ± 0.63 0.101 ± 0.179 
DFL 142 ± 41 5.33 ± 1.03 10.7 ± 3.0 3.73 ± 0.92 0.081 ± 0.136 
DFH 169 ± 27 5.44 ± 0.63 6.6 ± 2.2 1.62 ± 0.48 -0.12 ± 0.098 
Habituation measures exploration and memory with learning.  Fecal boli and center entries measure 
anxiety.  Nestlet shredding measures compulsivity, motivation, and welfare.  Novel Object Discrimination 
Index measures learning and memory.  Data are represented as mean ± SEM.  For the center entries test, 
data from the first five-minute segment in the open field were used for the B6J mice analysis, and data 
from the second five-minute segment was used for the D2J analysis.  These time frames were selected 
based on greatest total distance travelled for each strain.  Treatment group letter codes: B=B6J, D=D2J, 
M=male, F=female, L=low fat diet, H=high fat diet.  DI = discrimination index. 
 
 
Supplementary Table A10.  Dopamine Release and Reuptake in the Striatum 
Treatment Group 
Dopamine 




Release VS  
Dopamine 
Reuptake VS 
BML 151.5 ± 18.3 3.22 ± 0.32 174.0 ± 11.6 2.89 ± 0.32 
BMH 136.8 ± 8.5 3.73 ± 0.36 180.8 ± 13.6 1.63 ± 0.19 
BFL 128.3 ± 6.1 4.10 ± 0.43 185.8 ± 10.7 2.23 ± 0.33 
BFH 163.6 ± 9.3 3.89 ± 0.46 187.2 ± 7.0 2.57 ± 0.63 
DML 133.7 ± 6.7 4.81 ± 0.56 196.5 ± 11.5 3.53 ± 0.43 
DMH 149.0 ± 8.7 3.41 ± 0.35 206.8 ± 8.7 2.13 ± 0.24 
DFL 140.0 ± 7.8 4.74 ± 0.64 188.0 ± 26.1 3.64 ± 0.58 
DFH 145.9 ± 7.3 3.44 ± 0.32 214.1 ± 6.8 3.12 ± 0.24 
Data are represented as mean ± SEM.  Dopamine release was calculated as a ratio of five-pulse release to 
one-pulse release to provide information regarding the dynamic capacity to release dopamine from the 
dorsal and ventral striatum.  Units for dopamine release are % pulse.  Dopamine reuptake is measured as 
maximal rate of dopamine uptake (Vmax) by dopamine transporter.  Units for reuptake are mol/L·s.  DS 
= dorsal striatum, VS = ventral striatum.  Treatment group letter codes: B=B6J, D=D2J, M=male, F=female, 











Figure B1.  Open Field Set Up.  Four acrylic cubes were used for the open field and novel object 
recognition tests with one mouse placed in each cube.  Each cube is assigned an individual camera with 





Figure B2.  Open Field Single Cube.  Each acrylic cube measures 29 cm x 29 cm x 38 cm.  Mice were placed 






Figure B3.  Objects Used for Novel Object Recognition Test.  Nonporous objects were chosen with similar 
size and color but distinct shape.  Two owls were used in phase II (familiarization phase).  One owl and 
one squirrel were used for phase III (testing phase), with the owl as the familiar object and the squirrel as 






Figure B4.  Novel Object Recognition Test.  Phase I (A) is the 30-minute habituation phase for mice to 
gain exposure to the testing arena.  Phase II (B) is the familiarization phase for mice to explore an identical 
object for five minutes.  Phase III (C) is the testing phase for mice to explore either the familiar object or 





Figure B5.  Nestlet Shredding Set Up.  Polycarbonate mouse cages were filled with bedding to a depth of 
0.5 cm.  Pre-weighed cotton nestlet squares (5.8cm x 5.8cm x 0.2cm) were placed in the middle of each 
cage before placing each mouse inside.  Fitted filter tops were used to enclose the cage during testing 





Figure B6.  Nestlet Shredding Result Example.  After each 30-minute nestlet shredding test, shredded 
nestlet material was carefully removed from each nestlet square. Individual nestlets were dried for 24 
hours before weighing.  Percent shredding was calculated for each mouse as a measure of motivation and 
compulsivity. 
